RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Animal Disease Models
Accession: DOID:9006205
browse the term
Definition: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Synonyms: exact_synonym: Animal Disease Model
primary_id: MESH:D004195
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcb4
ATP binding cassette subfamily B member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16472600 PMID:29808285
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc6
ATP binding cassette subfamily C member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23415960
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
G
Acsl4
acyl-CoA synthetase long-chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Ahcy
adenosylhomocysteinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aif1
allograft inflammatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25658812 PMID:32045588
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16642209 PMID:17963606
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29031482
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Alpl
alkaline phosphatase, biomineralization associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27466191
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
App
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746438 PMID:16651627 PMID:25881725 PMID:27567873 PMID:31939705
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Aqp4
aquaporin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Arg1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Artn
artemin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
G
Atp7a
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17483305
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp7b
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11803042 PMID:15911138 PMID:21146535 PMID:21364284
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Axin2
axin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25462787
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Bzw2
basic leucine zipper and W2 domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26831068
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Calca
calcitonin-related polypeptide alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Caly
calcyon neuron-specific vesicular protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30753204
NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551
G
Car2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15816485
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Cct5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
G
Cdh2
cadherin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cldn11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
G
Cln6
CLN6, transmembrane ER protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23789114
NCBI chr 8:63,303,356...63,318,360
Ensembl chr 8:63,303,029...63,318,360
G
Cln8
CLN8, transmembrane ER and ERGIC protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22302580
NCBI chr16:74,749,662...74,759,553
Ensembl chr16:74,749,662...74,759,774
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23072421
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cnr2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27317300
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Col2a1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17299831
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27737899
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csrp3
cysteine and glycine rich protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctu1
cytosolic thiouridylase subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 1:94,115,431...94,121,224
Ensembl chr 1:94,115,420...94,121,221
G
Ctu2
cytosolic thiouridylase subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr19:50,539,184...50,544,629
Ensembl chr19:50,539,352...50,544,623
G
Dek
DEK proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
G
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29698737
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dmd
dystrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22795790 PMID:26930420 PMID:30074247
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Dstn
destrin, actin depolymerizing factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379
G
Eif2b1
eukaryotic translation initiation factor 2B subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:32,025,593...32,033,848
Ensembl chr12:32,025,557...32,046,601
G
Eif3e
eukaryotic translation initiation factor 3 subunit E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:74,339,848...74,372,483
Ensembl chr 7:74,339,828...74,373,096
G
Elp3
elongator acetyltransferase complex subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr15:39,754,635...39,816,482
Ensembl chr15:39,754,632...39,816,445
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22302033
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20962747
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21127298
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22536412 PMID:26590112
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fbl
fibrillarin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
G
Fkbp11
FKBP prolyl isomerase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gar1
GAR1 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gata4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
Gfap
glial fibrillary acidic protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27585885
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
G
Golm1
golgi membrane protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057
G
Gpi
glucose-6-phosphate isomerase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grwd1
glutamate-rich WD repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
G
H1f10
H1.10 linker histone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
G
Hand2
heart and neural crest derivatives expressed 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr16:32,917,448...32,920,791
Ensembl chr16:32,917,823...32,919,891
G
Hbb
hemoglobin subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23975182 PMID:29255069
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hbegf
heparin-binding EGF-like growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21937979
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747469
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Hells
helicase, lymphoid specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Hk1
hexokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Hk2
hexokinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Hmgb2
high mobility group box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27469509
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16845661
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27580383 PMID:28411859
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Impdh2
inosine monophosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
G
Ipo4
importin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
G
Ipo5
importin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
G
Irak4
interleukin-1 receptor-associated kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28003376
NCBI chr 7:125,682,502...125,708,294
Ensembl chr 7:125,682,488...125,717,837
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37047547
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Kl
Klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25550330
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Kpna2
karyopherin subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26390243 PMID:27588471 PMID:33380422
NCBI chr 4:178,185,418...178,218,484
G
Ldha
lactate dehydrogenase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Lef1
lymphoid enhancer binding factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35235096
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lmnb1
lamin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapt
microtubule-associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24556215
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mecp2
methyl CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28592917 PMID:33010341
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mir219a1
microRNA 219a-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35962723
NCBI chr20:4,829,687...4,829,796
Ensembl chr20:4,829,687...4,829,796
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21051829
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mre11
MRE11 homolog, double strand break repair nuclease
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
G
Mrpl12
mitochondrial ribosomal protein L12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrps5
mitochondrial ribosomal protein S5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:114,821,046...114,837,291
Ensembl chr 3:114,821,046...114,837,291
G
Mx1
MX dynamin like GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mybpc3
myosin binding protein C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25566086
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:151,656,056...151,661,304
Ensembl chr X:151,656,056...151,661,252
G
Ncl
nucleolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:27012417 PMID:29255069
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nop56
NOP56 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
G
Nop58
NOP58 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
G
Nphp3
nephrocystin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12089381
NCBI chr 8:104,621,908...104,662,383
Ensembl chr 8:104,621,864...104,662,383
G
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Npm3
nucleophosmin/nucleoplasmin, 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
G
Nppb
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29142166 PMID:32062620
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nudt21
nudix hydrolase 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33812996
NCBI chr20:31,811,817...31,838,562
Ensembl chr20:31,811,817...31,838,561
G
P2rx7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27466191
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
Pabpc4
poly(A) binding protein, cytoplasmic 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:135,563,142...135,578,985
Ensembl chr 5:135,563,562...135,578,979
G
Pcbd1
pterin-4 alpha-carbinolamine dehydratase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
G
Pde6b
phosphodiesterase 6B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17213800
NCBI chr14:1,323,310...1,366,450
Ensembl chr14:1,323,310...1,366,450
G
Pign
phosphatidylinositol glycan anchor biosynthesis, class N
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25812446
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Pkd1
polycystin 1, transient receptor potential channel interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25877301
NCBI chr10:13,573,779...13,621,138
Ensembl chr10:13,573,021...13,621,128
G
Polr1d
RNA polymerase I and III subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:7,970,592...8,004,157
Ensembl chr12:7,970,595...8,005,624
G
Ppan
peter pan homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
G
Prkcg
protein kinase C, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15882845
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Psat1
phosphoserine aminotransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psen1
presenilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16651627 PMID:27567873
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
G
Pth
parathyroid hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30639440
NCBI chr 1:167,508,121...167,511,530
Ensembl chr 1:167,508,598...167,511,530
G
Rangrf
RAN guanine nucleotide release factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:53,677,467...53,678,880
Ensembl chr10:53,677,467...53,678,840
G
Rcl1
RNA terminal phosphate cyclase-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
G
Rfc4
replication factor C subunit 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
Rhoa
ras homolog family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25783350
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
G
Rpl10a
ribosomal protein L10A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357
G
Rpl13a
ribosomal protein L13A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
G
Rpl27a
ribosomal protein L27A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:163,539,732...163,542,771
G
Rpl36a
ribosomal protein L36A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:97,766,179...97,768,892
Ensembl chr X:97,766,179...97,768,892
G
Rpsa
ribosomal protein SA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
G
Rrm1
ribonucleotide reductase catalytic subunit M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rrm2
ribonucleotide reductase regulatory subunit M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rrs1
ribosome biogenesis regulator 1 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
G
Rsad2
radical S-adenosyl methionine domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
S100a10
S100 calcium binding protein A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21682946
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100b
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12888777 PMID:34792689
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Satb1
SATB homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Serpine1
serpin family E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21051829
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sh3pxd2b
SH3 and PX domains 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28719234
NCBI chr10:16,918,611...17,027,499
Ensembl chr10:16,918,679...17,005,170
G
Shmt1
serine hydroxymethyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Slc15a2
solute carrier family 15 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
G
Slc19a1
solute carrier family 19 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
G
Slc29a1
solute carrier family 29 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27567601
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc4a4
solute carrier family 4 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc4a7
solute carrier family 4 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
G
Smarcc1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
G
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21892157 PMID:26075822
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Snord22
small nucleolar RNA, C/D box 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
G
Snrpg
small nuclear ribonucleoprotein polypeptide G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:118,812,278...118,819,827
Ensembl chr 4:118,812,252...118,819,826
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12586733 PMID:12684256 PMID:19227972 PMID:20177826 PMID:21867702 PMID:23583883 PMID:24885036 PMID:28038988 PMID:28123103 PMID:29374221 PMID:29434186 More...
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Srm
spermidine synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srr
serine racemase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25812446
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stk39
serine threonine kinase 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:52,913,583...53,179,060
Ensembl chr 3:52,913,585...53,179,060
G
Strbp
spermatid perinuclear RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
G
Suclg2
succinate-CoA ligase GDP-forming subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:128,067,031...128,337,146
Ensembl chr 4:128,067,033...128,337,170
G
Tbx20
T-box transcription factor 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 8:23,200,104...23,258,218
Ensembl chr 8:23,204,507...23,258,175
G
Tcf7l2
transcription factor 7 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
G
Tfam
transcription factor A, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28595911
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tg
thyroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30373627
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
G
Tgfbr1
transforming growth factor, beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27228633
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Timm10
translocase of inner mitochondrial membrane 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940
G
Timm8a1
translocase of inner mitochondrial membrane 8A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:97,717,932...97,722,170
Ensembl chr X:97,717,920...97,721,960
G
Timp1
TIMP metallopeptidase inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21051829
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tk1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tomm40
translocase of outer mitochondrial membrane 40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:79,358,781...79,370,882
Ensembl chr 1:79,358,786...79,370,915
G
Top2a
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23873029
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpi1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Ttpa
alpha tocopherol transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11095717 PMID:11752462
NCBI chr 5:33,497,537...33,518,936
Ensembl chr 5:33,497,137...33,518,073
G
Tyms
thymidylate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Uck2
uridine-cytidine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
G
Vcp
valosin-containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25884947
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16831193
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wnt11
Wnt family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25783350
NCBI chr 1:153,134,503...153,154,294
Ensembl chr 1:153,138,197...153,154,294
G
Xaf1
XIAP associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xrcc5
X-ray repair cross complementing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
G
Xrcc6
X-ray repair cross complementing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
G
Mag
myelin-associated glycoprotein
IEP
protein:decreased expression:optic nerve
RGD
PMID:9820787
RGD:9685300
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
G
Zc3h12a
zinc finger CCCH type containing 12A
disease_progression
ISO
RGD
PMID:26320658
RGD:11534569
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
treatment
IEP
RGD
PMID:18416460
RGD:13782074
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Bcl2l1
Bcl2-like 1
IEP
protein:increased expression:pancreas, mitochondrion (rat)
RGD
PMID:19331832
RGD:11353791
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
treatment
ISO
RGD
PMID:22850625
RGD:11560530
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP
RGD
PMID:10451498
RGD:10043817
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Ednra
endothelin receptor type A
treatment
IMP
RGD
PMID:12799311
RGD:1581841
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Fas
Fas cell surface death receptor
severity
ISO
protein:increased expression:Kupffer cell:
RGD
PMID:15797225 PMID:15797225
RGD:14700708 , RGD:14700708
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
severity
ISO
protein:increased expression:Kupffer cell:
RGD
PMID:15797225 PMID:15797225
RGD:14700708 , RGD:14700708
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gss
glutathione synthetase
IEP
RGD
PMID:17897920
RGD:11353819
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
Hmgb1
high mobility group box 1
treatment
IMP
RGD
PMID:23706497
RGD:10402063
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hspa5
heat shock protein family A (Hsp70) member 5
IEP
protein:increased expression:neutrophil:
RGD
PMID:26464680
RGD:11354914
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Icam1
intercellular adhesion molecule 1
treatment
IEP IMP
RGD
PMID:23706497 PMID:10201790
RGD:10402063 , RGD:11520782
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IEP
RGD
PMID:25323753
RGD:11049477
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il4
interleukin 4
treatment
IEP
RGD
PMID:24876883
RGD:10402805
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Jak1
Janus kinase 1
treatment
IEP
RGD
PMID:21369693
RGD:19165136
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Kmo
kynurenine 3-monooxygenase
disease_progression
ISO IMP
RGD
PMID:26752518 PMID:28398044
RGD:11342439 , RGD:13703053
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Kras
KRAS proto-oncogene, GTPase
IEP
RGD
PMID:8913708
RGD:11062095
NCBI chr 4:178,185,418...178,218,484
G
Lamp2
lysosomal-associated membrane protein 2
ISO
protein:decreased expression:pancreas
RGD
PMID:22850625
RGD:11560530
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:22850625
RGD:11560530
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Mir155
microRNA 155
treatment
ISO
RGD
PMID:29937734 PMID:30497068
RGD:21403683 , RGD:21408596
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
RGD
PMID:16127429
RGD:11075069
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:19680809
RGD:11100040
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Procr
protein C receptor
treatment
IEP IDA
protein:increased expression:blood
RGD
PMID:25688263 PMID:24749346
RGD:13515127 , RGD:13515128
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Ptafr
platelet-activating factor receptor
treatment
IDA
RGD
PMID:21633536
RGD:9999225
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Reg1a
regenerating family member 1 alpha
severity
IEP IMP
mRNA:increased expression:pancreas (rat)
RGD
PMID:1985964 PMID:19129610
RGD:729900 , RGD:9850139
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
G
Reg3b
regenerating family member 3 beta
IEP
protein:increased expression:serum (rat)
RGD
PMID:11066135
RGD:9831384
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
G
Serpinc1
serpin family C member 1
treatment
ISO
RGD
PMID:19546838
RGD:11035262
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Spink1
serine peptidase inhibitor, Kazal type 1
treatment
IDA
RGD
PMID:15765407
RGD:10043090
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Tnf
tumor necrosis factor
IEP
associated with Anemia, Hemolytic
RGD
PMID:12845374 PMID:15164724
RGD:10449461 , RGD:1580295
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
protein:increased expression:serum
RGD
PMID:15164724
RGD:1580295
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
IEP
protein:increased expression:serum
RGD
PMID:15164724
RGD:1580295
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Vwf
von Willebrand factor
IEP
protein:increased expression:plasma:
RGD
PMID:17708840
RGD:11079229
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Rhob
ras homolog family member B
IDA
RGD
PMID:1710770
RGD:704375
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
C3
complement C3
treatment
ISO
RGD
PMID:16947020
RGD:7401280
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Coq7
coenzyme Q7, hydroxylase
susceptibility
ISO
RGD
PMID:23166727
RGD:10402105
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
G
Csf1r
colony stimulating factor 1 receptor
ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:20008303
RGD:150524291
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:16767432
RGD:8655941
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il2
interleukin 2
treatment
ISO
RGD
PMID:9399664
RGD:8663451
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
RGD
PMID:21278795
RGD:36049796
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Jam3
junctional adhesion molecule 3
ISO
RGD
PMID:15994945
RGD:7488936
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Lect2
leukocyte cell-derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
G
Mapk14
mitogen activated protein kinase 14
ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:29907597
RGD:151665504
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Myd88
MYD88, innate immune signal transduction adaptor
treatment
ISO
mouse cell line in a mouse model
RGD
PMID:26111447
RGD:150521531
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16565519
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Dll4
delta like canonical Notch ligand 4
treatment
IEP
RGD
PMID:21526177
RGD:155663484
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Serpine1
serpin family E member 1
treatment severity
ISO IDA
mRNA:increased expression:retina (mouse) human gene in mouse model
RGD
PMID:12766088 PMID:26610445 PMID:11292663 PMID:12766088
RGD:8547735 , RGD:11073722 , RGD:8547737 , RGD:8547735
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Smo
smoothened, frizzled class receptor
treatment
IMP
RGD
PMID:21063852
RGD:12859045
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Cbs
cystathionine beta synthase
IEP
protein:increased expression:arcuate nucleus (rat)
RGD
PMID:27778022
RGD:38456012
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Gli1
GLI family zinc finger 1
IEP
RGD
PMID:24782623
RGD:12879405
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:22173919
RGD:10044253
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:22359633
RGD:11035224
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Ptch1
patched 1
IEP
RGD
PMID:24782623
RGD:12879405
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
G
Smo
smoothened, frizzled class receptor
IEP
RGD
PMID:24782623
RGD:12879405
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Spink1
serine peptidase inhibitor, Kazal type 1
treatment
IDA IEP
protein:increased secretion:pancreatic juice:
RGD
PMID:19904222 PMID:12123090 PMID:22173919
RGD:10043091 , RGD:10044261 , RGD:10044253
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Tgfb1
transforming growth factor, beta 1
IEP
RGD
PMID:26645248
RGD:14995470
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Ccl2
C-C motif chemokine ligand 2
IEP
mRNA:increased expression:spinal cord (rat)
RGD
PMID:12098510
RGD:8655962
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Nefh
neurofilament heavy chain
ISO
protein:decreased expression:spinal cord:
RGD
PMID:12742652
RGD:27226817
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Plp1
proteolipid protein 1
ISO
human sequence peptide in a mouse model; associated with Herpesviridae infections
RGD
PMID:12811845
RGD:30296670
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Serpine1
serpin family E member 1
ISO
RGD
PMID:17983428
RGD:13208507
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Cd40
CD40 molecule
treatment
IDA
RGD
PMID:19269163
RGD:11352683
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
IDA
RGD
PMID:19269163
RGD:11352683
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Ceacam20
CEA cell adhesion molecule 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34605108
NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782
G
Acsl3
acyl-CoA synthetase long-chain family member 3
ISO
RGD
PMID:23526225
RGD:13831300
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:29713367
RGD:13792581
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cd86
CD86 molecule
treatment
ISO
RGD
PMID:25344652
RGD:11354965
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:29713367
RGD:13792581
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:29713367
RGD:13792581
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Il23a
interleukin 23 subunit alpha
ISO
RGD
PMID:19935773 PMID:26344076
RGD:5037240 , RGD:11251537
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
A2m
alpha-2-macroglobulin
IEP
protein:increased expression:serum
RGD
PMID:6163339
RGD:10046032
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcb1a
ATP binding cassette subfamily B member 1A
IEP ISO
mRNA:altered expression:liver CTD Direct Evidence: marker/mechanism mRNA:decreased expression:intestinal mucosa (rat)
CTD RGD
PMID:17827786 PMID:19152228 PMID:17827786
RGD:2315573 , RGD:11040994
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc6
ATP binding cassette subfamily C member 6
IEP
mRNA:decreased expression:kidney
RGD
PMID:22974786
RGD:11038789
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
G
Abcg2
ATP binding cassette subfamily G member 2
IEP
mRNA:decreased expression:small intestine
RGD
PMID:19152228
RGD:2315573
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acan
aggrecan
treatment
IEP
RGD
PMID:25821409
RGD:12879456
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Ace
angiotensin I converting enzyme
IEP
RGD
PMID:20213806
RGD:2325221
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl4
acyl-CoA synthetase long-chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Acsl5
acyl-CoA synthetase long-chain family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
G
Adam10
ADAM metallopeptidase domain 10
IEP
RGD
PMID:23897050
RGD:13703039
NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889
G
Adam17
ADAM metallopeptidase domain 17
IEP
RGD
PMID:23897050
RGD:13703039
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Adipoq
adiponectin, C1Q and collagen domain containing
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23326410 PMID:21681567 PMID:19026984
RGD:5685385 , RGD:5686814
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adk
adenosine kinase
IMP
RGD
PMID:11160636
RGD:6482663
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Ahcy
adenosylhomocysteinase
IDA
RGD
PMID:11123369
RGD:1598898
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194622
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
treatment
IDA
RGD
PMID:22391142
RGD:10041007
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:19675173
RGD:5509599
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Anxa1
annexin A1
IMP ISO
RGD
PMID:10403283 PMID:23267026
RGD:2306928 , RGD:7421573
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
ameliorates
IMP
RGD
PMID:24819400
RGD:150519886
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Aoc3
amine oxidase, copper containing 3
IMP
RGD
PMID:16947396
RGD:2313925
NCBI chr10:86,272,757...86,280,702
G
Apoa4
apolipoprotein A4
IEP
protein:decreased expression:blood serum (rat)
RGD
PMID:10892728
RGD:5685694
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Arrb1
arrestin, beta 1
IEP
protein:increased expression:knee, synoviocyte (rat)
RGD
PMID:20965243
RGD:5509895
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
G
Arrb2
arrestin, beta 2
IEP
protein:increased expression:knee, synoviocyte (rat)
RGD
PMID:20965243
RGD:5509895
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
IMP
RGD
PMID:17408934
RGD:5144054
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:21199477 PMID:22978269
RGD:10054249 , RGD:10054498
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:21199477 PMID:22978269
RGD:10054249 , RGD:10054498
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdkrb1
bradykinin receptor B1
IMP
RGD
PMID:15001555
RGD:1625760
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bglap
bone gamma-carboxyglutamate protein
ISO
protein:decreased expression:serum
RGD
PMID:21406003
RGD:6483549
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Btk
Bruton tyrosine kinase
treatment
IMP
RGD
PMID:22228807 PMID:32083858
RGD:11040701 , RGD:151665122
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
G
C3
complement C3
treatment
ISO IDA
RGD
PMID:20051658 PMID:7347767
RGD:7411688 , RGD:11041098
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C5
complement C5
ISO IMP
RGD
PMID:20975959 PMID:12355496
RGD:5130175 , RGD:1600637
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Cabin1
calcineurin binding protein 1
ISO
RGD
PMID:22275266
RGD:10054391
NCBI chr20:12,893,314...13,015,357
Ensembl chr20:12,893,358...13,015,357
G
Calca
calcitonin-related polypeptide alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16690336
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbl
Cbl proto-oncogene
treatment
IDA
RGD
PMID:16984225
RGD:2306289
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Cblb
Cbl proto-oncogene B
IMP
RGD
PMID:16984225
RGD:2306289
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
G
Ccl2
C-C motif chemokine ligand 2
treatment
IMP IDA IEP
mRNA, protein:increased expression:synovium
RGD
PMID:18292571 PMID:24583103 PMID:17052673 PMID:18726678
RGD:2307052 , RGD:11526142 , RGD:2307143 , RGD:2307008
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
IEP
mRNA, protein:increased expression:synovium, monocytes
RGD
PMID:17052673
RGD:2307143
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
IMP IEP
mRNA, protein:increased expression:synovium, monocytes
RGD
PMID:9637726 PMID:17052673
RGD:4889940 , RGD:2307143
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
onset
ISO
RGD
PMID:17178563
RGD:6483780
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccn1
cellular communication network factor 1
ameliorates
IMP
RGD
PMID:27653023
RGD:150429754
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccr1
C-C motif chemokine receptor 1
ISO IEP
RGD
PMID:18608173 PMID:14674010
RGD:5688144 , RGD:1582346
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
IEP
RGD
PMID:16320322
RGD:4144893
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
treatment
IEP
mRNA:increased expression:ankle (rat)
RGD
PMID:14674010 PMID:22289897
RGD:1582346 , RGD:5687744
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd28
Cd28 molecule
IEP
RGD
PMID:18601859
RGD:2307202
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd4
Cd4 molecule
treatment
ISO IMP
RGD
PMID:15479897 PMID:12010568
RGD:10058957 , RGD:10058960
NCBI chr 4:157,668,878...157,695,366
G
Cd40
CD40 molecule
ISO
RGD
PMID:20435931
RGD:5490544
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
IDA ISO IEP
protein:increased expression:plasma (rat)
RGD
PMID:27218142 PMID:7689748 PMID:22611405
RGD:11344958 , RGD:11352696 , RGD:11352298
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd44
CD44 molecule
IEP
protein:increased expression:joint, macrophage, lymphocyte
RGD
PMID:8639178
RGD:2289388
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd46
CD46 molecule
ISO
RGD
PMID:21852528
RGD:6483461
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
G
Cd59b
CD59b molecule
IDA
RGD
PMID:14519760
RGD:1600483
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
G
Cd69
Cd69 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12882836
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Cd80
Cd80 molecule
ISO
RGD
PMID:22004797
RGD:6902903
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cdc42
cell division cycle 42
ISO
protein:increased activation:bone marrow, macrophage
RGD
PMID:21266780
RGD:5688271
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
treatment
ISO
RGD
PMID:10395320
RGD:8552686
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cfh
complement factor H
ISO
RGD
PMID:19828624
RGD:5684557
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Col2a1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16200597 PMID:21188452 PMID:23326410 PMID:24709313 PMID:25194622 PMID:25481498 PMID:26070417 PMID:29908986 PMID:29935983 PMID:36181686 More...
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Cp
ceruloplasmin
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19330884 PMID:19205849
RGD:2314686
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpox
coproporphyrinogen oxidase
IEP
protein:decreased activity:liver (rat)
RGD
PMID:9173682
RGD:1600958
NCBI chr11:41,936,585...41,946,568
Ensembl chr11:41,936,591...41,946,746
G
Crhr1
corticotropin releasing hormone receptor 1
IMP
RGD
PMID:17550594
RGD:1626231
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19330884
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf1
colony stimulating factor 1
IEP
protein:increased expression:dorsal root ganglion
RGD
PMID:32510872
RGD:127338469
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf1r
colony stimulating factor 1 receptor
treatment
IMP
RGD
PMID:18434589
RGD:151665814
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:12742377
RGD:11039465
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csk
C-terminal Src kinase
IMP
RGD
PMID:10411542
RGD:5134371
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
treatment
IMP ISO
RGD
PMID:22354915 PMID:7543497
RGD:7204500 , RGD:7204519
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctsb
cathepsin B
IEP
mRNA:increased expression:knee joint, synovium (rat)
RGD
PMID:17195213
RGD:2315521
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsk
cathepsin K
IEP
mRNA:increased expression:synovium, bone marrow
RGD
PMID:15353610
RGD:1601025
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Ctss
cathepsin S
ISO
RGD
PMID:21439785
RGD:5686915
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
RGD
PMID:11465708
RGD:4892002
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP
protein:increased expression:spinal cord
RGD
PMID:17123734 PMID:11465708
RGD:4891969 , RGD:4892002
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
RGD
PMID:19096963
RGD:4889415
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl6
C-X-C motif chemokine ligand 6
severity
IMP
RGD
PMID:10358204
RGD:5135272
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Ddr2
discoidin domain receptor tyrosine kinase 2
ameliorates
ISO
RGD
PMID:24819400
RGD:150519886
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Dhodh
dihydroorotate dehydrogenase (quinone)
IMP
RGD
PMID:15182735
RGD:2316231
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Dnase2
deoxyribonuclease 2, lysosomal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974942
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnmt1
DNA methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194984
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Drd1
dopamine receptor D1
treatment
IEP IDA
mRNA:increased expression:corpus striatum (rat)
RGD
PMID:23762129 PMID:23762129
RGD:7248592 , RGD:7248592
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
treatment
IEP IDA
mRNA:increased expression:corpus striatum (rat)
RGD
PMID:23762129 PMID:23762129
RGD:7248592 , RGD:7248592
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Edn1
endothelin 1
ISO
mRNA:increased expression:inguinal lymph node (mouse)
RGD
PMID:22249931
RGD:8661695
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7589090
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Esr1
estrogen receptor 1
treatment
ISO
associated with Osteoporosis
RGD
PMID:20112355
RGD:10045851
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
IDA
RGD
PMID:16269464
RGD:5508854
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21436072
RGD:5147764
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F2r
coagulation factor II (thrombin) receptor
severity
ISO
RGD
PMID:19674841
RGD:7387269
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:12511586
RGD:735010
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
Faslg
Fas ligand
treatment
IMP
RGD
PMID:22354915
RGD:7204500
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr1a
Fc gamma receptor 1A
ISO IEP
protein:increased expression:dorsal root ganglion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12875993 PMID:16670289 PMID:32510872
RGD:9685708 , RGD:127338469
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fcgr2a
Fc gamma receptor 2A
onset
ISO
RGD
PMID:18354234 PMID:16623928
RGD:5508446 , RGD:5508457
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
ISO
RGD
PMID:23341540
RGD:11344930
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fgf8
fibroblast growth factor 8
IMP
RGD
PMID:18699993
RGD:2314157
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:22833219
RGD:10402072
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Flt3
Fms related receptor tyrosine kinase 3
IAGP
RGD
PMID:10857786
RGD:61066
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP
RGD
PMID:24186846
RGD:405650594
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxp3
forkhead box P3
treatment
IEP
mRNA,protein:decreased expression:lung
RGD
PMID:29264841 PMID:23643080
RGD:38549364 , RGD:38599003
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gja1
gap junction protein, alpha 1
IMP
RGD
PMID:23165424
RGD:7207259
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gli1
GLI family zinc finger 1
treatment
IEP
RGD
PMID:25821409
RGD:12879456
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gpi
glucose-6-phosphate isomerase
ISO
RGD
PMID:23911657
RGD:11051957
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Grk2
G protein-coupled receptor kinase 2
disease_progression treatment
IEP
protein:increased expression:aorta (rat) protein:altered expression:T cell (rat)
RGD
PMID:28653218 PMID:28349925 PMID:28631356
RGD:13513975 , RGD:13513979 , RGD:13513976
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Grn
granulin precursor
ISO
RGD
PMID:21393509
RGD:5509782
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16713974
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gusb
glucuronidase, beta
treatment
IEP
RGD
PMID:827200
RGD:42724460
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Havcr2
hepatitis A virus cellular receptor 2
IEP
mRNA,protein:altered expression:bone:
RGD
PMID:25264706
RGD:9686117
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hdac6
histone deacetylase 6
treatment
ISO
RGD
PMID:23541634
RGD:9681550
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:21679445
RGD:8693318
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
IEP
protein:altered localization:cytoplasm, extracellular matrix
RGD
PMID:12384917
RGD:728698
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:17119970
RGD:5508468
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hp
haptoglobin
IEP
mRNA, protein:increased expression:tendon, ankle protein:increased expression:serum
RGD
PMID:12801280 PMID:15899029
RGD:1626375 , RGD:1626370
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hspd1
heat shock protein family D (Hsp60) member 1
IDA
RGD
PMID:15529360 PMID:10882416
RGD:1624244 , RGD:12910542
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Ifng
interferon gamma
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19203382 PMID:22450443 PMID:12412757 PMID:7774621
RGD:2311498 , RGD:10755750
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
IEP
protein:decreased expression:plasma
RGD
PMID:19246225
RGD:2306697
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp3
insulin-like growth factor binding protein 3
IEP
mRNA, protein:increased expression:kidney, serum
RGD
PMID:14642797
RGD:10402760
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO IMP
RGD
PMID:21087862 PMID:19652024
RGD:7495772 , RGD:7495778
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
IDA
RGD
PMID:16684367
RGD:12791276
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il10
interleukin 10
treatment
IEP ISO IDA
CTD Direct Evidence: marker/mechanism|therapeutic protein:decreased expression:serum:
CTD RGD
PMID:20974942 PMID:22450443 PMID:19193354 PMID:19169271 PMID:23140046 PMID:22052031 PMID:15270736 More...
RGD:2311059 , RGD:8662976 , RGD:7193038 , RGD:7364838 , RGD:1626677
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
treatment
ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10444273 PMID:17665443 PMID:11860705
RGD:4889497 , RGD:8549606
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il15
interleukin 15
ISO
RGD
PMID:20188418
RGD:5000761
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17a
interleukin 17A
treatment
IMP ISO IEP IDA
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:20974942 PMID:20925596 PMID:23377547 PMID:21194185 PMID:20925596
RGD:4781444 , RGD:9130803 , RGD:9068936 , RGD:4781444
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
disease_progression
IEP IMP
RGD
PMID:19096963 PMID:15147345
RGD:4889415 , RGD:4889503
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
IDA IEP
protein:increased expression:serum:
RGD
PMID:20379758 PMID:19169271
RGD:6907373 , RGD:8662976
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
treatment
IDA IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:19330884 PMID:20131233 PMID:20974942 PMID:22450443 PMID:21557995 PMID:29408684 PMID:24028507 PMID:23140046 More...
RGD:7175317 , RGD:13792834 , RGD:10755447 , RGD:7193038
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO IEP
rat model treated with human protein human gene in a rat model mRNA:increased expression:popliteal lymph node (rat) mouse model treated with human protein
RGD
PMID:15270736 PMID:12727108 PMID:10921508 PMID:22267332 PMID:23006786
RGD:1626677 , RGD:8551745 , RGD:8551741 , RGD:8549801 , RGD:6907376
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
treatment
IEP IDA
protein:increased expression:serum:
RGD
PMID:19169271 PMID:2492102
RGD:8662976 , RGD:10047055
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il20
interleukin 20
IMP
RGD
PMID:20722035
RGD:5147393
NCBI chr13:42,380,981...42,384,625
Ensembl chr13:42,380,981...42,384,625
G
Il2ra
interleukin 2 receptor subunit alpha
IDA
RGD
PMID:17928458
RGD:2325988
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
treatment
IMP ISO IEP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10444273 PMID:16869003 PMID:23972727 PMID:23140046
RGD:2317300 , RGD:10402790 , RGD:7193038
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
treatment
IEP ISO IDA IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20131233 PMID:20974942 PMID:22450443 PMID:24028507 PMID:8607900 PMID:10381487 PMID:23503893 More...
RGD:10755447 , RGD:11060267 , RGD:11049553 , RGD:11049551
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
RGD
PMID:20626857
RGD:5509945
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Itga4
integrin subunit alpha 4
treatment
IMP
RGD
PMID:12969328
RGD:9698440
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itgb2
integrin subunit beta 2
IMP
RGD
PMID:8881759
RGD:6482229
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Itgb3
integrin subunit beta 3
IMP
protein:increased expression:endothelial cell
RGD
PMID:16869003
RGD:2317300
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Jag1
jagged canonical Notch ligand 1
ISO
RGD
PMID:19265135
RGD:6482234
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Jak1
Janus kinase 1
treatment
IMP
RGD
PMID:29452839
RGD:19165139
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
treatment
ISO IDA
RGD
PMID:22339472 PMID:23711144 PMID:22800927
RGD:10403066 , RGD:10403081 , RGD:10403074
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jak3
Janus kinase 3
treatment
IMP IEP
RGD
PMID:25762693 PMID:18234077 PMID:21434883
RGD:11533938 , RGD:11533944 , RGD:11533942
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
RGD
PMID:25131209
RGD:150521609
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Klkb1
kallikrein B1
IMP IEP
RGD
PMID:22739815 PMID:9783057
RGD:7297047 , RGD:7327138
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
G
Kng2
kininogen 2
IEP
peptidoglycan-polysaccharide-induced arthritis in Lewis rats
RGD
PMID:9214434 PMID:1996642
RGD:1600547 , RGD:11059895
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Kyat1
kynurenine aminotransferase 1
IMP
RGD
PMID:16984225
RGD:2306289
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
G
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15142272
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals3
galectin 3
IEP
RGD
PMID:16507131
RGD:1625684
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
RGD
PMID:16331767
RGD:10412332
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mif
macrophage migration inhibitory factor
IDA
RGD
PMID:10765927
RGD:1642012
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir146a
microRNA 146a
ISO
mRNA:increased expression:joints (mouse)
RGD
PMID:22660635
RGD:155663483
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir152
microRNA 152
ISO IEP
CTD Direct Evidence: marker/mechanism miRNA:decreased exression:synovial membrane of synovial joint
CTD RGD
PMID:25194984 PMID:25194984
RGD:21066343
NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
G
Mir23b
microRNA 23b
treatment
ISO
mRNA:decreased expression:joint (mouse)
RGD
PMID:22660635 PMID:22660635
RGD:155663483 , RGD:155663483
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mir26a
microRNA 26a
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:24423102
NCBI chr 8:118,755,289...118,755,378
Ensembl chr 8:118,755,289...118,755,378
G
Mmp1
matrix metallopeptidase 1
IDA IEP
RGD
PMID:21288455 PMID:24011916 PMID:21108488
RGD:7207362 , RGD:8549748 , RGD:7207365
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
treatment
IEP IDA
RGD
PMID:24244039 PMID:11435459
RGD:8694124 , RGD:1582329
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp3
matrix metallopeptidase 3
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:ankle joint
CTD RGD
PMID:20974942 PMID:20703013 PMID:24244039 PMID:24244039 PMID:24011916 PMID:21679445 More...
RGD:7241231 , RGD:8694124 , RGD:8694124 , RGD:8549748 , RGD:8693318
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
IEP
protein:increased expression:cartilage, serum, synovial fluid
RGD
PMID:17463159
RGD:1642035
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
susceptibility
ISO
DNA:transversion: :m.7778G>T (mouse)
RGD
PMID:19759059
RGD:5490297
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mtor
mechanistic target of rapamycin kinase
treatment
IEP
RGD
PMID:22391142
RGD:10041007
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Myd88
MYD88, innate immune signal transduction adaptor
ISO
RGD
PMID:20131263
RGD:8552884
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Myod1
myogenic differentiation 1
treatment
IEP
RGD
PMID:23781298
RGD:9686078
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
G
Myog
myogenin
treatment
IDA
RGD
PMID:23781298
RGD:9686078
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Ncf1
neutrophil cytosolic factor 1
severity
IAGP
DNA:missense mutations:cds:p.M106V, p.M153T (rat)
RGD
PMID:12461526
RGD:628543
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
RGD
PMID:21424514 PMID:20131263
RGD:5508728 , RGD:8552884
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
IMP ISO
protein:increased expression:ankle joint (mouse)
RGD
PMID:12826065 PMID:21880869
RGD:1358527 , RGD:5509060
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:29337196
RGD:13504725
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Npsr1
neuropeptide S receptor 1
treatment
IMP
RGD
PMID:24884567
RGD:9831205
NCBI chr 8:22,606,946...22,831,558
Ensembl chr 8:22,606,946...22,831,558
G
Nqo1
NAD(P)H quinone dehydrogenase 1
severity
ISO
RGD
PMID:16905546
RGD:11073695
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
ISO
RGD
PMID:21859686
RGD:6480864
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
ISO
RGD
PMID:21859686
RGD:6480864
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nras
NRAS proto-oncogene, GTPase
IEP
RGD
PMID:18706093
RGD:2300006
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Nts
neurotensin
IEP
RGD
PMID:8518953
RGD:9743903
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Orm1
orosomucoid 1
IEP
protein:increased expression:liver
RGD
PMID:16166348
RGD:2316639
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
P2ry12
purinergic receptor P2Y12
IMP
RGD
PMID:22028806
RGD:6480518
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
G
Pam
peptidylglycine alpha-amidating monooxygenase
IDA
RGD
PMID:17138865
RGD:6483527
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Parp1
poly (ADP-ribose) polymerase 1
severity
ISO
RGD
PMID:16356201
RGD:5684009
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdyn
prodynorphin
treatment
IEP
RGD
PMID:25102697
RGD:401851905
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Pecam1
platelet and endothelial cell adhesion molecule 1
severity
ISO
protein:increased expression:knee joint, blood vessels (mouse)
RGD
PMID:22548760 PMID:14613294 PMID:21982514
RGD:6484738 , RGD:6771222 , RGD:6771177
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pgf
placental growth factor
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
ISO
RGD
PMID:18412166
RGD:6482696
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
RGD
PMID:20374644 PMID:18412166
RGD:6482684 , RGD:6482696
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:20973954
RGD:6483801
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pomc
proopiomelanocortin
treatment
IEP
RGD
PMID:25102697
RGD:401851905
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36181686
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Ptch1
patched 1
treatment
IEP
RGD
PMID:25821409
RGD:12879456
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
G
Ptger4
prostaglandin E receptor 4
treatment disease_progression
ISO IEP IMP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:tarsal joint, synovium (rat)
CTD RGD
PMID:18287210 PMID:20423341 PMID:11207665 PMID:18287210
RGD:10003041 , RGD:10043377 , RGD:10003052
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptges
prostaglandin E synthase
IEP
mRNA, protein:increased expression:paw
RGD
PMID:12707354
RGD:2300108
NCBI chr 3:14,177,892...14,189,236
G
Ptges3
prostaglandin E synthase 3
IEP
mRNA:increased expression:paw (rat)
RGD
PMID:12707354
RGD:2300108
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IEP
mRNA, protein:increased expression:synovium
RGD
PMID:22289897
RGD:5687744
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP IEP ISO
mRNA, protein:increased expression:synovium protein:increased expression:autopod joint
RGD
PMID:18758904 PMID:22289897 PMID:21765105
RGD:2300221 , RGD:5687744 , RGD:5508310
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
IEP
protein:increased expression:metatarsophalangeal joint, mononuclear cell (rat)
RGD
PMID:24998229
RGD:11532752
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
Rag2
recombination activating 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20974942
NCBI chr 3:87,902,373...87,910,227
Ensembl chr 3:87,902,238...87,911,066
G
RT1-Db1
RT1 class II, locus Db1
ISO
RGD
PMID:21665435 PMID:19950279
RGD:5147558 , RGD:5147586
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
S100a8
S100 calcium binding protein A8
IEP
RGD
PMID:8343166
RGD:633930
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
IEP
RGD
PMID:8343166
RGD:633930
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Serpinc1
serpin family C member 1
IEP
protein:decreased expression:plasma
RGD
PMID:22781611
RGD:11035273
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Sfrp4
secreted frizzled-related protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194984
NCBI chr17:45,278,867...45,330,806
Ensembl chr17:45,234,097...45,330,736
G
Shh
sonic hedgehog signaling molecule
treatment
IEP
RGD
PMID:25821409
RGD:12879456
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Slc11a1
solute carrier family 11 member 1
severity
ISO
RGD
PMID:17122779
RGD:5684943
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
IEP
protein:decreased expression:articular cartilage of joint
RGD
PMID:10449524 PMID:9744360
RGD:634208 , RGD:9999431
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Smo
smoothened, frizzled class receptor
treatment
IEP
RGD
PMID:25821409
RGD:12879456
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Socs3
suppressor of cytokine signaling 3
IEP
mRNA:increased expression:mononuclear cell
RGD
PMID:16507131
RGD:1625684
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Spn
sialophorin
IMP
associated with Staphylococcal Infections
RGD
PMID:7927732
RGD:2303983
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
G
Stat1
signal transducer and activator of transcription 1
IDA ISO
protein:increased tyrosine phosphorylation:macrophage, synovial cell CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15188379 PMID:14674010
RGD:1582346
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15188379 PMID:21937456 PMID:23711144
RGD:10403081
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tac1
tachykinin, precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9259450
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tgfb1
transforming growth factor, beta 1
IEP
RGD
PMID:29763498
RGD:15036801
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr2
transforming growth factor, beta receptor 2
IEP
protein:increased expression:synovium
RGD
PMID:9010265
RGD:1601623
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Thbd
thrombomodulin
ISO
RGD
PMID:16879225
RGD:5685015
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Timp4
TIMP metallopeptidase inhibitor 4
IMP
RGD
PMID:12483743
RGD:2290463
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
G
Tjp1
tight junction protein 1
IEP
RGD
PMID:18848892
RGD:2325138
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr2
toll-like receptor 2
IEP ISO
RGD
PMID:21725847 PMID:20131263
RGD:7241099 , RGD:8552884
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
IEP IMP
mRNA, protein:increased expression:spleen (rat)
RGD
PMID:20500834 PMID:20500834
RGD:5128706 , RGD:5128706
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tnf
tumor necrosis factor
treatment
IDA IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum:
CTD RGD
PMID:7589090 PMID:9598899 PMID:19203382 PMID:19330884 PMID:19765281 PMID:20131233 PMID:20974942 PMID:21452922 PMID:22450443 PMID:23052485 PMID:29408684 PMID:24028507 PMID:24394943 PMID:19169271 PMID:21690068 PMID:23140046 More...
RGD:7245941 , RGD:13792834 , RGD:10755447 , RGD:10450611 , RGD:8662976 , RGD:8661761 , RGD:7193038
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
treatment
IEP ISO
mRNA:decreased expression:bone Sinomenine CHEBI:9163 CTD Direct Evidence: therapeutic
CTD RGD
PMID:23333834 PMID:16696922 PMID:24066131
RGD:1624171 , RGD:42721982
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IDA IEP ISO
RGD
PMID:23052485 PMID:21690068 PMID:20370892
RGD:7245941 , RGD:8661761 , RGD:8661729
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
treatment
ISO IEP IDA
human protein in rat model
RGD
PMID:21463515 PMID:21690068 PMID:23052485
RGD:5131255 , RGD:8661761 , RGD:7245941
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
treatment
ISO
RGD
PMID:25869297
RGD:9999444
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Txndc5
thioredoxin domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326410
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9598899 PMID:26221077
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
IDA
RGD
PMID:7516431
RGD:6480480
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vip
vasoactive intestinal peptide
ISO IDA
RGD
PMID:21998117 PMID:19055696
RGD:5685376 , RGD:5685612
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Xdh
xanthine dehydrogenase
IEP
protein:increased expression:brain, mitochondrion
RGD
PMID:25870945
RGD:13208957
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xylt1
xylosyltransferase 1
IEP
mRNA:decreased expression:articular cartilage
RGD
PMID:19001053
RGD:2313142
NCBI chr 1:171,643,925...171,929,774
Ensembl chr 1:171,643,925...171,926,783
G
A2m
alpha-2-macroglobulin
treatment
IDA
RGD
PMID:1710603
RGD:10046021
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Adam17
ADAM metallopeptidase domain 17
IEP
RGD
PMID:15878627
RGD:1559178
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Adam8
ADAM metallopeptidase domain 8
ISO
RGD
PMID:9670863
RGD:2325244
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Aif1
allograft inflammatory factor 1
IEP
protein:altered expression:spinal cord (rat)
RGD
PMID:19246105
RGD:2313022
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akap12
A-kinase anchoring protein 12
IEP
mRNA,protein:increased expression:spinal cord
RGD
PMID:20155814
RGD:14348972
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Alox15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:15328042
RGD:5509618
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Amigo2
adhesion molecule with Ig like domain 2
severity
ISO
RGD
PMID:28119027
RGD:14392778
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Anxa1
annexin A1
IEP
protein:increased expression:brain, astrocyte, macrophage
RGD
PMID:9472682
RGD:2306942
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Apoe
apolipoprotein E
IEP
RGD
PMID:28578430
RGD:13703134
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp4
aquaporin 4
disease_progression severity
ISO IEP
RGD
PMID:21056916 PMID:23707078 PMID:21157915 PMID:19660138
RGD:5148015 , RGD:8696030 , RGD:5490117 , RGD:5490116
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
B2m
beta-2 microglobulin
ISO
RGD
PMID:15837577
RGD:6482690
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
B4galt6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:astrocyte
RGD
PMID:25216636
RGD:14390079
NCBI chr18:11,958,382...12,015,247
Ensembl chr18:11,958,390...12,015,247
G
Bdnf
brain-derived neurotrophic factor
IEP
RGD
PMID:23212569
RGD:10059360
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
C3
complement C3
IEP
protein:increased expression:cerebrospinal fluid
RGD
PMID:22320401
RGD:7175513
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C6
complement C6
severity
IAGP
RGD
PMID:11970970
RGD:625607
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
IEP
RGD
PMID:11353727
RGD:1580151
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
Calca
calcitonin-related polypeptide alpha
no_association
ISO
RGD
PMID:19563774
RGD:5684360
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
IEP
protein:increased activity, increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
IEP
protein:increased activity, increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
IEP
protein:increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav3
caveolin 3
onset
IEP
Protein:increased expression:spinal cord, astrocyte
RGD
PMID:15925413
RGD:1582168
NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137
G
Cblb
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
G
Ccl1
C-C motif chemokine ligand 1
IEP
mRNA:decreased expression:lymph node
RGD
PMID:19865101
RGD:4145472
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl11
C-C motif chemokine ligand 11
IEP
mRNA:increased expression:lymph node
RGD
PMID:19865101
RGD:4145472
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
IEP
mRNA:increased expression:spinal cord mRNA:decreased expression:lymph node mRNA:increased expression:optic chiasma (rat)
RGD
PMID:17666800 PMID:19865101 PMID:11241588
RGD:2307114 , RGD:4145472 , RGD:8548888
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
IEP
mRNA:increased expression:spinal cord
RGD
PMID:17666800
RGD:2307114
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
ISO IEP
protein:increased expression:brain (mouse) mRNA:increased expression:spinal cord
RGD
PMID:15833367 PMID:17666800
RGD:4890027 , RGD:2307114
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr1
C-C motif chemokine receptor 1
IEP IMP
RGD
PMID:14655765 PMID:14512166
RGD:5688165 , RGD:5688167
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
IEP
mRNA:increased expression:spinal cord
RGD
PMID:9655467
RGD:632391
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:15034073
RGD:6893394
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:spinal cord, macrophage, microglia (rat)
RGD
PMID:17484785
RGD:4890436
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd28
Cd28 molecule
IMP
RGD
PMID:16061730
RGD:2307203
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd4
Cd4 molecule
treatment
IEP IMP
protein:decreased expression:T lymphocyte:
RGD
PMID:9138014 PMID:3097071
RGD:10058963 , RGD:10058968
NCBI chr 4:157,668,878...157,695,366
G
Cd80
Cd80 molecule
IMP
RGD
PMID:9379015
RGD:6902906
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
resistance disease_progression
ISO IEP
protein:increased expression:spinal cord, blood vessel (rat)
RGD
PMID:10477557 PMID:20451260
RGD:4892227 , RGD:4892207
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Ciita
class II, major histocompatibility complex, transactivator
IAGP
RGD
PMID:15821736
RGD:1358146
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
IDA
RGD
PMID:21107918 PMID:7541143 PMID:10650887
RGD:6483335 , RGD:6483353 , RGD:6483351
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Comt
catechol-O-methyltransferase
treatment
ISO
RGD
PMID:25242632
RGD:13450949
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cpb2
carboxypeptidase B2
IEP
RGD
PMID:22768796
RGD:7243111
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
G
Cspg4
chondroitin sulfate proteoglycan 4
ISO IEP
protein:increased expression:spinal cord
RGD
PMID:21679768 PMID:20162860
RGD:5686852 , RGD:5686863
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:9379015
RGD:6902906
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctsc
cathepsin C
IEP
RGD
PMID:843913
RGD:1599653
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Ctss
cathepsin S
ISO
RGD
PMID:21439785
RGD:5686915
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
RGD
PMID:16053521
RGD:4891973
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP IMP
RGD
PMID:16053521 PMID:24706865
RGD:4891973 , RGD:9491767
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:19616545
RGD:7257694
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
IMP
RGD
PMID:21038468
RGD:5135506
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Dab2
DAB adaptor protein 2
disease_progression
IEP
RGD
PMID:21890121
RGD:7243155
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
G
Dlk1
delta like non-canonical Notch ligand 1
ISO
RGD
PMID:24676147
RGD:150520045
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
G
Dll1
delta like canonical Notch ligand 1
ISO
RGD
PMID:17947672
RGD:6482235
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
G
Dll4
delta like canonical Notch ligand 4
ameliorates
ISO
RGD
PMID:21813770
RGD:155663662
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Dusp10
dual specificity phosphatase 10
ISO
RGD
PMID:15306813
RGD:7775013
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
disease_progression
IEP
RGD
PMID:19524108
RGD:9685491
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18382691
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:21565615 PMID:21182085
RGD:5508732 , RGD:5508735
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Faslg
Fas ligand
treatment
ISO
RGD
PMID:10944459
RGD:12903984
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr2a
Fc gamma receptor 2A
ISO
RGD
PMID:12576552
RGD:5508383
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fgf2
fibroblast growth factor 2
IEP
mRNA:increased expression:spinal cord
RGD
PMID:8929896 PMID:9814819
RGD:8655647 , RGD:9831448
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Flt1
Fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:18721816
RGD:10402153
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Foxo3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27742544
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Ghrh
growth hormone releasing hormone
resistance
ISO
RGD
PMID:21846799
RGD:5687168
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
G
Ghrl
ghrelin and obestatin prepropeptide
treatment
IDA
RGD
PMID:19620309
RGD:12905041
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Gjc2
gap junction protein, gamma 2
ISO
protein:decreased expression:white matter of spinal cord, gap junction (mouse)
RGD
PMID:22461072
RGD:13208593
NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467
G
Gli1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Glud1
glutamate dehydrogenase 1
ISO
mRNA, protein:decreased expression:spinal cord
RGD
PMID:9145307
RGD:6484657
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Gpx3
glutathione peroxidase 3
IEP
RGD
PMID:22320401
RGD:7175513
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Havcr2
hepatitis A virus cellular receptor 2
ISO IEP
mRNA:increased expression:spinal cord:
RGD
PMID:11823861 PMID:15913792
RGD:9686086 , RGD:9686113
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO IMP
RGD
PMID:17085013 PMID:14691063
RGD:5508469 , RGD:5508476
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Ifnb1
interferon beta 1
ameliorates treatment exacerbates
ISO IDA IMP
RGD
PMID:9578846 PMID:8955226 PMID:19380780 PMID:18997868
RGD:401854237 , RGD:401854247 , RGD:401854246 , RGD:5147399
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
disease_progression treatment
ISO
RGD
PMID:15661899 PMID:22896638
RGD:7987912 , RGD:10755692
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
treatment
ISO
human protein in a rat model
RGD
PMID:7541143
RGD:6483353
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:23872438
RGD:7364993
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il10ra
interleukin 10 receptor subunit alpha
IEP
RGD
PMID:12620647
RGD:2316323
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
G
Il12a
interleukin 12A
ISO
RGD
PMID:12471147
RGD:724447
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
IEP
mRNA, protein:increased expression:lymph node
RGD
PMID:19233473
RGD:4831840
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il13
interleukin 13
severity
ISO
RGD
PMID:18250480 PMID:7523520
RGD:5684366 , RGD:5684367
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il16
interleukin 16
IMP
RGD
PMID:17641011
RGD:5024940
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Il17a
interleukin 17A
treatment
IEP ISO IDA
mRNA, protein:increased expression:lymph node
RGD
PMID:19233473 PMID:16200068 PMID:20003332 PMID:16785554
RGD:4831840 , RGD:9212317 , RGD:4888522 , RGD:4889113
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
IMP IEP
mRNA:increased expression:spinal cord
RGD
PMID:9834127 PMID:9846824
RGD:4889543 , RGD:4889542
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18r1
interleukin 18 receptor 1
IEP
mRNA:increased expression:lymph node
RGD
PMID:19269041
RGD:2311529
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:7593560
RGD:8551836
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il21
interleukin 21
IDA
RGD
PMID:18997868
RGD:5147399
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il21r
interleukin 21 receptor
no_association disease_progression
ISO
RGD
PMID:18546146 PMID:18353312
RGD:6892939 , RGD:6892940
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
Il22
interleukin 22
IEP
RGD
PMID:19269041
RGD:2311529
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il27
interleukin 27
ISO
protein:decreased expression:blood serum (mouse)
RGD
PMID:33403844
RGD:126790527
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il2ra
interleukin 2 receptor subunit alpha
IEP
RGD
PMID:19269041
RGD:2311529
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4
interleukin 4
treatment
ISO IEP
RGD
PMID:18239607 PMID:1383385
RGD:7829778 , RGD:8142395
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
IEP ISO
protein:increased expression:oligodendrocytes (rat)
RGD
PMID:9358769 PMID:23322593
RGD:2307412 , RGD:12791289
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itga4
integrin subunit alpha 4
treatment susceptibility
IMP IDA
rat bone marrow cells in a mouse model
RGD
PMID:12626659 PMID:18722022
RGD:9698418 , RGD:9698436
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Jag1
jagged canonical Notch ligand 1
ISO
RGD
PMID:17947672
RGD:6482235
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Jak2
Janus kinase 2
ISO
RGD
PMID:22066025
RGD:6483041
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jak3
Janus kinase 3
treatment
IDA
RGD
PMID:25012120
RGD:11533939
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Kdr
kinase insert domain receptor
ISO
RGD
PMID:19233483
RGD:5684404
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
RGD
PMID:25972476
RGD:12910744
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Lrp1
LDL receptor related protein 1
ISO
protein:increased expression:cerebellum, spinal cord
RGD
PMID:19299462
RGD:13800552
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Lta
lymphotoxin alpha
IEP
mRNA:increased expression:spinal cord mRNA:increased expression:brain
RGD
PMID:7593556 PMID:9184655
RGD:1625038 , RGD:4143220
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Mapt
microtubule-associated protein tau
treatment
IDA
RGD
PMID:15494405
RGD:1358431
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mbp
myelin basic protein
ISO
human sequence peptide in a rat model; associated with Herpesviridae infections CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11501064 PMID:15159442 PMID:17884951 PMID:24070732 PMID:16285900 PMID:12811845 More...
RGD:7349334 , RGD:30296670
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mdk
midkine
IEP
RGD
PMID:9814819
RGD:9831448
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Mir146a
microRNA 146a
ISO
mRNA:increased expression:spinal cord (mouse)
RGD
PMID:22660635
RGD:155663483
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir23b
microRNA 23b
treatment
ISO
mRNA:decreased expression:spinal cord (mouse)
RGD
PMID:22660635 PMID:22660635
RGD:155663483 , RGD:155663483
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mmp2
matrix metallopeptidase 2
IDA
RGD
PMID:19922364
RGD:2325703
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp7
matrix metallopeptidase 7
IEP
RGD
PMID:9549496
RGD:8547909
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mmp9
matrix metallopeptidase 9
treatment
IEP ISO
protein:increased expression:multiple tissues
RGD
PMID:9549496 PMID:24797785 PMID:20810258 PMID:22800566
RGD:8547909 , RGD:13204801 , RGD:13204762 , RGD:8547936
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mobp
myelin-associated oligodendrocyte basic protein
ISO
RGD
PMID:10623862
RGD:27226694
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
G
Mog
myelin oligodendrocyte glycoprotein
IDA ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12904460 PMID:16931536 PMID:17654737 PMID:17728465 PMID:18566399 PMID:18667803 PMID:21068375 PMID:21317386 PMID:21341682 PMID:23360710 PMID:23547115 PMID:23639249 PMID:30661753 PMID:10384097 PMID:14624757 PMID:14624757 PMID:12799014 More...
RGD:9685372 , RGD:9685375 , RGD:9685375 , RGD:9685373
NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474
G
Mt1
metallothionein 1
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Ncam1
neural cell adhesion molecule 1
IEP
protein:decreased expression:hippocampus
RGD
PMID:17064783
RGD:40924670
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Nefl
neurofilament light chain
IEP
protein:increased expression:cerebrospinal fluid, spinal cord
RGD
PMID:16182933
RGD:2299007
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19910389
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ngf
nerve growth factor
IEP
protein, mRNA:increased expression:thalamus and cortex, CNS
RGD
PMID:8866783
RGD:5508386
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
severity
ISO IEP
mRNA:increased expression:central nervous system
RGD
PMID:16519950 PMID:8866783
RGD:5508312 , RGD:5508386
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nos2
nitric oxide synthase 2
ISO
RGD
PMID:21857957
RGD:5509069
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
ISO
RGD
PMID:21266776
RGD:6480877
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
RGD
PMID:17322387
RGD:4892331
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IEP
mRNA:increased expression:brain subventricular zone:
RGD
PMID:15589512
RGD:5684777
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Olig1
oligodendrocyte transcription factor 1
treatment
ISO
RGD
PMID:24941845
RGD:40902822
NCBI chr11:30,514,379...30,516,521
Ensembl chr11:30,514,379...30,516,521
G
Olig2
oligodendrocyte transcription factor 2
treatment
ISO IEP
RGD
PMID:24941845 PMID:29682587
RGD:40902822 , RGD:40902863
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
G
Pdcd1
programmed cell death 1
susceptibility
ISO
RGD
PMID:24648472
RGD:40818258
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pdgfb
platelet derived growth factor subunit B
treatment
IDA
RGD
PMID:16042218
RGD:11080975
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
IDA
RGD
PMID:16042218
RGD:11080975
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
treatment
IDA
RGD
PMID:16042218
RGD:11080975
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
RGD
PMID:20303183
RGD:6482686
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Plp1
proteolipid protein 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21068375 PMID:24941845
RGD:40902822
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17261635
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Prf1
perforin 1
ISO
RGD
PMID:20708278
RGD:6482806
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
severity
ISO
RGD
PMID:19486896
RGD:6484540
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO IEP
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:microglia, macrophage,
RGD
PMID:21667309 PMID:10229132
RGD:5688149 , RGD:5688250
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO IEP
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:endothelial cell
RGD
PMID:21667309 PMID:10229132
RGD:5688149 , RGD:5688250
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptn
pleiotrophin
IEP
mRNA:increased expression:spinal cord (rat)
RGD
PMID:9814819
RGD:9831448
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Qki
QKI, KH domain containing RNA binding
IEP
RGD
PMID:22740327
RGD:10045997
NCBI chr 1:50,387,716...50,501,568
Ensembl chr 1:50,387,698...50,498,831
G
Rangrf
RAN guanine nucleotide release factor
IDA
RGD
PMID:8557821
RGD:6771380
NCBI chr10:53,677,467...53,678,880
Ensembl chr10:53,677,467...53,678,840
G
Rhoa
ras homolog family member A
severity
IEP
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
RT1-Ba
RT1 class II, locus Ba
IMP IDA
RGD
PMID:18050272 PMID:9834080 PMID:16723470
RGD:5147622 , RGD:5147666 , RGD:5147639
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
IMP IDA ISO
RGD
PMID:16723470 PMID:9834080 PMID:16194572
RGD:5147639 , RGD:5147666 , RGD:5147647
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Da
RT1 class II, locus Da
ISO
RGD
PMID:8676084
RGD:5490166
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
RT1-Db1
RT1 class II, locus Db1
ISO
RGD
PMID:16194572
RGD:5147647
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Serpine1
serpin family E member 1
ISO
mRNA,protein:increased expression,increased activity:spinal cord, astrocyte:
RGD
PMID:11733372
RGD:13208549
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Shh
sonic hedgehog signaling molecule
IEP ISO
RGD
PMID:15892298 PMID:18991353
RGD:12801423 , RGD:12801440
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Sigmar1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23547115
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
IDA
RGD
PMID:22436018
RGD:9999395
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sncb
synuclein, beta
IDA
RGD
PMID:12496452
RGD:730073
NCBI chr17:9,846,802...9,855,013
Ensembl chr17:9,846,802...9,855,012
G
Srsf9
serine and arginine rich splicing factor 9
treatment
ISO
RGD
PMID:20616573
RGD:11040805
NCBI chr12:41,278,225...41,284,502
Ensembl chr12:41,275,687...41,284,499
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:22066025
RGD:6483041
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
ISO
RGD
PMID:22066025 PMID:17878325
RGD:6483041 , RGD:6892946
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat4
signal transducer and activator of transcription 4
IEP
RGD
PMID:11240014
RGD:7207888
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Tgfb1
transforming growth factor, beta 1
IEP
mRNA, protein:increased expression:central nervous system
RGD
PMID:17204936
RGD:2302088
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
IEP
mRNA, protein:decreased expression:central nervous system
RGD
PMID:17204936
RGD:2302088
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Timp3
TIMP metallopeptidase inhibitor 3
IEP
protein:increased expression:spinal cord
RGD
PMID:15878627
RGD:1559178
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tlr2
toll-like receptor 2
IEP
protein:increased expression:spinal cord
RGD
PMID:18644848
RGD:2312575
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IEP
protein:increased expression:spinal cord
RGD
PMID:18644848
RGD:2312575
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IEP
RGD
PMID:11421579
RGD:12904661
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vcam1
vascular cell adhesion molecule 1
IDA
RGD
PMID:12196270
RGD:1580348
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vdr
vitamin D receptor
treatment
ISO
RGD
PMID:21318047 PMID:21287548
RGD:8158064 , RGD:13210791
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
IDA ISO IEP
mRNA:decreased expression:Cerebrospinal Fluid: mRNA,protein:decreased expression:spinal cord:
RGD
PMID:12387457 PMID:17083617 PMID:17083617
RGD:634258 , RGD:7421596 , RGD:7421596
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:20978211
RGD:5685386
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Arpc5
actin related protein 2/3 complex, subunit 5
treatment
IEP
RGD
PMID:17997938
RGD:11049469
NCBI chr13:64,904,504...64,913,413
Ensembl chr13:64,887,136...64,913,410
G
C3
complement C3
ISO IEP
RGD
PMID:17962462 PMID:147324
RGD:7401263 , RGD:11040804
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C6
complement C6
susceptibility
IAGP
RGD
PMID:17034580
RGD:1600670
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
Cd40lg
CD40 ligand
treatment
IMP
RGD
PMID:11359850
RGD:8547800
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cfb
complement factor B
treatment
IMP
RGD
PMID:25355917
RGD:11041161
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Chrna1
cholinergic receptor nicotinic alpha 1 subunit
treatment
ISO
RGD
PMID:10606626
RGD:704386
NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840
G
Ctsl
cathepsin L
IEP
mRNA:increased expression:quadriceps (rat)
RGD
PMID:16365386
RGD:2315588
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cxcl10
C-X-C motif chemokine ligand 10
IMP IEP
RGD
PMID:19232748 PMID:15843529
RGD:2311364 , RGD:1598501
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl9
C-X-C motif chemokine ligand 9
IEP
RGD
PMID:15843529
RGD:1598501
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP IMP
RGD
PMID:15843529 PMID:19232748
RGD:1598501 , RGD:2311364
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Il15
interleukin 15
IEP
protein:increased expression:skeletal muscle
RGD
PMID:11585642
RGD:1626617
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il23r
interleukin 23 receptor
IEP
mRNA:increased expression:lymph node
RGD
PMID:21193288
RGD:5108250
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il2ra
interleukin 2 receptor subunit alpha
IDA
RGD
PMID:18250419
RGD:2325986
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4r
interleukin 4 receptor
IEP
protein:increased expression:skeletal muscle
RGD
PMID:19395316
RGD:4889981
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Musk
muscle associated receptor tyrosine kinase
IDA
RGD
PMID:17081697
RGD:2317084
NCBI chr 5:73,058,427...73,169,696
Ensembl chr 5:73,058,121...73,171,932
G
Myog
myogenin
IEP
RGD
PMID:1312030
RGD:9686077
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Rapsn
receptor-associated protein of the synapse
IEP
protein:decreased expression:neuromuscular junction
RGD
PMID:19344765
RGD:8549750
NCBI chr 3:77,015,073...77,024,378
Ensembl chr 3:76,983,471...77,024,373
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
RGD
PMID:23674516
RGD:8695925
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Ager
advanced glycosylation end product-specific receptor
IEP
protein:increased expression:heart
RGD
PMID:24599045
RGD:8696002
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Casp3
caspase 3
treatment
IEP ISO
RGD
PMID:28903333 PMID:23833961
RGD:13702869 , RGD:13702874
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:23833961
RGD:13702874
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
ISO
RGD
PMID:23833961
RGD:13702874
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
IEP
RGD
PMID:17060028
RGD:1625364
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cav2
caveolin 2
IEP
RGD
PMID:17060028
RGD:1625364
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
G
Ccl2
C-C motif chemokine ligand 2
disease_progression
IEP
mRNA, protein:increased expression:heart, serum (rat)
RGD
PMID:11472393
RGD:8549580
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cd28
Cd28 molecule
treatment severity
IDA ISO
RGD
PMID:19907173 PMID:8759765
RGD:13702882 , RGD:13702883
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:25297507
RGD:13702884
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Fgl2
fibrinogen-like 2
severity
IEP
RGD
PMID:28892130
RGD:38549573
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Foxp3
forkhead box P3
severity treatment
IEP
RGD
PMID:28892130 PMID:19907173
RGD:38549573 , RGD:13702882
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Grk2
G protein-coupled receptor kinase 2
treatment
IEP
RGD
PMID:30024944
RGD:13792695
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Hamp
hepcidin antimicrobial peptide
IEP
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hmgb1
high mobility group box 1
IEP
protein:increased expression:heart, serum
RGD
PMID:24599045
RGD:8696002
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
RGD
PMID:21927577
RGD:5685668
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:11701617
RGD:13702911
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IEP
RGD
PMID:19907173
RGD:13702882
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
treatment
IMP
RGD
PMID:15902684
RGD:8549607
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
mouse gene in a rat model
RGD
PMID:15795329
RGD:8551728
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
treatment
IDA
RGD
PMID:26339812
RGD:11062109
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcna5
potassium voltage-gated channel subfamily A member 5
IEP
RGD
PMID:15306225
RGD:7242784
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Myh6
myosin heavy chain 6
ISO
RGD
PMID:10199887
RGD:12792956
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
G
Pparg
peroxisome proliferator-activated receptor gamma
IEP
protein:increased expression:myocardium (rat)
RGD
PMID:15167281
RGD:8553039
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Reg3b
regenerating family member 3 beta
IEP
mRNA:increased expression:heart, cardiomyocyte (rat)
RGD
PMID:18774541
RGD:9831381
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
G
Rorc
RAR-related orphan receptor C
severity
IEP
RGD
PMID:28892130
RGD:38549573
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Rps6
ribosomal protein S6
IDA
RGD
PMID:22014063
RGD:11041642
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:17322642
RGD:9586020
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Adam8
ADAM metallopeptidase domain 8
ISO
RGD
PMID:9670863
RGD:2325244
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:spinal cord (rat)
RGD
PMID:15710454
RGD:2313042
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Anxa1
annexin A1
IEP
protein:increased expression:sciatic nerve
RGD
PMID:10603033
RGD:2306914
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
App
amyloid beta precursor protein
treatment
IDA
RGD
PMID:28446186
RGD:13782060
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Cav1
caveolin 1
IEP
protein:increased phosphorylation:sciatic nerve
RGD
PMID:17234162
RGD:2289125
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccr1
C-C motif chemokine receptor 1
ISO
protein:increased expression:sciatic nerve, macrophage, T cell
RGD
PMID:20500551
RGD:5688140
NCBI chr 8:123,556,286...123,561,841
G
Cd14
CD14 molecule
severity
IEP
RGD
PMID:19162137
RGD:2312712
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd28
Cd28 molecule
IMP
RGD
PMID:12864982
RGD:2307204
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd40
CD40 molecule
IEP
RGD
PMID:17188497
RGD:5491181
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
IEP
RGD
PMID:17188497
RGD:5491181
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd59b
CD59b molecule
IEP
protein:increased expression:Schwann cell (rat)
RGD
PMID:10450801
RGD:1600494
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
RGD
PMID:18448252
RGD:4891968
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP
RGD
PMID:18448252
RGD:4891968
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Dcc
DCC netrin 1 receptor
IEP
RGD
PMID:16337279
RGD:2314374
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
G
Dhodh
dihydroorotate dehydrogenase (quinone)
treatment
IMP
RGD
PMID:11522581
RGD:11040446
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Epas1
endothelial PAS domain protein 1
IEP
RGD
PMID:23603807
RGD:10395381
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Epo
erythropoietin
IEP
RGD
PMID:20361946
RGD:10400894
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Foxp3
forkhead box P3
IEP
protein:decreased expression:sciatic nerve
RGD
PMID:30464413
RGD:38549576
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Havcr2
hepatitis A virus cellular receptor 2
disease_progression
IEP
mRNA,protein:increased expression:sciatic nerve:
RGD
PMID:21784136
RGD:9686114
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
RGD
PMID:23603807
RGD:10395381
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
disease_progression
IMP
RGD
PMID:17286627
RGD:5508466
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Ifnb1
interferon beta 1
ameliorates
IDA
RGD
PMID:10494101
RGD:401854240
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Il17a
interleukin 17A
ISO IEP
mRNA, protein:increased expression:sciatic nerve, inguinal lymph node
RGD
PMID:10785455 PMID:19207263
RGD:4888513 , RGD:4831923
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
treatment
IEP
RGD
PMID:18400050
RGD:7401218
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il5
interleukin 5
treatment
IDA
RGD
PMID:22310911
RGD:11522768
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Mmp7
matrix metallopeptidase 7
IEP
RGD
PMID:9546322
RGD:9685357
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mmp9
matrix metallopeptidase 9
IEP
RGD
PMID:9546322
RGD:9685357
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nos2
nitric oxide synthase 2
IEP
protein:increased expression:nerve root, leukocyte, Schwann cell (rat)
RGD
PMID:15144861
RGD:1580265
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IEP
protein:increased expression:
RGD
PMID:12916703
RGD:5688236
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP
protein:increased expression:
RGD
PMID:12916703
RGD:5688236
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rhoa
ras homolog family member A
IEP
protein:increased expression:spinal ganglion, macrophage, T cell
RGD
PMID:17367505
RGD:1642966
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Spp1
secreted phosphoprotein 1
IDA
RGD
PMID:15531104
RGD:1581323
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tlr2
toll-like receptor 2
severity
IEP
RGD
PMID:19162137
RGD:2312712
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IEP
mRNA:increased expression:multiple tissues
RGD
PMID:18434754
RGD:2312677
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
IEP
mRNA:increased expression:multiple tissues
RGD
PMID:18434754
RGD:2312677
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
treatment
IEP
RGD
PMID:18400050
RGD:7401218
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
IDA IEP
mRNA:increased expression:sciatic nerve,peripheral blood mononuclar cell
RGD
PMID:28260057 PMID:28260057
RGD:127284841 , RGD:127284841
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Ccl2
C-C motif chemokine ligand 2
IEP
protein:increased expression:testis (rat)
RGD
PMID:14638441
RGD:1358455
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Hnrnph1
heterogeneous nuclear ribonucleoprotein H1
IDA
RGD
PMID:16092147
RGD:1624236
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
G
Hspd1
heat shock protein family D (Hsp60) member 1
IDA
RGD
PMID:16092147
RGD:1624236
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Inha
inhibin subunit alpha
IEP
protein:decreased expression:serum:
RGD
PMID:11431143
RGD:8694089
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Serpina1
serpin family A member 1
IEP
protein:increased expression:serum
RGD
PMID:16092147
RGD:1624236
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Ccl2
C-C motif chemokine ligand 2
IEP
mRNA:increased expression:iris, ciliary body, popliteal lymph nodes (rat)
RGD
PMID:15109911
RGD:8549495
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
no_association
ISO
RGD
PMID:24736166 PMID:19357362
RGD:8657357 , RGD:8657383
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:14528321 PMID:11481266
RGD:7204514 , RGD:7421509
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
mRNA, protein:increased expression:iris, ciliary body, aqueous humor
RGD
PMID:16030495
RGD:9479740
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP ISO
RGD
PMID:16030495 PMID:19689733
RGD:9479740 , RGD:9491397
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Dll4
delta like canonical Notch ligand 4
disease_progression
IEP
RGD
PMID:31209505
RGD:155791448
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Fas
Fas cell surface death receptor
susceptibility
ISO
RGD
PMID:11067900
RGD:8662852
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:8100190
RGD:8158117
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment disease_progression
ISO IEP
RGD
PMID:18495789 PMID:31209505 PMID:16043105 PMID:18390724
RGD:7365044 , RGD:155791448 , RGD:7365069 , RGD:7365052
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
treatment
IMP IDA IEP
mRNA:increased expression:lymph node (rat)
RGD
PMID:24117055 PMID:23626769 PMID:21686325
RGD:9074484 , RGD:9173789 , RGD:9158567
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1rn
interleukin 1 receptor antagonist
ISO
human protein in mouse model
RGD
PMID:16009838
RGD:8549788
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Mmp1
matrix metallopeptidase 1
onset
IEP
mRNA, protein:increased expression:eye (rat)
RGD
PMID:19755419
RGD:7207388
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Notch1
notch receptor 1
disease_progression
IEP
RGD
PMID:31209505
RGD:155791448
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Rpe65
retinoid isomerohydrolase RPE65
ISO
human peptides in a rat model
RGD
PMID:16109648
RGD:9585652
NCBI chr 2:248,766,497...248,798,403
Ensembl chr 2:248,766,612...248,798,403
G
RT1-CE13
RT1 class I, locus CE13
treatment
ISO
human HLA-B27 peptide in rat model human peptide in rat model; HLA-B27
RGD
PMID:15681796 PMID:9232451
RGD:7364916 , RGD:7364942
NCBI chr20:3,314,830...3,318,106
G
Socs1
suppressor of cytokine signaling 1
ameliorates
ISO
RGD
PMID:24993154
RGD:151232288
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:22238646
RGD:8694304
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:20207969
RGD:7794846
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Ace2
angiotensin converting enzyme 2
treatment
ISO
human gene in a mouse model
RGD
PMID:25228068
RGD:40818264
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
C3
complement C3
ISO
RGD
PMID:16143328
RGD:7401262
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Ccl2
C-C motif chemokine ligand 2
ISO
mRNA:increased expression:eye:
RGD
PMID:12605265
RGD:8661671
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:eye:
RGD
PMID:12605265
RGD:8661671
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd40lg
CD40 ligand
treatment
ISO
RGD
PMID:15972638
RGD:8547777
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cfb
complement factor B
treatment
ISO IMP
RGD
PMID:20806290 PMID:21216963
RGD:7411717 , RGD:7411732
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Icam1
intercellular adhesion molecule 1
treatment
IMP
RGD
PMID:7909311
RGD:8547706
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
IEP
mRNA,protein:increased expression:eye:
RGD
PMID:1572694
RGD:8142388
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
treatment
ISO IDA
RGD
PMID:22629453 PMID:11359436 PMID:15240742 PMID:21296818
RGD:7364830 , RGD:7365084 , RGD:7365075 , RGD:7364849
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il2
interleukin 2
disease_progression
ISO IEP
mRNA:increased expression:uvea:
RGD
PMID:7929845 PMID:7803357
RGD:8662951 , RGD:8662946
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
disease_progression
IEP
mRNA:increased expression:uvea:
RGD
PMID:7803357
RGD:8662946
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Stat3
signal transducer and activator of transcription 3
ISO
RGD
PMID:18424728
RGD:8694299
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
RGD
PMID:19635911
RGD:8661744
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Ace
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:24239644 PMID:17342403
RGD:40400720 , RGD:40400748
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Acer3
alkaline ceramidase 3
severity
ISO
mRNA,protein:decreased expression, decreased activity:colon:
RGD
PMID:26938296 PMID:26938296
RGD:35673322 , RGD:35673322
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
G
Adam17
ADAM metallopeptidase domain 17
treatment
IEP
RGD
PMID:11884025
RGD:632022
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Adrb3
adrenoceptor beta 3
no_association
IEP
mRNA:unaltered expression:colon (rat)
RGD
PMID:11803250
RGD:5684894
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Akt1
AKT serine/threonine kinase 1
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Atm
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:20179206
RGD:126781749
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atp5f1a
ATP synthase F1 subunit alpha
treatment
IEP
RGD
PMID:25689466
RGD:13703055
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc3
baculoviral IAP repeat-containing 3
exacerbates
ISO
RGD
PMID:26037070
RGD:11537970
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Cd68
Cd68 molecule
treatment
ISO
RGD
PMID:25004394
RGD:40925931
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
treatment
IMP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Csf1r
colony stimulating factor 1 receptor
ameliorates
ISO
RGD
PMID:23451116
RGD:150524300
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:16689657
RGD:11039462
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ereg
epiregulin
ISO
protein:increased expression:colonic mucosa (mouse)
RGD
PMID:20498653
RGD:39457688
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:31160593
RGD:126779602
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:22368862
RGD:10054108
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fgf10
fibroblast growth factor 10
treatment
ISO IDA
human protein in mouse model human gene product in mouse model human protein in mouse model with bacterial delivery system
RGD
PMID:10381813 PMID:11952999 PMID:23676805 PMID:19736360
RGD:126928132 , RGD:127284874 , RGD:127284855 , RGD:126928133
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgf7
fibroblast growth factor 7
treatment
ISO
human protein in mouse model
RGD
PMID:10219846
RGD:126928136
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Foxp3
forkhead box P3
treatment
ISO IDA
mRNA:increased expression:mucosa: protein:increased expression:colon:
RGD
PMID:26925602 PMID:28733028 PMID:27498708 PMID:17229795
RGD:38455994 , RGD:38549362 , RGD:14975101 , RGD:38455995
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Hamp
hepcidin antimicrobial peptide
IEP
protein:increased expression:colon
RGD
PMID:24764672
RGD:11041628
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hsf1
heat shock transcription factor 1
IEP
protein:increased acetylation:colon (rat)
RGD
PMID:25608526
RGD:10402402
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
RGD
PMID:10092309 PMID:29572553
RGD:11522714 , RGD:152995414
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
IEP ISO
protein:increased expression:plasma:
RGD
PMID:15030379 PMID:27498708
RGD:10755756 , RGD:14975101
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il10
interleukin 10
treatment
ISO IEP
associated with Helicobacter Infections
RGD
PMID:16982822 PMID:29572553 PMID:27815529 PMID:25727887
RGD:11049170 , RGD:152995414 , RGD:14975260 , RGD:11049485
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
treatment
ISO
RGD
PMID:31175857
RGD:14975282
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8978354
RGD:8551835
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
IEP
RGD
PMID:16630696
RGD:8662978
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il23a
interleukin 23 subunit alpha
severity
ISO
mRNA:increased expression:colon (mouse)
RGD
PMID:24028683
RGD:39458035
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il25
interleukin 25
treatment
ISO
RGD
PMID:19118508
RGD:39456129
NCBI chr15:28,408,766...28,412,157
Ensembl chr15:28,408,842...28,411,893
G
Il33
interleukin 33
severity treatment
ISO
RGD
PMID:25112700 PMID:28423665
RGD:39938951 , RGD:39939041
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il6
interleukin 6
treatment
IEP ISO IDA
RGD
PMID:16630696 PMID:27096537 PMID:16133010
RGD:8662978 , RGD:11062146 , RGD:11062139
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf9
interferon regulatory factor 9
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Itga2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:16534417
RGD:11530069
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga4
integrin subunit alpha 4
IEP
protein:increased expression:colon (rat)
RGD
PMID:12183646
RGD:729408
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Jak2
Janus kinase 2
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
IEP
mRNA, protein:increased expression:colon
RGD
PMID:23986198
RGD:10412026
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kl
Klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:20004202
RGD:10403055
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Mapk1
mitogen activated protein kinase 1
treatment
IEP
RGD
PMID:27028006
RGD:13800882
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29037916
RGD:13800567
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mif
macrophage migration inhibitory factor
severity
ISO
RGD
PMID:15807847
RGD:36947390
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:colon, small intestine (mouse)
RGD
PMID:24092752
RGD:126925183
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
treatment
ISO IMP
associated with Helicobacter Infections
RGD
PMID:30927737 PMID:28461115 PMID:28752563 PMID:30253332 PMID:21880981 PMID:28246471 More...
RGD:21079443 , RGD:25314295 , RGD:24922208 , RGD:21081536 , RGD:21079473 , RGD:21079463
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
ameliorates
ISO
RGD
PMID:23826144
RGD:41404691
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mmp2
matrix metallopeptidase 2
treatment
IEP
RGD
PMID:23323009
RGD:13207328
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:23323009
RGD:13207328
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Myd88
MYD88, innate immune signal transduction adaptor
exacerbates
ISO
RGD
PMID:25362351
RGD:150521530
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22350949
RGD:10412739
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IDA
RGD
PMID:21642017
RGD:10413866
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP
protein:increased expression:colonic mucosa:
RGD
PMID:22997830
RGD:13204727
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Npy
neuropeptide Y
treatment
IMP
RGD
PMID:20533056
RGD:10448943
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
IEP
RGD
PMID:24115822
RGD:11080973
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
treatment
IEP
RGD
PMID:24115822
RGD:11080973
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Phex
phosphate regulating endopeptidase X-linked
ISO
mRNA:decreased expression:bone:
RGD
PMID:16890604
RGD:11556253
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
susceptibility
ISO
RGD
PMID:20347874
RGD:38599183
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Ptger4
prostaglandin E receptor 4
treatment
IMP
RGD
PMID:12100473
RGD:727388
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rnasel
ribonuclease L
severity
ISO
RGD
PMID:23567782
RGD:40902808
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
G
Slc11a1
solute carrier family 11 member 1
ISO
RGD
PMID:19116231
RGD:5684934
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Smad4
SMAD family member 4
susceptibility
ISO
RGD
PMID:23090737
RGD:12880038
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Socs3
suppressor of cytokine signaling 3
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Tnf
tumor necrosis factor
treatment
IMP IEP
RGD
PMID:21296062 PMID:29572553
RGD:8661763 , RGD:152995414
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IMP
RGD
PMID:21296062
RGD:8661763
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Aacs
acetoacetyl-CoA synthetase
IDA
protein:decreased activity:liver
RGD
PMID:12034369
RGD:2301022
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
G
Aanat
aralkylamine N-acetyltransferase
IEP
RGD
PMID:18624957
RGD:2301030
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
G
Abat
4-aminobutyrate aminotransferase
IDA
RGD
PMID:9846053
RGD:1598518
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Abcb1a
ATP binding cassette subfamily B member 1A
disease_progression treatment
IAGP IEP IDA
protein: decreased expression mRNA:increased expression:brain mRNA:increased expression:ileum, intestinal mucosa (rat)
RGD
PMID:17074306 PMID:17664251 PMID:26460146 PMID:21685928
RGD:1598559 , RGD:2312730 , RGD:11041112 , RGD:8657121
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
disease_progression
IDA IEP
mRNA:increased expression:brain mRNA:increased expression:ileum, intestinal mucosa (rat)
RGD
PMID:17074306 PMID:17664251 PMID:26460146
RGD:1598559 , RGD:2312730 , RGD:11041112
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcb4
ATP binding cassette subfamily B member 4
IDA
RGD
PMID:12055592
RGD:1598588
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc2
ATP binding cassette subfamily C member 2
IEP
protein: increased expression mRNA:decreased expression:liver mRNA: increased expression: brain
RGD
PMID:19356064 PMID:20487213 PMID:17664251
RGD:2312728 , RGD:11541075 , RGD:2312730
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
IEP
mRNA:increased expression:liver
RGD
PMID:20487213
RGD:11541075
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc9
ATP binding cassette subfamily C member 9
IEP
mRNA, protein:decreased expression:heart
RGD
PMID:22257425
RGD:12792003
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
G
Abcg2
ATP binding cassette subfamily G member 2
IEP
protein:decreased expression:cerebral cortex
RGD
PMID:17915193
RGD:2315584
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg5
ATP binding cassette subfamily G member 5
IEP
RGD
PMID:14618236
RGD:1558629
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
IEP
RGD
PMID:14618236
RGD:1558629
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Acaa1a
acetyl-CoA acyltransferase 1A
IEP
mRNA:increased expression:heart
RGD
PMID:17632588
RGD:2313044
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
G
Acadvl
acyl-CoA dehydrogenase, very long chain
ISO
protein:decreased expression:brain
RGD
PMID:25260493
RGD:10047114
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
G
Ace
angiotensin I converting enzyme
IEP ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22191573 PMID:18679036
RGD:2313799
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
protein:altered expression:kidney
RGD
PMID:18679036
RGD:2313799
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ache
acetylcholinesterase
treatment
IEP IDA
protein:increased expression:blood
RGD
PMID:1385785 PMID:19303406 PMID:19296211 PMID:19347982
RGD:2312437 , RGD:2312430 , RGD:2312432 , RGD:150517552
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acmsd
aminocarboxymuconate semialdehyde decarboxylase
treatment
IDA IEP
RGD
PMID:12042425 PMID:19169727
RGD:13831125 , RGD:13831126
NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209
G
Acot1
acyl-CoA thioesterase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acot2
acyl-CoA thioesterase 2
IEP
protein:increased expression:heart, mitochondrion (rat)
RGD
PMID:17438340
RGD:2315861
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acox1
acyl-CoA oxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Acp5
acid phosphatase 5, tartrate resistant
IEP
protein:increased activity:femoral bone (rat)
RGD
PMID:19699734
RGD:2315882
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9452481
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl3
acyl-CoA synthetase long-chain family member 3
IEP
RGD
PMID:21136146
RGD:13831298
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Acsl6
acyl-CoA synthetase long-chain family member 6
IEP
mRNA:decreased expression:heart
RGD
PMID:16428347
RGD:1599808
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
G
Ada
adenosine deaminase
IEP ISO
protein:increased expression:platelet
RGD
PMID:19166862 PMID:9784839
RGD:2313538 , RGD:2313540
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adcyap1
adenylate cyclase activating polypeptide 1
IEP
protein:increased expression:pancreas, hypothalamus
RGD
PMID:9864055
RGD:2325314
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
G
Adipoq
adiponectin, C1Q and collagen domain containing
IEP ISO
mRNA, protein:decreased expression:adipose tissue, serum protein:increased expression:retina
RGD
PMID:16201273 PMID:23174569
RGD:1599146 , RGD:8694416
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adipor2
adiponectin receptor 2
no_association
IDA ISO
RGD
PMID:17884446 PMID:19220660 PMID:18222103
RGD:2312495 , RGD:2312478 , RGD:2312488
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adk
adenosine kinase
IEP
protein:decreased expression:spleen, lymphocyte
RGD
PMID:12729803
RGD:2313360
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Adm
adrenomedullin
IEP
protein:increased expression:pigmented epithelial cell, retina
RGD
PMID:16955796
RGD:1625296
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adora1
adenosine A1 receptor
treatment
IDA IEP ISO
protein:decreased expression:hippocampus associated with hypertension
RGD
PMID:11593763 PMID:16256246 PMID:19276628 PMID:9597368
RGD:2313808 , RGD:2313805 , RGD:2313804 , RGD:1625365
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2a
adenosine A2a receptor
IEP
protein:increased expression:hippocampus
RGD
PMID:16256246
RGD:2313805
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adra1a
adrenoceptor alpha 1A
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19133277 PMID:17054657
RGD:1625775
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Adrb1
adrenoceptor beta 1
IEP
protein:decreased expression:left ventricle muscular part
RGD
PMID:21054861
RGD:5129115
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb3
adrenoceptor beta 3
IEP ISO
protein:increased expression:left ventricle muscular part CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17622774 PMID:21054861
RGD:5129115
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
G
Adsl
adenylosuccinate lyase
IEP
protein:increased activity:heart (rat)
RGD
PMID:3360219
RGD:1598762
NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760
G
Adss1
adenylosuccinate synthase 1
IEP
protein:increased activity:heart (rat)
RGD
PMID:3360219
RGD:1598762
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP IDA ISO
protein:increased expression:lacrimal gland mRNA:increased expression:renal cortex (mouse)
RGD
PMID:16283249 PMID:22476978 PMID:21458563 PMID:20801062
RGD:1625335 , RGD:7245558 , RGD:7244188 , RGD:7243964
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15831366 PMID:17177138 PMID:18829990
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr2
angiotensin II receptor, type 2
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:12172324
RGD:6903861
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23499715
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Aire
autoimmune regulator
susceptibility
ISO
RGD
PMID:18399912
RGD:2306853
NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060
G
Akr1b1
aldo-keto reductase family 1 member B1
IEP
mRNA:increased expression:kidney (rat)
RGD
PMID:8204669
RGD:8548781
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akt1
AKT serine/threonine kinase 1
IDA IEP
protein:decreased serine phosphorylation:cornea protein:increased serine phosphorylation:cortex of kidney
RGD
PMID:21330660 PMID:18599524
RGD:5131482 , RGD:8657153
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alad
aminolevulinate dehydratase
susceptibility treatment
IEP IDA ISO
protein:decreased activity:liver, kidney (rat) protein:decreased activity:liver, erythrocyte (rat) protein:decreased activity:blood, liver
RGD
PMID:19043199 PMID:10224671 PMID:18668330 PMID:21864646 PMID:24947461 PMID:7728901 More...
RGD:4144150 , RGD:15039405 , RGD:12904704 , RGD:12904702 , RGD:12904692 , RGD:12904683
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Alas1
5'-aminolevulinate synthase 1
IEP
protein:decreased activity:liver (rat)
RGD
PMID:6688350
RGD:4144808
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldob
aldolase, fructose-bisphosphate B
IEP
mRNA:reduced expression:liver, small intestine (rat)
RGD
PMID:2984252
RGD:2313437
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Andpro
androgen regulated protein
IEP
protein:decreased expression:corpus cavernosum penis (rat)
RGD
PMID:20007950
RGD:14696816
NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966
G
Angpt1
angiopoietin 1
IEP
protein:increased expression:retina
RGD
PMID:15047628 PMID:17294737
RGD:2313817 , RGD:1626163
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Angpt2
angiopoietin 2
IEP
protein:increased expression:retina
RGD
PMID:15047628
RGD:2313817
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
G
Angptl3
angiopoietin-like 3
ISO
protein:increased expression:liver
RGD
PMID:15094378
RGD:2314234
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Anxa1
annexin A1
IEP
protein:increased glycation:respiratory system blood vessel endothelium
RGD
PMID:11423489
RGD:2306888
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
IEP
protein:increased glycation:respiratory system blood vessel endothelium
RGD
PMID:11423489
RGD:2306888
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Aoc1
amine oxidase, copper containing 1
IEP
RGD
PMID:1632778
RGD:2312809
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
G
Aoc3
amine oxidase, copper containing 3
ISO IEP IMP
CTD Direct Evidence: marker/mechanism protein:increased expression:kidney, serum
CTD RGD
PMID:14977883 PMID:12606817 PMID:2218072 PMID:19635478
RGD:2313824 , RGD:2313828 , RGD:2313819
NCBI chr10:86,272,757...86,280,702
G
Apoa1
apolipoprotein A1
treatment
IDA
RGD
PMID:17488882
RGD:7241577
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apob
apolipoprotein B
IEP
RGD
PMID:17292734
RGD:1642185
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
IEP
protein:decreased expression:plasma (rat)
RGD
PMID:16947119
RGD:1599198
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Apom
apolipoprotein M
ISO
protein:decreased secretion:plasma
RGD
PMID:16516154
RGD:2314249
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
G
Aprt
adenine phosphoribosyl transferase
IEP
protein:decreased activity:mammary gland (rat)
RGD
PMID:2451510
RGD:1599204
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
G
Aqp1
aquaporin 1
IEP
protein:increased expression:retina
RGD
PMID:19596320
RGD:2316078
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Aqp2
aquaporin 2
IEP ISO
protein:increased expression:Kidney Medulla protein:decreased expression:kidney collecting duct
RGD
PMID:11380083 PMID:15705184
RGD:2314347 , RGD:2314326
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
G
Aqp4
aquaporin 4
IEP
mRNA,protein:increased expression:retina:
RGD
PMID:22449442
RGD:8695996
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Ar
androgen receptor
ISO IEP
protein:decreased expression:pancreatic B cell mRNA, protein:decreased expression:epididymis, prostate gland, testis
RGD
PMID:18543106 PMID:16398356
RGD:2306772 , RGD:2306774
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arg1
arginase 1
IEP
protein:increased expression:aorta, liver (rat)
RGD
PMID:17967788
RGD:4142848
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Arg2
arginase 2
IEP
protein:increased activity:kidney (rat)
RGD
PMID:12841630
RGD:4143269
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Aspa
aspartoacylase
ISO
protein:increased expression:duodenum, brain
RGD
PMID:16707098
RGD:1601247
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
G
Ass1
argininosuccinate synthase 1
IEP
mRNA, protein:increased expression:aorta (rat)
RGD
PMID:11384198
RGD:1599310
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atf3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atg7
autophagy related 7
treatment
ISO IEP
protein:decreased expression:myocardium
RGD
PMID:24874076 PMID:24993523
RGD:11557993 , RGD:11557996
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
IEP
RGD
PMID:28483572
RGD:12910731
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
IDA IEP ISO
protein:increased carbonylation:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:21300842 PMID:20122173 PMID:28483572
RGD:6904139 , RGD:13782130 , RGD:12910731
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:20122173
RGD:13782130
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp4b
ATPase H+/K+ transporting subunit beta
IEP
RGD
PMID:20237950
RGD:14696743
NCBI chr16:76,144,150...76,153,063
Ensembl chr16:76,144,150...76,153,063
G
Atp5f1a
ATP synthase F1 subunit alpha
IEP
protein:decreased expression:cerebral cortex, mitochondrion (rat)
RGD
PMID:28526935
RGD:13703047
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
G
Atp5f1b
ATP synthase F1 subunit beta
IEP
associated with polycystic ovary syndrome;mRNA, protein:decreased expression:pancreas (rat)
RGD
PMID:28397049
RGD:13703107
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
G
Atp5pd
ATP synthase peripheral stalk subunit d
IEP
protein:decreased expression:retina (rat)
RGD
PMID:17465459
RGD:5147874
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
G
Atp5pf
ATP synthase peripheral stalk subunit F6
treatment
IEP
RGD
PMID:28731155
RGD:13800891
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
G
Avp
arginine vasopressin
ISO
mRNA:increased expression:hypothalamus
RGD
PMID:18420743
RGD:2301919
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Bad
BCL2-associated agonist of cell death
IDA
protein:increased expression, decreased phosphorylation, altered activity:testis protein:decreased serine phosphorylation:cornea
RGD
PMID:17870134 PMID:21330660
RGD:2292685 , RGD:5131482
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP ISO
protein:increased expression:retina CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23090186 PMID:18991018 PMID:23267840
RGD:2311240 , RGD:10054099
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bche
butyrylcholinesterase
IDA
protein:decreased expression:retina
RGD
PMID:11478742 PMID:12379509 PMID:16187484
RGD:2306783 , RGD:2306781 , RGD:1599458
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bckdha
branched chain keto acid dehydrogenase E1 subunit alpha
IEP
protein:increased expression:liver
RGD
PMID:9460082
RGD:1599467
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
G
Bckdhb
branched chain keto acid dehydrogenase E1 subunit beta
IEP
Protein:increased expression:liver;
RGD
PMID:9460082
RGD:1599467
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
G
Bcl2
BCL2, apoptosis regulator
IEP ISO
protein:increased expression:retina CTD Direct Evidence: marker/mechanism mRNA:decreased expression:embryo
CTD RGD
PMID:16959961 PMID:23090186 PMID:18991018 PMID:15649569
RGD:2311240 , RGD:1599491
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
IDA ISO
protein:decreased expression, altered activity:testis CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16959961 PMID:17870134
RGD:2292685
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
IEP
protein:decreased activity:heart, mitochondrion (rat)
RGD
PMID:3548709
RGD:2326100
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdkrb1
bradykinin receptor B1
IEP ISO IDA
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21430409 PMID:12489796 PMID:20092893 PMID:12522068
RGD:704379 , RGD:7241569 , RGD:704380
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
IEP
protein:increased expression:hindbrain, spinal cord mRNA:increased expression:heart
RGD
PMID:16138314 PMID:12489796
RGD:4890452 , RGD:704379
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP
RGD
PMID:24857910
RGD:10059399
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:24993523
RGD:11557996
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bglap
bone gamma-carboxyglutamate protein
IEP
protein:reduced expression:serum (rat)
RGD
PMID:19494718
RGD:2316184
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bmal1
basic helix-loop-helix ARNT like 1
IEP
RGD
PMID:18624957
RGD:2301030
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
G
Bmpr2
bone morphogenetic protein receptor type 2
IEP
protein:increased expression:lung
RGD
PMID:21521772
RGD:5135278
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
G
Btc
betacellulin
ISO
RGD
PMID:14988244 PMID:19819964 PMID:18388935
RGD:1357906 , RGD:2313774 , RGD:2306965
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
G
Cacng4
calcium voltage-gated channel auxiliary subunit gamma 4
IEP
mRNA:decreased expression:sinoatrial node:
RGD
PMID:27096430
RGD:13524560
NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
IEP
protein:decreased activity:mammary gland (rat)
RGD
PMID:1476792
RGD:5132591
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Calca
calcitonin-related polypeptide alpha
IEP
protein:increased expression:penis erectile tissue, seminal vesicle protein:decreased expression:dorsal root ganglion, neuron
RGD
PMID:19152794 PMID:17151309
RGD:2314033 , RGD:2314035
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Cald1
caldesmon 1
IEP
RGD
PMID:10644879
RGD:2314036
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Capn10
calpain 10
IEP
mRNA, protein:decreased expression:kidney cortex
RGD
PMID:22568896
RGD:7247732
NCBI chr 9:93,498,132...93,510,494
Ensembl chr 9:93,498,478...93,510,494
G
Carhsp1
calcium regulated heat stable protein 1
treatment
IEP
RGD
PMID:19997081
RGD:39128203
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Casp1
caspase 1
IEP
mRNA:increased expression:retina
RGD
PMID:18398369
RGD:2315888
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
treatment
IEP ISO
protein:increased activity:hypothalamus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20654064 PMID:19094082 PMID:28843149
RGD:2311447 , RGD:13782300
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IDA
protein:increased activity:heart left ventricle
RGD
PMID:15662549
RGD:2301316
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
treatment
ISO IEP
protein:increased expression, increased activity:pituitary gland protein:increased activity, increased expression:pituitary gland, prolactin secreting cell
RGD
PMID:17563067 PMID:28843149 PMID:19540304 PMID:15976052
RGD:2311429 , RGD:13782300 , RGD:2311427 , RGD:2311319
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
IEP
protein:increased activity, increased expression:pituitary gland
RGD
PMID:15976052
RGD:2311319
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Casq1
calsequestrin 1
IEP
protein:increased activity:skeletal muscle tissue
RGD
PMID:11976916
RGD:2314137
NCBI chr13:84,670,648...84,680,339
Ensembl chr13:84,670,649...84,680,339
G
Casr
calcium-sensing receptor
IEP
protein:increased expression:pancreas, liver, kidney (rat)
RGD
PMID:22844268
RGD:7205442
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
G
Cat
catalase
IEP ISO
associated with alcohol use disorder; protein:decreased activity;testis, epididymis (rat) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12123627 PMID:15855331 PMID:20709041 PMID:20376213 PMID:25541261
RGD:5130772 , RGD:405255664
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18266981 PMID:25086377
RGD:10045572
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cav3
caveolin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18266981
NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137
G
Cbr1
carbonyl reductase 1
IEP
protein:decreased expression:pancreas (rat)
RGD
PMID:18452227
RGD:2302233
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cck
cholecystokinin
IDA
RGD
PMID:15536283
RGD:2313638
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Cckbr
cholecystokinin B receptor
IEP
mRNA, protein:decreased expression:pancreas
RGD
PMID:15161757
RGD:1358452
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Ccl2
C-C motif chemokine ligand 2
treatment
IEP IDA
protein:increased expression:gingiva protein:increased expression:plasma
RGD
PMID:17876613 PMID:16891764 PMID:18976114
RGD:2306992 , RGD:8549535 , RGD:2306984
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21340626
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccn1
cellular communication network factor 1
ISO
mRNA:increased expression:retina (mouse)
RGD
PMID:22160564
RGD:329845551
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
IEP
mRNA, protein:increased expression:heart, myocardium (rat) mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:19820199 PMID:19625611
RGD:2314021 , RGD:2314487
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
IEP
RGD
PMID:20031167
RGD:2316310
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:20031167
RGD:2316310
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd3
cyclin D3
IEP
protein:increased expression:kidney, glomerulus
RGD
PMID:19276076
RGD:2316018
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccnt1
cyclin T1
IEP
mRNA,protein:decreased expression:liver:
RGD
PMID:20828602
RGD:9698426
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
G
Ccr5
C-C motif chemokine receptor 5
IEP
protein:increased expression:retina
RGD
PMID:21575160
RGD:11533943
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd28
Cd28 molecule
ISO
RGD
PMID:11160314
RGD:2307200
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd36
CD36 molecule
treatment
IEP
mRNA:increased expression:multiple organs
RGD
PMID:16838191 PMID:23691525
RGD:2307214 , RGD:11041145
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd3e
CD3 epsilon subunit of T-cell receptor complex
ISO
RGD
PMID:16628253
RGD:2314179
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
G
Cd40lg
CD40 ligand
treatment
ISO IEP
protein:increased expression:platelet (rat)
RGD
PMID:21831422 PMID:19237211
RGD:11352661 , RGD:2312338
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd68
Cd68 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20388520
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd80
Cd80 molecule
ISO
RGD
PMID:11160314
RGD:2307200
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
ISO
RGD
PMID:8993020
RGD:2313930
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdk9
cyclin-dependent kinase 9
IEP
mRNA,protein:decreased expression:liver:
RGD
PMID:20828602
RGD:9698426
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP
protein:increased expression:testes:
RGD
PMID:24828139
RGD:8662307
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cel
carboxyl ester lipase
IEP
protein:decreased expression:pancreas,
RGD
PMID:8446851
RGD:2313971
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
G
Cfd
complement factor D
IEP
protein:decreased expression:serum
RGD
PMID:8372111
RGD:1624344
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Cftr
CF transmembrane conductance regulator
severity
ISO
RGD
PMID:16804061
RGD:2314614
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Chat
choline O-acetyltransferase
IEP
protein:decreased expression:telencephalon
RGD
PMID:26282349
RGD:402463971
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
G
Chrm2
cholinergic receptor, muscarinic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18603373
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Clps
colipase
IEP
RGD
PMID:19577003
RGD:2314624
NCBI chr20:6,620,529...6,622,709
Ensembl chr20:6,620,529...6,622,689
G
Clu
clusterin
IEP
protein:increased expression:retina protein:increased expression:pancreatic islet
RGD
PMID:12763621 PMID:23351716
RGD:9068392 , RGD:9068411
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cma1
chymase 1
IEP
protein:increased expression:mesenteric artery, mast cell (rat)
RGD
PMID:15337505
RGD:5128799
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Cnr1
cannabinoid receptor 1
IEP
protein:increased expression:hypothalamus, striatum
RGD
PMID:18401837
RGD:2314633
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
IDA
protein:decreased expression:liver
RGD
PMID:12010186
RGD:2289789
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cp
ceruloplasmin
IEP
Protein:increased expression:plasma
RGD
PMID:16947119
RGD:1599198
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cps1
carbamoyl-phosphate synthase 1
IEP
protein:increased activity:liver (rat)
RGD
PMID:2882780
RGD:4144110
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Cpt1a
carnitine palmitoyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt1b
carnitine palmitoyltransferase 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Crh
corticotropin releasing hormone
IEP
mRNA:increased expression:paraventricular hypothalamic nucleus (rat)
RGD
PMID:9652969
RGD:5508166
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crp
C-reactive protein
IDA ISO
RGD
PMID:21736771 PMID:21736794
RGD:6482316 , RGD:6907422
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Crtc2
CREB regulated transcription coactivator 2
IMP
RGD
PMID:23595987
RGD:9685169
NCBI chr 2:175,709,603...175,719,768
Ensembl chr 2:175,709,644...175,719,763
G
Cs
citrate synthase
IEP
protein:increased expression:hippocampus protein decreased expression:heart, soleus
RGD
PMID:21088877 PMID:12077722
RGD:329337352 , RGD:329337354
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Csf1
colony stimulating factor 1
IEP
mRNA,protein:increased expression:retina (rat)
RGD
PMID:19219684
RGD:151665779
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf1r
colony stimulating factor 1 receptor
IEP
mRNA,protein:increased expression:retina (rat)
RGD
PMID:19219684
RGD:151665779
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Ctsb
cathepsin B
IEP
protein:decreased activity:glomerulus (rat)
RGD
PMID:10393385
RGD:2315531
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsc
cathepsin C
IEP
RGD
PMID:148980
RGD:1599652
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Ctsl
cathepsin L
IEP
mRNA:increased expression:gastrocnemius muscle (rat)
RGD
PMID:14718385
RGD:1641826
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP ISO
mRNA:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20388520 PMID:15153757
RGD:4891992
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP
mRNA:increased expression:kidney
RGD
PMID:15153757
RGD:4891992
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
mRNA:increased expression:pancreatic islet
RGD
PMID:17372021
RGD:2311360
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP ISO
protein:increased expression:retina
RGD
PMID:18201529 PMID:17878289
RGD:2306555 , RGD:2306557
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cyba
cytochrome b-245 alpha chain
IEP ISO
mRNA, protein:increased expression:aorta CTD Direct Evidence: marker/mechanism mRNA:increased expression:pancreas:
CTD RGD
PMID:11812764 PMID:12967931 PMID:20226688 PMID:23905384
RGD:2317852 , RGD:11040693
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
IEP ISO
mRNA:increased expression:aorta CTD Direct Evidence: marker/mechanism mRNA:increased expression:cerebral cortex;associated with reperfusion injury
CTD RGD
PMID:19478208 PMID:11157681 PMID:15148062
RGD:1599691 , RGD:1599683
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
IEP
mRNA:decreased expression:sciatic nerve (rat)
RGD
PMID:20826654
RGD:4145530
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
IEP
mRNA:increased expression:kidney
RGD
PMID:18582458
RGD:2307289
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
IEP
protein:decreased expression:ovary, testis (rat)
RGD
PMID:20428845
RGD:4890359
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IDA ISO
protein:increased expression:liver, microsome (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22342832 PMID:10711628
RGD:2307074
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
IDA
RGD
PMID:3295473
RGD:2307313
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
IEP
protein:increased expression:liver
RGD
PMID:17015271
RGD:2301459
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22342832 PMID:11465407
RGD:2315743
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IEP
mRNA, protein:increased expression:kidney, liver
RGD
PMID:12700423 PMID:19406192
RGD:2313685 , RGD:2313683
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dbh
dopamine beta-hydroxylase
IEP
mRNA, protein:increased expression:adrenal gland (rat)
RGD
PMID:16396986
RGD:5130724
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Dcn
decorin
IEP
RGD
PMID:15713786
RGD:2311414
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Defb1
defensin beta 1
IEP
RGD
PMID:16740310
RGD:2312491
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Dhodh
dihydroorotate dehydrogenase (quinone)
IEP
protein:decreased activity:mammary gland (rat)
RGD
PMID:1476792 PMID:1723607
RGD:5132591 , RGD:11040445
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Dpp4
dipeptidylpeptidase 4
ISO
RGD
PMID:19765579
RGD:2313699
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Drd1
dopamine receptor D1
treatment
IEP IDA
protein:decreased activity:striatum (rat)
RGD
PMID:1386820 PMID:20513244
RGD:2311600 , RGD:7248621
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
IEP
protein:altered activity:hypothalamus, pancreatic islet, brainstem (rat)
RGD
PMID:17174299
RGD:1624999
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dusp1
dual specificity phosphatase 1
IEP
mRNA, protein:decreased expression:ventricle myocardium mRNA:increased expression:retina
RGD
PMID:17647144 PMID:17063547
RGD:2298672 , RGD:7771540
NCBI chr10:16,680,478...16,683,275
G
Ece1
endothelin converting enzyme 1
IEP
mRNA:increased expression:thoracic aorta
RGD
PMID:23600389
RGD:7243858
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
G
Edn1
endothelin 1
treatment
IEP ISO IDA
mRNA:increased expression:heart, kidney, retina (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12458661 PMID:12967931 PMID:18516100 PMID:18351623 PMID:18351623
RGD:2313282 , RGD:2312288 , RGD:2312288
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Ednra
endothelin receptor type A
IMP
RGD
PMID:20690982
RGD:4892336
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Eef2
eukaryotic translation elongation factor 2
treatment
IEP
protein:decreased expression:cardiac muscle:
RGD
PMID:7513958
RGD:10401649
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Egfr
epidermal growth factor receptor
IDA
protein:decreased tyrosine phosphorylation:cornea
RGD
PMID:21330660
RGD:5131482
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eln
elastin
IEP
mRNA:increased expression:bladder:
RGD
PMID:18279932
RGD:9585725
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
G
Eno2
enolase 2
IEP
protein:increased expression:brain
RGD
PMID:15780189
RGD:2293753
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
IEP
protein:decreased expression:retina:
RGD
PMID:22864860
RGD:9685437
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
IEP
protein,mRNA:increased expression:glial cell, retina: protein:enzyme activity:platelet
RGD
PMID:18687327 PMID:17119848
RGD:9685473 , RGD:9685486
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Ep300
E1A binding protein p300
treatment
ISO IDA IMP IEP
mRNA:increased expression:retina, kidney (mouse) mRNA:increased expression:heart (rat)
RGD
PMID:18351623 PMID:22228707 PMID:18413674 PMID:18657544
RGD:2312288 , RGD:7296926 , RGD:2312263 , RGD:2312287
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
IEP
mRNA:increased expression:Schwann cell:
RGD
PMID:24673486
RGD:11041670
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
IEP
mRNA:increased expression:Schwann cell:
RGD
PMID:24673486
RGD:11041670
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
IEP
RGD
PMID:22228707
RGD:7296926
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc4
ERCC excision repair 4, endonuclease catalytic subunit
treatment
IEP
RGD
PMID:22228707
RGD:7296926
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
G
Esr1
estrogen receptor 1
IEP
protein:decreased expression:penis protein:decreased expression:vagina,nucleus
RGD
PMID:15596216 PMID:16734901
RGD:2306775 , RGD:2314014
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esrra
estrogen related receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23090186
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
G
Ets1
ETS proto-oncogene 1, transcription factor
IEP
protein:increased expression:retina
RGD
PMID:17622743
RGD:2313849
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
IEP
protein:increased expression:kidney
RGD
PMID:23508046
RGD:9587808
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
F11r
F11 receptor
IEP
RGD
PMID:18506084
RGD:7488940
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:kidney
RGD
PMID:15990447
RGD:2313862
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F3
coagulation factor III, tissue factor
ISO
protein:increased activity:kidney
RGD
PMID:15990447
RGD:2313862
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
F7
coagulation factor VII
IDA IEP
protein:decreased activity:plasma (rat)
RGD
PMID:11474472 PMID:16779662
RGD:2312396 , RGD:2312313
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fabp3
fatty acid binding protein 3
IEP
mRNA, protein:decreased expression:aorta
RGD
PMID:7744030
RGD:2307330
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
G
Fabp4
fatty acid binding protein 4
IEP
protein:decreased expresssion:fat cell
RGD
PMID:9059981
RGD:1625411
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fads1
fatty acid desaturase 1
IEP
RGD
PMID:16099631
RGD:1625413
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fas
Fas cell surface death receptor
onset
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:heart ventricle
CTD RGD
PMID:16123366 PMID:20004692 PMID:19820199
RGD:2315698 , RGD:2314021
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
IEP
protein:increased expression:heart ventricle
RGD
PMID:19820199
RGD:2314021
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbn1
fibrillin 1
IEP
protein:increased expression:renal glomerulus (rat)
RGD
PMID:16380460
RGD:7365080
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
G
Fcgbpl1
Fc fragment of IgG binding protein-like 1
IEP
RGD
PMID:20973890
RGD:5490977
NCBI chr 1:83,424,788...83,462,802
Ensembl chr 1:83,424,788...83,462,799
G
Fga
fibrinogen alpha chain
IEP
protein:increased expression:plasma (rat)
RGD
PMID:23086277
RGD:9684989
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgf2
fibroblast growth factor 2
IEP
protein:increased expression:vitreous humor
RGD
PMID:12663474 PMID:10792180
RGD:2315880 , RGD:8655613
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgf21
fibroblast growth factor 21
treatment
IEP ISO
protein:decreased expression:serum: CTD Direct Evidence: therapeutic
CTD RGD
PMID:23499715 PMID:23262585 PMID:25359298 PMID:23262585
RGD:10401916 , RGD:10401921 , RGD:10401916
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Flt1
Fms related receptor tyrosine kinase 1
IEP ISO
mRNA:decreased expression:heart mRNA:decreased expression:skeletal muscle
RGD
PMID:16741021 PMID:16816123
RGD:2313724 , RGD:2313725
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fn1
fibronectin 1
treatment
IEP
protein:increased expression:kidney
RGD
PMID:22937115 PMID:22228707
RGD:7206838 , RGD:7296926
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Foxa2
forkhead box A2
IEP
mRNA:increased expression:kidney cortex
RGD
PMID:19433262
RGD:2312358
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Foxa3
forkhead box A3
IEP
mRNA:increased expression:liver
RGD
PMID:11018767
RGD:2315085
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
G
Foxo3
forkhead box O3
IEP ISO
protein:increased phosphorylation, increased expression:glomerulus, cytoplasm: CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver:
CTD RGD
PMID:23090186 PMID:23792339 PMID:17082237 PMID:12683947 PMID:17082237
RGD:10402196 , RGD:10402199 , RGD:10402196
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Foxp3
forkhead box P3
treatment
IEP
mRNA,protein:increased expression: peripheral blood, spleen, lymphoid node
RGD
PMID:18328191 PMID:32341701
RGD:38599142 , RGD:38599143
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Fuca1
alpha-L-fucosidase 1
ISO
RGD
PMID:3924473
RGD:2315947
NCBI chr 5:148,152,718...148,169,972
Ensembl chr 5:148,152,700...148,169,972
G
Furin
furin (paired basic amino acid cleaving enzyme)
disease_progression
IEP
protein:decreased expression:kidney
RGD
PMID:16541018
RGD:1582625
NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
treatment
IEP
protein:increased activity:liver, kidney
RGD
PMID:16176150 PMID:27366200
RGD:2315960 , RGD:14695533
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
IEP
protein:increased expression:lens protein:decreased expression:liver
RGD
PMID:16718375 PMID:25116122 PMID:19374864
RGD:2307345 , RGD:10449121 , RGD:2307337
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
IEP
RGD
PMID:2849069
RGD:2315971
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gal
galanin and GMAP prepropeptide
ISO IEP
protein:decreased expression:pancreatic islet
RGD
PMID:7505518 PMID:11489087
RGD:2313742 , RGD:2313740
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Galp
galanin-like peptide
IMP IEP
mRNA:increased expression:arcuate nucleus, pars posterior
RGD
PMID:16046316 PMID:15256810
RGD:2313737 , RGD:2313739
NCBI chr 1:67,684,023...67,703,121
Ensembl chr 1:67,684,025...67,702,269
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
treatment
IEP
RGD
PMID:27655796
RGD:13792671
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gata4
GATA binding protein 4
IEP
protein:increased serine phosphorylation:heart
RGD
PMID:22293779
RGD:7207042
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
Gc
GC, vitamin D binding protein
IEP
protein:decreased expression:serum
RGD
PMID:3838933
RGD:2315540
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gcg
glucagon
treatment
IEP
RGD
PMID:18996945
RGD:10402370
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Gch1
GTP cyclohydrolase 1
treatment
ISO IEP
protein:increased degradation:heart associated with type 1 diabetes mellitus
RGD
PMID:27295516 PMID:18061195 PMID:18596126
RGD:329961323 , RGD:2314434 , RGD:401700392
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gck
glucokinase
IMP ISO
protein:decreased activity:liver:reduced activity, energy of activation and affinity for glucose in streptozotocin diabetic rats CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:2132180
RGD:2301955
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
IDA
mRNA:increased expression:heart
RGD
PMID:7560067
RGD:632804
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
G
Gfpt1
glutamine fructose-6-phosphate transaminase 1
IEP
protein:decreased expression:epididymal fat pad, liver, skeletal muscle
RGD
PMID:7589852
RGD:2313355
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
G
Ggt1
gamma-glutamyltransferase 1
IEP
protein:increased activity:serum
RGD
PMID:18291430
RGD:2315577
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gh1
growth hormone 1
IDA IEP
protein:decreased expression:serum, pituitary gland
RGD
PMID:2931155 PMID:19370419
RGD:2315682 , RGD:2315655
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Ghr
growth hormone receptor
ISO IEP
RGD
PMID:12529387 PMID:7964296
RGD:2307365 , RGD:11567222
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Ghrh
growth hormone releasing hormone
treatment
IDA
RGD
PMID:22393012
RGD:10401241
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
G
Ghrhr
growth hormone releasing hormone receptor
IEP
RGD
PMID:18285528
RGD:10401258
NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
G
Ghrl
ghrelin and obestatin prepropeptide
disease_progression
ISO IEP
protein:increased expression:plasma
RGD
PMID:18657539 PMID:23965296
RGD:2313750 , RGD:12905048
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Ghsr
growth hormone secretagogue receptor
IEP
mRNA:increased expression:Arcuate nucleus :
RGD
PMID:23965296
RGD:12905048
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
G
Gip
gastric inhibitory polypeptide
IEP
mRNA:increased expression:retina (rat)
RGD
PMID:12789546
RGD:2312548
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
G
Gipr
gastric inhibitory polypeptide receptor
IEP
mRNA:increased expression:retina (rat)
RGD
PMID:12789546
RGD:2312548
NCBI chr 1:78,804,287...78,814,462
Ensembl chr 1:78,805,593...78,814,462
G
Gja1
gap junction protein, alpha 1
treatment
IEP ISO IDA
protein:increased expression:dermis protein:decreased expression:retina, blood vessel protein:altered expression:retina:
RGD
PMID:22455314 PMID:20130277 PMID:22110070 PMID:20609064
RGD:7207269 , RGD:8662383 , RGD:7364887 , RGD:7207415
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gja5
gap junction protein, alpha 5
treatment
IDA
RGD
PMID:20609064
RGD:7207415
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
G
Gjb2
gap junction protein, beta 2
IEP
mRNA,protein:decreased expression:retina:
RGD
PMID:22110070
RGD:7364887
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gjb6
gap junction protein, beta 6
IEP
RGD
PMID:21567444
RGD:7364783
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
G
Gjd3
gap junction protein, delta 3
IEP
protein:decreased expression:retina:
RGD
PMID:23385797
RGD:7364769
NCBI chr10:83,933,694...83,935,759
Ensembl chr10:83,934,135...83,934,971
G
Glp1r
glucagon-like peptide 1 receptor
IDA
RGD
PMID:10580413
RGD:1624356
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
G
Glrx
glutaredoxin
IEP
protein:increase activity:retina:
RGD
PMID:17324929
RGD:9686046
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glul
glutamate-ammonia ligase
treatment
IEP
mRNA, protein:decreased expression: retina protein:decreased expression:retina
RGD
PMID:21770802 PMID:23595285 PMID:25335981 PMID:23284834 PMID:26677078
RGD:401794412 , RGD:401794586 , RGD:401794423 , RGD:401794421 , RGD:401794418
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gmps
guanine monophosphate synthase
IEP
protein:increased activity:liver (rat)
RGD
PMID:3043317
RGD:5135485
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
G
Gnat1
G protein subunit alpha transducin 1
IEP
protein:decreased expression:retina
RGD
PMID:15939031
RGD:1600001
NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671
G
Gnat3
G protein subunit alpha transducin 3
IEP
mRNA, protein;increased expression:taste bud
RGD
PMID:18824257
RGD:2302147
NCBI chr 4:17,162,500...17,212,283
Ensembl chr 4:17,162,490...17,212,283
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9452481
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
G
Gpx1
glutathione peroxidase 1
treatment
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:glomerulus
CTD RGD
PMID:16123366 PMID:19229592 PMID:25744399 PMID:15039483 PMID:18387670
RGD:2306606 , RGD:11353782 , RGD:2306161 , RGD:2306607
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx3
glutathione peroxidase 3
treatment
IEP ISO IDA
protein, mRNA:decreased expression:kidney (rat)
RGD
PMID:12753302 PMID:32546886 PMID:23407453 PMID:16651743 PMID:12753302
RGD:2312629 , RGD:401827917 , RGD:401827857 , RGD:2312631 , RGD:2312629
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
treatment
IEP
RGD
PMID:23595285
RGD:401794586
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IEP
mRNA, protein:increased expression:cerebellum (rat)
RGD
PMID:20056114
RGD:4107025
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Grk1
G protein-coupled receptor kinase 1
IEP
protein:increased expression:retina
RGD
PMID:15939031
RGD:1600001
NCBI chr16:76,122,501...76,135,792
Ensembl chr16:76,123,842...76,135,792
G
Gsk3a
glycogen synthase kinase 3 alpha
treatment
IEP
RGD
PMID:8526919
RGD:10401824
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
G
Gsr
glutathione-disulfide reductase
treatment
IEP ISO
protein:decreased activity:plasma: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20620209 PMID:20187988 PMID:25050809
RGD:7257587 , RGD:10401889
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta4
glutathione S-transferase alpha 4
IEP
protein:increased expression:pancreas, kidney, liver (rat)
RGD
PMID:14693714
RGD:5687773
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Guk1
guanylate kinase 1
IEP
protein:decreased expression:retina (rat)
RGD
PMID:17465459
RGD:5147874
NCBI chr10:43,971,514...43,988,658
Ensembl chr10:43,971,509...43,980,107
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
IDA
RGD
PMID:20923496
RGD:6784507
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
G
Hadh
hydroxyacyl-CoA dehydrogenase
IEP
RGD
PMID:7050060
RGD:2302232
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
protein:decreased expression:brain
RGD
PMID:25260493
RGD:10047114
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hbb-bs
hemoglobin, beta adult s chain
IEP
RGD
PMID:20973890
RGD:5490977
NCBI chr 1:158,218,356...158,219,741
Ensembl chr 1:158,120,200...158,252,012
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
protein:increased expression:neuron:
RGD
PMID:19815055
RGD:9693680
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Hcn2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
IEP
protein:increased expression:neuron:
RGD
PMID:19815055
RGD:9693680
NCBI chr 7:9,969,801...9,988,839
Ensembl chr 7:9,970,368...9,988,841
G
Hcn3
hyperpolarization-activated cyclic nucleotide-gated potassium channel 3
IEP
protein:increased expression:neuron:
RGD
PMID:19815055
RGD:9693680
NCBI chr 2:174,551,861...174,567,459
Ensembl chr 2:174,551,680...174,565,966
G
Hdac1
histone deacetylase 1
IEP
protein:increased activity:renal cortex:
RGD
PMID:19553350
RGD:9590229
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hdac2
histone deacetylase 2
IEP
protein:increased activity:renal cortex:
RGD
PMID:19553350
RGD:9590229
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Hdac4
histone deacetylase 4
IEP
protein:increased activity:renal cortex:
RGD
PMID:19553350
RGD:9590229
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hgf
hepatocyte growth factor
IEP
protein:increased expression:kidney
RGD
PMID:16297324
RGD:2313568
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:sciatic nerve (rat)
RGD
PMID:15663958
RGD:8694461
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hk1
hexokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Hmbs
hydroxymethylbilane synthase
IEP
protein:decreased activity:liver (rat)
RGD
PMID:6688350
RGD:4144808
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
G
Hmgb1
high mobility group box 1
IEP
associated with Endotoxemia;protein:increased expression:serum protein:increased expression, altered localization:retina, cytoplasm
RGD
PMID:19959191 PMID:23261684
RGD:2316737 , RGD:10402069
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcl
3-hydroxy-3-methylglutaryl-CoA lyase
IEP
protein:increased activity:liver (rat)
RGD
PMID:5667251
RGD:2326171
NCBI chr 5:148,178,203...148,192,072
Ensembl chr 5:148,178,252...148,192,068
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
IMP
RGD
PMID:15111316
RGD:2313760
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
IEP
protein:increased expression:pancreas
RGD
PMID:18452227
RGD:2302233
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
IEP
protein:increased expression:liver (rat)
RGD
PMID:7902069
RGD:2326135
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
IEP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:16123366 PMID:16959961 PMID:18375438 PMID:19804535 PMID:15734859
RGD:1582713
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf4a
hepatocyte nuclear factor 4, alpha
IEP ISO
mRNA:decreased expression:kidney, liver protein:increased expression:liver:
RGD
PMID:18184923 PMID:19179483
RGD:2301838 , RGD:12904769
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
IEP
protein:increased expression:urinary bladder (rat)
RGD
PMID:18337374
RGD:9685410
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpk
heterogeneous nuclear ribonucleoprotein K
treatment
IDA
RGD
PMID:16837467
RGD:10002795
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
G
Hp
haptoglobin
IEP
protein:increased expression:serum
RGD
PMID:11072799
RGD:1626381
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
IEP
protein:decreased activity:liver (rat)
RGD
PMID:3043317
RGD:5135485
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hras
HRas proto-oncogene, GTPase
IEP
mRNA, protein:increased expression:retina blood vessel
RGD
PMID:18514235
RGD:2314841
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14697232
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:21104931
RGD:5686396
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspd1
heat shock protein family D (Hsp60) member 1
IEP
RGD
PMID:17280490
RGD:1624229
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hspg2
heparan sulfate proteoglycan 2
IEP
mRNA:decreased expression:retina
RGD
PMID:9068943
RGD:1624265
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
G
Htr2a
5-hydroxytryptamine receptor 2A
IEP
protein:increased expression:lung
RGD
PMID:21521772
RGD:5135278
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Iapp
islet amyloid polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920
G
Icam1
intercellular adhesion molecule 1
treatment
ISO IEP
mRNA:increased expression:aorta CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:14871415 PMID:20388520 PMID:24513509 PMID:18093596 PMID:20136425 PMID:18413153 More...
RGD:2306988 , RGD:8547703 , RGD:2306987
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Ide
insulin degrading enzyme
IEP
protein:decreased expression:cerebral cortex
RGD
PMID:29940507
RGD:13792791
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
G
Ifnar1
interferon alpha and beta receptor subunit 1
IMP
RGD
PMID:27999109
RGD:12910492
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
G
Ifnar1em1
interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1
IMP
RGD
PMID:27999109
RGD:12910492
G
Ifnar1em2
interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2
IMP
RGD
PMID:27999109
RGD:12910492
G
Ifng
interferon gamma
ISO IEP
mRNA:increased expression:pancreas CTD Direct Evidence: marker/mechanism protein:increased expression:retina
CTD RGD
PMID:21340626 PMID:18789669 PMID:20213480
RGD:2311492 , RGD:5147915
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
IEP ISO
protein:decreased expression:cerebellum, serum CTD Direct Evidence: therapeutic mRNA,protein:decreased expression:corpus cavernosum: protein:decreased expression:oviduct protein:decreased expression:heart
CTD RGD
PMID:24632065 PMID:19382144 PMID:22133301 PMID:18676006 PMID:20555424
RGD:2306671 , RGD:10046054 , RGD:2311502 , RGD:4142788
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP ISO
protein:decreased phosphorylation:heart protein:decreased expression:oviduct
RGD
PMID:20555424 PMID:18676006
RGD:4142788 , RGD:2311502
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
treatment
ISO IEP
DNA, mRNA:hypermethylation, decreased expression mRNA:decreased expression:brain protein:increased expression:oviduct protein:increased expression:multiple
RGD
PMID:18724775 PMID:23364485 PMID:10686593 PMID:18676006 PMID:17184497
RGD:2311511 , RGD:10402565 , RGD:5509973 , RGD:2311502 , RGD:2311513
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igf2r
insulin-like growth factor 2 receptor
ISO
protein:increased expression:oviduct
RGD
PMID:18676006
RGD:2311502
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Igfbp3
insulin-like growth factor binding protein 3
treatment
ISO IMP IEP
protein:increased expression:skeletal muscle mRNA, protein:increased expression:penis
RGD
PMID:16180585 PMID:25582342 PMID:18068478
RGD:2313766 , RGD:12743617 , RGD:2289159
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
IDA
protein:increased phosphorylation:liver
RGD
PMID:20362663
RGD:7495777
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
IEP ISO
protein:increase expression:serum
RGD
PMID:18787467 PMID:18779928
RGD:2308945 , RGD:2308946
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
IEP
protein:increased expression:gingiva (rat)
RGD
PMID:21826658
RGD:9068940
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1a
interleukin 1 alpha
IEP
protein:increased expression:heart
RGD
PMID:20555424
RGD:4142788
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
IEP ISO IDA
mRNA:increased expression:skeletal muscle CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12123627 PMID:17669395 PMID:23197974
RGD:1626620 , RGD:7175529
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
human gene in a rat model
RGD
PMID:19545727 PMID:17221214 PMID:8037760
RGD:6907397 , RGD:8551855 , RGD:6907425
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
IEP
protein:increased expression:retina
RGD
PMID:20213480
RGD:5147915
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il2ra
interleukin 2 receptor subunit alpha
IDA
RGD
PMID:18503494
RGD:2311530
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4
interleukin 4
treatment
IEP
RGD
PMID:25191525
RGD:10402795
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
ISO
RGD
PMID:12165974
RGD:4889983
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
IEP ISO IDA
protein:increased expression:heart CTD Direct Evidence: marker/mechanism protein:increased expression:extracellular space (rat) protein:increased expression:blood
CTD RGD
PMID:22138235 PMID:20555424 PMID:24582317 PMID:19328014 PMID:18976114
RGD:4142788 , RGD:11049554 , RGD:2307252 , RGD:2306984
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2975197 PMID:3044883
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Insig1
insulin induced gene 1
ISO
RGD
PMID:16327801
RGD:2308858
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insr
insulin receptor
disease_progression treatment
IDA IEP ISO
protein:decreased expression:erythrocyte (rat) mRNA:increased expression:liver nuclei, liver cell membrane (rat) protein:altered activity:liver plasma membrane CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, adipose tissue (rat) protein:decreased expression:kidney
CTD RGD
PMID:9243097 PMID:22138235 PMID:18376071 PMID:1280238 PMID:2180315 PMID:23874448 PMID:18638371 PMID:17855644 More...
RGD:2307339 , RGD:15036814 , RGD:14981592 , RGD:10403045 , RGD:2307025 , RGD:2290475
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Irs1
insulin receptor substrate 1
treatment
IDA ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:multiple
CTD RGD
PMID:22138235 PMID:22983684 PMID:22820932
RGD:7207061 , RGD:7207063
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
G
Irs2
insulin receptor substrate 2
IEP ISO
protein:decreased phosphorylation:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25808216 PMID:20555424
RGD:4142788
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
G
Isg15
ISG15 ubiquitin-like modifier
IEP
RGD
PMID:20973890
RGD:5490977
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Itga3
integrin subunit alpha 3
IEP
protein:decreased expression:renal cortex (rat)
RGD
PMID:20525748
RGD:2325818
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itgam
integrin subunit alpha M
IEP
protein:increased expression:neutrophil (rat)
RGD
PMID:10752954
RGD:329902069
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb1
integrin subunit beta 1
IEP
protein:decreased expression:epidermal stem cell (rat)
RGD
PMID:20187441
RGD:2325322
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Itgb3
integrin subunit beta 3
IEP
protein:increased expression:aorta:
RGD
PMID:12606526
RGD:8693385
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Jak3
Janus kinase 3
IEP
protein:increased expression:retina
RGD
PMID:21575160
RGD:11533943
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Kcna2
potassium voltage-gated channel subfamily A member 2
IEP
RGD
PMID:17982915
RGD:7242761
NCBI chr 2:194,704,555...194,718,387
Ensembl chr 2:194,704,639...194,718,400
G
Kcna5
potassium voltage-gated channel subfamily A member 5
IEP
RGD
PMID:17982915
RGD:7242761
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Kcne2
potassium voltage-gated channel subfamily E regulatory subunit 2
IEP
mRNA:decreased expression:left heart ventricle
RGD
PMID:19267230
RGD:7243942
NCBI chr11:31,517,176...31,530,026
Ensembl chr11:31,295,614...31,530,043
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
IEP ISO
protein:decreased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:23785408
RGD:7296920
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
IEP
mRNA, protein:decreased expression:aorta, smooth muscle
RGD
PMID:24589593
RGD:10412030
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Kcnmb1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
IEP
protein:decreased expression:aorta, smooth muscle
RGD
PMID:24589593
RGD:10412030
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
IEP
mRNA, protein:increased expression:aorta, smooth muscle
RGD
PMID:24589593 PMID:29167619
RGD:10412030 , RGD:401784495
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Kdm6a
lysine demethylase 6A
IEP
RGD
PMID:31266808
RGD:151665138
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
G
Kdr
kinase insert domain receptor
ISO IEP
mRNA:decreased expression:skeletal muscle mRNA:increased expression:retina mRNA:decreased expression:heart
RGD
PMID:16816123 PMID:22121831 PMID:16741021
RGD:2313725 , RGD:5684538 , RGD:2313724
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Khk
ketohexokinase
IEP
RGD
PMID:6088170
RGD:2302253
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
G
Kif1a
kinesin family member 1A
IEP
mRNA:increased expression:hippocampus
RGD
PMID:23776493
RGD:11059542
NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480
G
Kif5b
kinesin family member 5B
IEP
mRNA:increased expression:hippocampus
RGD
PMID:23776493
RGD:11059542
NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IEP
protein:increased expression:pancreas
RGD
PMID:17235568
RGD:2311225
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Klk1
kallikrein 1
IEP
mRNA:decreased expression:myocardium
RGD
PMID:10604522
RGD:1641812
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
G
Kmt5c
lysine methyltransferase 5C
IEP
mRNA:increased expression:retina
RGD
PMID:21357467
RGD:9586742
NCBI chr 1:69,099,531...69,107,145
Ensembl chr 1:69,099,539...69,107,145
G
Lcn2
lipocalin 2
IEP
mRNA:increased expression:retina (rat) protein:increased expression:urine
RGD
PMID:15623795 PMID:23085980
RGD:2316515 , RGD:7245484
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lct
lactase
IDA
RGD
PMID:16021836
RGD:1600251
NCBI chr13:39,781,929...39,824,456
Ensembl chr13:39,781,929...39,824,456
G
Ldlr
low density lipoprotein receptor
IEP
mRNA:decreased expression:liver
RGD
PMID:18054320
RGD:2324626
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
onset
IMP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28242381 PMID:31313498 PMID:31483951 PMID:19491210 PMID:19428774 PMID:20695765 More...
RGD:2311124 , RGD:2311126 , RGD:5128579
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15093691 PMID:16427799 PMID:17065336 PMID:19452630 PMID:19478208 PMID:20567778 PMID:22933112 PMID:24263156 PMID:26939912 PMID:27151219 PMID:30635400 PMID:35472412 PMID:36066211 More...
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lgals3
galectin 3
treatment
IEP
RGD
PMID:21249158
RGD:9685210
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lipc
lipase C, hepatic type
IDA IEP
protein:decreased activity:liver (rat)
RGD
PMID:18758746 PMID:1868959
RGD:2307432 , RGD:2308849
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Litaf
lipopolysaccharide-induced TNF factor
IEP
protein:increased expression:retina
RGD
PMID:21575160
RGD:11533943
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lpin1
lipin 1
IEP
mRNA:increased expression:skeletal muscle
RGD
PMID:14718385
RGD:1641826
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpl
lipoprotein lipase
treatment
IEP IDA
RGD
PMID:18780778 PMID:27158912
RGD:2313303 , RGD:13794379
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrp2
LDL receptor related protein 2
IEP
protein:decreased expression:kidney, proximal convoluted tubule, apical plasma membrane
RGD
PMID:11685557
RGD:1641843
NCBI chr 3:54,189,305...54,346,769
Ensembl chr 3:54,189,308...54,346,708
G
Ltbp1
latent transforming growth factor beta binding protein 1
IEP
RGD
PMID:17574405
RGD:2302087
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Mafa
MAF bZIP transcription factor A
treatment
ISO
RGD
PMID:28487936
RGD:13506743
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
G
Map2k3
mitogen activated protein kinase kinase 3
IEP
mRNA:increased expression:kidney, glomerulus
RGD
PMID:11473637
RGD:7495813
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map2k6
mitogen-activated protein kinase kinase 6
IEP
mRNA:increased expression:kidney, glomerulus
RGD
PMID:11473637
RGD:7495813
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18342293
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
IEP
protein:increased activity:serum:
RGD
PMID:28724746
RGD:151356966
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
IEP IDA
protein:decreased phosphorylation:cornea
RGD
PMID:22045654 PMID:21330660
RGD:7243969 , RGD:5131482
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
IDA
protein:decreased phosphorylation:cornea
RGD
PMID:21330660
RGD:5131482
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapt
microtubule-associated protein tau
treatment
IDA
RGD
PMID:28400135
RGD:13800903
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
IEP
mRNA:increased expression:renal cortex (rat)
RGD
PMID:18679036
RGD:2313799
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Mbp
myelin basic protein
IDA
RGD
PMID:23667870
RGD:7327197
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mdm2
MDM2 proto-oncogene
IEP
protein:increased degradation:myocardium
RGD
PMID:23530877
RGD:10412313
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mef2a
myocyte enhancer factor 2a
IEP
mRNA:increased expression:heart
RGD
PMID:18413674
RGD:2312263
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
G
Mef2c
myocyte enhancer factor 2C
IEP
mRNA:increased expression:heart
RGD
PMID:18413674
RGD:2312263
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
G
Met
MET proto-oncogene, receptor tyrosine kinase
IEP
mRNA, protein:increased expression:kidney, tubule, epithelium (rat)
RGD
PMID:8997394
RGD:2317555
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21505870
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mfn2
mitofusin 2
treatment
IEP
protein:increased expression:heart, mitochondrion (rat)
RGD
PMID:28483572 PMID:27998959
RGD:12910731 , RGD:12910739
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mif
macrophage migration inhibitory factor
ISO
protein:increased expression:pancreatic islet
RGD
PMID:15790730
RGD:1641951
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mmp1
matrix metallopeptidase 1
IEP
protein:increased expression:periodontal ligament, alveolar bone of mandible (rat)
RGD
PMID:20082587
RGD:7207377
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21963884
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
IEP ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism mRNA:increased expression:retina
CTD RGD
PMID:21963884 PMID:22191573 PMID:17569353 PMID:23089644 PMID:23423566
RGD:2290354 , RGD:8547974 , RGD:8547881
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
IEP ISO
protein:increased activity:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20388520 PMID:18436980
RGD:2317971
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-cyb
mitochondrially encoded cytochrome b
IEP
mRNA:decreased expression:heart
RGD
PMID:15126286
RGD:1578536
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
G
Mthfr
methylenetetrahydrofolate reductase
IEP
protein:decreased activity:kidney (rat)
RGD
PMID:9836532
RGD:6893689
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mtor
mechanistic target of rapamycin kinase
IDA
protein:hyperphosphorylation:muscle
RGD
PMID:28536139
RGD:13506787
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
IEP
protein:decreased activity:liver
RGD
PMID:18936199
RGD:7207081
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP
mRNA:increased expression:renal cortex (rat)
RGD
PMID:18030501
RGD:7207459
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nampt
nicotinamide phosphoribosyltransferase
IEP
protein:decreased expression:fat cell
RGD
PMID:18410550
RGD:2311099
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Ncf1
neutrophil cytosolic factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14871415 PMID:16380483
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf2
neutrophil cytosolic factor 2
IDA IEP
protein:altered localization:glomerulus protein:increased expression:heart, membrane fraction
RGD
PMID:14514646 PMID:18061195
RGD:2314451 , RGD:2314434
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
IEP
protein:decreased expression:dorsal root ganglia (rat)
RGD
PMID:20876714
RGD:6484699
NCBI chr13:83,654,402...83,671,474
Ensembl chr13:83,654,406...83,671,420
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
IEP
protein:decreased expression:dorsal root ganglia (rat) mRNA, protein:decreased expression:brain
RGD
PMID:20876714 PMID:22387129
RGD:6484699 , RGD:13824971
NCBI chr 3:76,876,646...76,883,824
Ensembl chr 3:76,876,646...76,883,824
G
Nefh
neurofilament heavy chain
treatment
IEP
RGD
PMID:12941778
RGD:9698428
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nefm
neurofilament medium chain
treatment
IEP
RGD
PMID:12941778
RGD:9698428
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Neurod1
neuronal differentiation 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 3:64,359,554...64,363,526
Ensembl chr 3:64,359,395...64,363,649
G
Neurog3
neurogenin 3
ISO
RGD
PMID:19819964
RGD:2313774
NCBI chr20:30,079,780...30,081,262
Ensembl chr20:30,079,780...30,081,262
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO IEP
protein:increased localization:blood, mononuclear cell, nucleus
RGD
PMID:22869588 PMID:23331247 PMID:24740568
RGD:10412694 , RGD:7244270 , RGD:10412720
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb2
nuclear factor kappa B subunit 2
IEP
RGD
PMID:18633731
RGD:2298775
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP IDA
protein:decreased expression:kidney
RGD
PMID:22483164 PMID:20188823
RGD:10413864 , RGD:10413873
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Ngf
nerve growth factor
treatment
IEP ISO
mRNA, protein:decreased expression:sciatic nerve protein:decreased processing:hippocampus protein:increased expression:retina
RGD
PMID:19149268 PMID:25728260 PMID:26282349 PMID:21136036
RGD:2303795 , RGD:402463972 , RGD:402463971 , RGD:5144144
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
IEP
protein:increased expression:retina protein:decreased expression:telencephalon
RGD
PMID:21136036 PMID:26282349
RGD:5144144 , RGD:402463971
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nkx6-1
NK6 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr14:7,969,756...7,976,689
Ensembl chr14:7,969,756...7,976,681
G
Nos1
nitric oxide synthase 1
IDA
protein:decreased dimerization:stomach
RGD
PMID:17347455
RGD:1642144
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
no_association
IEP ISO
associated with Infarction, Middle Cerebral Artery; protein:increased expression:brain (rat) CTD Direct Evidence: marker/mechanism protein:increased expression:renal glomerulus (rat)
CTD RGD
PMID:16380483 PMID:16959961 PMID:21993016 PMID:9349594
RGD:5509105 , RGD:5509107
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IDA IEP ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:thoracic aorta (mouse) protein:increased expression:heart
CTD RGD
PMID:11696579 PMID:14871415 PMID:15490108 PMID:16959961 PMID:18266981 PMID:19478208 PMID:22191573 PMID:22933112 PMID:18825362 PMID:28976888 PMID:21050844 PMID:21050844 PMID:18287592 More...
RGD:4892007 , RGD:13450939 , RGD:7777108 , RGD:7777108 , RGD:2292100
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox4
NADPH oxidase 4
IEP
protein:increased expression:aorta
RGD
PMID:19686728
RGD:2324658
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
IEP
mRNA:increased expression:intestine, liver
RGD
PMID:17292734
RGD:1642185
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Nppa
natriuretic peptide A
IEP
protein:decreased expression:retina protein:increased expression:plasma, kidney, heart;
RGD
PMID:15789000 PMID:17151304
RGD:1580773 , RGD:7248602
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
IEP
protein:increased expression:atrium myocardium, plasma
RGD
PMID:17151299
RGD:1642199
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Npy
neuropeptide Y
IEP
protein:increased expression:paraventricular nucleus of hypothalamus
RGD
PMID:21042571
RGD:10448960
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Npy1r
neuropeptide Y receptor Y1
IEP
RGD
PMID:18201831
RGD:10448967
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
G
Npy2r
neuropeptide Y receptor Y2
IEP
RGD
PMID:18201831
RGD:10448967
NCBI chr 2:167,901,999...167,912,165
Ensembl chr 2:167,903,879...167,905,024
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23458895
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
IDA
DNA:hypomethylation:promoter
RGD
PMID:21136146
RGD:13831298
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
IEP
mRNA:decreased expression:liver
RGD
PMID:15047603
RGD:1625080
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
treatment
IEP
RGD
PMID:20636876
RGD:9835393
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IEP
protein:increased expression:placenta
RGD
PMID:21744335
RGD:12879479
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nrp1
neuropilin 1
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:16816123
RGD:2313725
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nt5e
5' nucleotidase, ecto
IEP
protein:increased expression:cerebral cortex, synaptosome (rat)
RGD
PMID:19723569
RGD:5134343
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IEP
protein:increased tyrosine nitration, decreased tyrosine phosphorylation:retina
RGD
PMID:21136036 PMID:22044876
RGD:5144144 , RGD:5684337
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
IEP
mRNA:decreased expression:dorsal root ganglion
RGD
PMID:9541170
RGD:2325654
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
G
Ogg1
8-oxoguanine DNA glycosylase
IEP ISO
protein:altered localization:pancreatic islet
RGD
PMID:18676009 PMID:18599524 PMID:15677345
RGD:2317137 , RGD:8657153 , RGD:8657146
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
treatment
IDA
RGD
PMID:15561949
RGD:9590198
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Oprk1
opioid receptor, kappa 1
IEP
protein:increased expression:sciatic nerve, peroneal nerve:
RGD
PMID:16924480
RGD:9834947
NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
IDA
RGD
PMID:16901587
RGD:2316626
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Osbp
oxysterol binding protein
IDA
protein:increased tyrosine phosphorylation:aorta
RGD
PMID:18230613
RGD:2291921
NCBI chr 1:208,888,697...208,918,511
Ensembl chr 1:208,887,895...208,918,506
G
Otc
ornithine transcarbamylase
IEP
protein:decreased activity:small intestine (rat)
RGD
PMID:9628242
RGD:4144123
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
Oxct1
3-oxoacid CoA transferase 1
IEP
protein:decreased activity:heart, mitochondrion (rat)
RGD
PMID:3548709
RGD:2326100
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
RGD
PMID:18657544
RGD:2312287
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pax6
paired box 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pc
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pck1
phosphoenolpyruvate carboxykinase 1
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20363216 PMID:17651728
RGD:2311641
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pcsk1
proprotein convertase subtilisin/kexin type 1
IEP ISO
mRNA, protein:increased expression:spleen, spleen white pulp (rat) protein:increased expression:pancreatic alpha cell (mouse) mRNA, protein:increased expression:spleen (mouse)
RGD
PMID:11730986 PMID:17698597 PMID:11730986
RGD:2308905 , RGD:2308931 , RGD:2308905
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
IEP ISO
mRNA:increased expression:spleen CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:11730986
RGD:2308905
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
G
Pde3a
phosphodiesterase 3A
IEP
mRNA, protein:increased expression:mesenteric artery
RGD
PMID:12793980
RGD:2300416
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pde5a
phosphodiesterase 5A
IMP
RGD
PMID:19542492
RGD:2314461
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
G
Pdgfb
platelet derived growth factor subunit B
IEP IDA ISO
mRNA:increased expression:glomerulus mRNA: increased expression: mesenteric artery mRNA:increased expression:retina mRNA:decreased expression:retina
RGD
PMID:8094359 PMID:9763208 PMID:21367419 PMID:12606528 PMID:14685146
RGD:2311650 , RGD:10449499 , RGD:6483042 , RGD:1581759 , RGD:2311648
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfrb
platelet derived growth factor receptor beta
IEP
protein:increased expression:glomerulus
RGD
PMID:10802145
RGD:2311654
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pdk4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
IEP
RGD
PMID:12765946
RGD:1582364
NCBI chr19:386,408...394,068
Ensembl chr19:386,406...394,074
G
Pdx1
pancreatic and duodenal homeobox 1
IMP ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:pancreatic delta cell (rat) protein:increased expression:pancreas (rat)
CTD RGD
PMID:16123366 PMID:17460716 PMID:15561947 PMID:14988244 PMID:17235568 PMID:17226789 More...
RGD:2311224 , RGD:2311226 , RGD:1357906 , RGD:2311225 , RGD:2311311
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
G
Pdyn
prodynorphin
IEP
protein:increased expression:sciatic nerve, peroneal nerve, tibial nerve, footpad skin:
RGD
PMID:16924480
RGD:9834947
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IEP
protein:decreased expression:corpus callosum, endothelium (rat)
RGD
PMID:21967314
RGD:6771179
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pemt
phosphatidylethanolamine N-methyltransferase
IEP
protein:increased expression:liver
RGD
PMID:17116711
RGD:1642370
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
G
Pfas
phosphoribosylformylglycinamidine synthase
IEP
protein:increased activity:liver (rat)
RGD
PMID:3043317
RGD:5135485
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:53,691,626...53,708,420
G
Pfkm
phosphofructokinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
G
Pgf
placental growth factor
IEP
mRNA, protein:decreased expression:placenta, trophoblast cell
RGD
PMID:17917370
RGD:6483782
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Phka1
phosphorylase kinase regulatory subunit alpha 1
IDA
RGD
PMID:11692172
RGD:1599897
NCBI chr X:67,601,302...67,738,504
Ensembl chr X:67,601,302...67,738,455
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
IEP
protein:increased expression:gastrocnemius (rat)
RGD
PMID:18430054
RGD:2307338
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pklr
pyruvate kinase L/R
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20363216 PMID:16900249
RGD:1625589
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Plcb3
phospholipase C beta 3
IEP
protein:decreased expression:heart left ventricle
RGD
PMID:15362504
RGD:2314509
NCBI chr 1:204,143,257...204,160,384
Ensembl chr 1:204,144,956...204,160,228
G
Plcg1
phospholipase C, gamma 1
IEP
protein:increased tyrosine phosphorylation:lens
RGD
PMID:17612968
RGD:2299877
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
G
Pnmt
phenylethanolamine-N-methyltransferase
IEP
protein:increased expression:adrenal gland (rat)
RGD
PMID:16396986
RGD:5130724
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
G
Polg
DNA polymerase gamma, catalytic subunit
IEP ISO IDA
mRNA,protein:decreased expression:retina,mitochondrion: DNA:hypermethylation:promoter:
RGD
PMID:22743328 PMID:22229649 PMID:22743328
RGD:8694093 , RGD:8694187 , RGD:8694093
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
G
Polg2
DNA polymerase gamma 2, accessory subunit
ISO
mRNA,protein:decreased expression:retina,mitochondrion:
RGD
PMID:22229649
RGD:8694187
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
G
Pon1
paraoxonase 1
ISO
RGD
PMID:18358245 PMID:18358245
RGD:2313268 , RGD:2313268
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12967931 PMID:14563825 PMID:23090186
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
IEP
mRNA, protein:decreased expression:heart
RGD
PMID:18573863
RGD:2313781
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
IEP ISO
mRNA:altered expression:aorta, kidney cortex, retina CTD Direct Evidence: marker/mechanism protein:decreased expression:retina
CTD RGD
PMID:12967931 PMID:16123366 PMID:21757225 PMID:18641696 PMID:18806296
RGD:2301849 , RGD:2301844
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
IEP ISO IMP IDA
mRNA:decreased expression:pancreatic islet CTD Direct Evidence: marker/mechanism protein:decreased expression:dorsal root ganglia (mouse)
CTD RGD
PMID:14563825 PMID:18270681 PMID:19520786 PMID:22561641 PMID:23272147
RGD:2311391 , RGD:2311445 , RGD:7242175 , RGD:7241845
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
IEP
protein:increased activity:kidney (rat)
RGD
PMID:2451505
RGD:5135016
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
treatment
IEP
RGD
PMID:32535406
RGD:401850547
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkca
protein kinase C, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12198386
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkcb
protein kinase C, beta
IEP
protein:increased expression:myocardium
RGD
PMID:17250813
RGD:1625511
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkcd
protein kinase C, delta
IEP ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12198386 PMID:11576956
RGD:1642532
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12198386
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkci
protein kinase C, iota
IEP
protein:increased expression:ventricle myocardium, membrane fraction
RGD
PMID:14691046
RGD:2314944
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
G
Prkg1
protein kinase cGMP-dependent 1
treatment
IEP
protein:decreased expression:aorta
RGD
PMID:20186099 PMID:15939056
RGD:7775064 , RGD:7777110
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Prkra
protein activator of interferon induced protein kinase EIF2AK2
IEP
RGD
PMID:21897745
RGD:7777145
NCBI chr 3:61,575,447...61,594,393
Ensembl chr 3:61,575,447...61,594,347
G
Psmb9
proteasome 20S subunit beta 9
IEP
mRNA:increased expression:hippocampus (rat)
RGD
PMID:20968039
RGD:9850284
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Ptgis
prostaglandin I2 synthase
treatment
IEP
RGD
PMID:8888351
RGD:401960094
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IEP
protein:decreased expression:spinal cord
RGD
PMID:12086957
RGD:727386
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:lung protein:increased expression:sciatic nerve
CTD RGD
PMID:14514642 PMID:21414306 PMID:18706904 PMID:21521772 PMID:17720896
RGD:2300222 , RGD:5135278 , RGD:1642588
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
ISO
protein:increased activity:retina (mouse)
RGD
PMID:19029027
RGD:401965415
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
G
Ptprn
protein tyrosine phosphatase, receptor type, N
severity
ISO
RGD
PMID:19513530
RGD:2313594
NCBI chr 9:76,741,010...76,756,704
Ensembl chr 9:76,741,016...76,756,190
G
Ptpru
protein tyrosine phosphatase, receptor type, U
IEP
protein:decreased expression:glomerulus
RGD
PMID:16539708
RGD:1642656
NCBI chr 5:143,950,542...144,024,791
Ensembl chr 5:143,950,965...144,024,768
G
Pygm
glycogen phosphorylase, muscle associated
IDA
protein:increased expression:sarcoplasmic reticulum
RGD
PMID:11692172
RGD:1599897
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
G
Qdpr
quinoid dihydropteridine reductase
IEP
protein:decreased activity:brain (rat)
RGD
PMID:2758679
RGD:5128601
NCBI chr14:65,670,251...65,683,853
Ensembl chr14:65,670,131...65,683,854
G
Ramp2
receptor activity modifying protein 2
IEP
mRNA:increased expression:kidney
RGD
PMID:14717924
RGD:1642701
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
G
Rap1b
RAP1B, member of RAS oncogene family
IEP
protein:increased expression:renal glomerulus (rat)
RGD
PMID:12196513
RGD:10041023
NCBI chr 7:53,423,039...53,456,349
Ensembl chr 7:53,423,130...53,456,370
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
IEP
protein:decreased expression:brain, membrane (rat)
RGD
PMID:19002579
RGD:10003129
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rbfox2
RNA binding fox-1 homolog 2
ISO
mRNA:splice variant: heart (mouse) protein:increased expression:heart, cytoplasm (mouse)
RGD
PMID:27239029 PMID:24151077
RGD:329845874 , RGD:329848997
NCBI chr 7:108,810,627...109,054,420
Ensembl chr 7:108,810,628...109,054,691
G
Reg1a
regenerating family member 1 alpha
treatment
IDA IEP
protein:increased expression:pancreas, islet cell (rat)
RGD
PMID:8170952 PMID:8574288
RGD:9850123 , RGD:9850143
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
G
Reg3b
regenerating family member 3 beta
susceptibility
ISO
RGD
PMID:21245462
RGD:9831432
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
G
Rela
RELA proto-oncogene, NF-kB subunit
IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:nucleus, skeletal muscle, liver
CTD RGD
PMID:22138235 PMID:18633731 PMID:18500427
RGD:2298775 , RGD:2298780
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18829990
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Rgn
regucalcin
IEP
protein:decreased expression:liver
RGD
PMID:9062895
RGD:9590177
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rhoa
ras homolog family member A
IDA
RGD
PMID:17589825
RGD:1642825
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rpe65
retinoid isomerohydrolase RPE65
IEP
mRNA:decreased expression:retina (rat)
RGD
PMID:21862641
RGD:9585653
NCBI chr 2:248,766,497...248,798,403
Ensembl chr 2:248,766,612...248,798,403
G
Ryr2
ryanodine receptor 2
IDA
RGD
PMID:17027851
RGD:1599247
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
G
S100a6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S100b
S100 calcium binding protein B
IEP
protein:increased expression:cerebellum, cerebral cortex, hippocampus protein:altered expression:hippocampus, astrocyte
RGD
PMID:14583344 PMID:18708122
RGD:5508821 , RGD:5508836
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
S1pr2
sphingosine-1-phosphate receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22406263
NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
G
S1pr4
sphingosine-1-phosphate receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22406263
NCBI chr 7:8,207,767...8,210,043
Ensembl chr 7:8,208,098...8,211,893
G
S1pr5
sphingosine-1-phosphate receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22406263
NCBI chr 8:19,786,676...19,791,862
Ensembl chr 8:19,786,663...19,791,795
G
Scap
SREBF chaperone
IEP
RGD
PMID:20973890
RGD:5490977
NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666
G
Scd
stearoyl-CoA desaturase
treatment
IEP
RGD
PMID:32535406
RGD:401850547
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scp2
sterol carrier protein 2
treatment
IEP
RGD
PMID:7628371
RGD:9850252
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
G
Serpinc1
serpin family C member 1
treatment
IDA IEP
RGD
PMID:22309505 PMID:24671746
RGD:11035271 , RGD:11035293
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
ISO
protein:increased expression:heart (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21757225 PMID:20630999
RGD:8547862
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
IEP
protein:decreased expression:platelet
RGD
PMID:19237211
RGD:2312338
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Si
sucrase-isomaltase
IEP
protein:increased expression:small intestine mucosa
RGD
PMID:12940455
RGD:1625543
NCBI chr 2:157,505,893...157,586,228
Ensembl chr 2:157,506,342...157,585,260
G
Sirt1
sirtuin 1
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23090186 PMID:23792339 PMID:22179968
RGD:9586012
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc1a3
solute carrier family 1 member 3
treatment
IEP
RGD
PMID:23595285
RGD:401794586
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
G
Slc22a1
solute carrier family 22 member 1
IDA
RGD
PMID:14718608
RGD:2317435
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
IEP
protein:decreased expression:kidney
RGD
PMID:19356064
RGD:2312728
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc28a2
solute carrier family 28 member 2
IDA
RGD
PMID:16014043
RGD:2317455
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc28a3
solute carrier family 28 member 3
IDA
RGD
PMID:16014043
RGD:2317455
NCBI chr17:6,062,563...6,112,965
Ensembl chr17:6,062,549...6,114,038
G
Slc29a1
solute carrier family 29 member 1
IEP
mRNA:decreased expression:cardiac muscle cell
RGD
PMID:16873415
RGD:2316941
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc2a1
solute carrier family 2 member 1
treatment
IEP
mRNA, protein:decreased expression:brain
RGD
PMID:17935675 PMID:8345816
RGD:2313617 , RGD:12879858
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a2
solute carrier family 2 member 2
IEP ISO
mRNA:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:19433262
RGD:2312358
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
G
Slc2a3
solute carrier family 2 member 3
IEP
mRNA, protein:decreased expression:brain
RGD
PMID:17935675
RGD:2313617
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc2a4
solute carrier family 2 member 4
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11947963 PMID:14563825 PMID:18266981 PMID:22138235 PMID:19252289
RGD:2313621
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc37a4
solute carrier family 37 member 4
IEP
protein:increased expression:liver
RGD
PMID:10567346
RGD:1625641
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc38a2
solute carrier family 38, member 2
IEP
RGD
PMID:11798158
RGD:9999213
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc8a1
solute carrier family 8 member A1
IEP
mRNA, protein:decreased expression:cardiac muscle cell
RGD
PMID:10944172
RGD:1642714
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a1
solute carrier family 9 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20003708
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Slc9a3
solute carrier family 9 member A3
IDA ISO
protein:increased activity:kidney cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20003708 PMID:16244498
RGD:1625673
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
G
Smad1
SMAD family member 1
severity
IEP
protein:increased expression:glomerulus, urine
RGD
PMID:16482100
RGD:1643228
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smarca4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
treatment
IEP
RGD
PMID:23853776
RGD:9586347
NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
G
Smpd1
sphingomyelin phosphodiesterase 1
IDA
protein:decreased expression:gastrocnemius
RGD
PMID:14983401
RGD:1601347
NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794
G
Snap25
synaptosome associated protein 25
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
G
Soat2
sterol O-acyltransferase 2
IDA
RGD
PMID:15242859
RGD:1581191
NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
G
Socs3
suppressor of cytokine signaling 3
susceptibility
IEP ISO
mRNA, protein:increased expression:retina
RGD
PMID:18356406 PMID:17562326
RGD:2298911 , RGD:2313787
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod1
superoxide dismutase 1
IEP ISO
protein:increased expression:hippocampus (rat) associated with alcohol use disorder; protein:decreased activity;testis, epididymis (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23090186 PMID:20924670 PMID:25541261
RGD:8655956 , RGD:405255664
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
IEP ISO
protein:increased activity:testes CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15855331 PMID:23090186 PMID:19891634
RGD:2317382
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sord
sorbitol dehydrogenase
IEP
protein:increased expression:liver
RGD
PMID:15064821
RGD:1601360
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Sox2
SRY-box transcription factor 2
IEP
RGD
PMID:23828673
RGD:8661677
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Spp1
secreted phosphoprotein 1
IDA
RGD
PMID:16528250
RGD:1581322
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
IEP ISO
mRNA, protein:increased expression:renal proximal tubule, epithelial cell CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10900012 PMID:23090186 PMID:19048273 PMID:32535406
RGD:2308804 , RGD:401850547
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sstr1
somatostatin receptor 1
IEP
RGD
PMID:7956902
RGD:2325008
NCBI chr 6:75,832,292...75,836,806
Ensembl chr 6:75,832,530...75,836,802
G
Sstr2
somatostatin receptor 2
IEP
RGD
PMID:7956902
RGD:2325008
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
G
Sstr3
somatostatin receptor 3
IEP
RGD
PMID:7956902
RGD:2325008
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
G
Sstr5
somatostatin receptor 5
IEP
RGD
PMID:7956902
RGD:2325008
NCBI chr10:14,506,868...14,512,946
Ensembl chr10:14,506,868...14,512,946
G
Star
steroidogenic acute regulatory protein
IEP
mRNA:decreased expression:sciatic nerve (rat)
RGD
PMID:20826654
RGD:4145530
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stat1
signal transducer and activator of transcription 1
IDA
protein:increased tyrosine phosphorylation:glomerulus
RGD
PMID:14678947
RGD:1600105
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
IEP ISO
protein:increased tyrosine phosphorylation:aorta endothelium
RGD
PMID:18230613 PMID:22660795
RGD:2291921 , RGD:8694292
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat4
signal transducer and activator of transcription 4
ISO
RGD
PMID:10553062
RGD:7207889
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Stat5b
signal transducer and activator of transcription 5B
IMP
RGD
PMID:17003334
RGD:2291940
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
G
Stra6
signaling receptor and transporter of retinol STRA6
IEP
protein:decreased expression:optic cup (rat)
RGD
PMID:28734946
RGD:155631297
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
G
Sts
steroid sulfatase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24497646
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Tert
telomerase reverse transcriptase
IEP
RGD
PMID:20031167
RGD:2316310
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tf
transferrin
IEP
RGD
PMID:17081048
RGD:1601532
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb1
transforming growth factor, beta 1
IEP ISO
protein:increased expression:urine CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17177138 PMID:23090186 PMID:15855808
RGD:1601583
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
IEP
protein:increased expression:parotid gland
RGD
PMID:17574405
RGD:2302087
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Th
tyrosine hydroxylase
IEP
protein:increased expression:seminal vesicle
RGD
PMID:17151307
RGD:1601629
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Thbs1
thrombospondin 1
IMP
RGD
PMID:17640965
RGD:2317942
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Timm44
translocase of inner mitochondrial membrane 44
IEP
protein:decreased expression:retina
RGD
PMID:23255365
RGD:13463486
NCBI chr12:2,612,581...2,629,374
Ensembl chr12:2,612,581...2,629,351
G
Timp1
TIMP metallopeptidase inhibitor 1
IEP ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21963884 PMID:17569353 PMID:17192464
RGD:2290354 , RGD:2312467
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp2
TIMP metallopeptidase inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21963884
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Timp3
TIMP metallopeptidase inhibitor 3
ISO
mRNA:increased expression:glomerulus
RGD
PMID:8840279
RGD:2312482
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tjp1
tight junction protein 1
IEP
protein:decreased expression:glomerulus
RGD
PMID:16567508
RGD:2325150
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr2
toll-like receptor 2
IEP ISO
RGD
PMID:16740310 PMID:17707128
RGD:2312491 , RGD:2312684
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IEP
RGD
PMID:16740310
RGD:2312491
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnc
tenascin C
IEP
RGD
PMID:17999372
RGD:4889609
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
treatment
IEP ISO
protein:increased expression:heart CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:12123627 PMID:12193562 PMID:19478208 PMID:20388520 PMID:22138235 PMID:24513509 PMID:20555424 PMID:19220660 PMID:24374093 PMID:21481476 More...
RGD:4142788 , RGD:2312478 , RGD:10450575 , RGD:5131250
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP ISO
protein:increased expression:liver (rat) CTD Direct Evidence: therapeutic
CTD RGD
PMID:12193562 PMID:21481476
RGD:5131250
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
human protein in rat model
RGD
PMID:21481476
RGD:5131250
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf10
TNF superfamily member 10
ISO IEP
RGD
PMID:12577054 PMID:19572802 PMID:18649770
RGD:2312744 , RGD:2312737 , RGD:2312738
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tomm40
translocase of outer mitochondrial membrane 40
IEP
protein:decreased expression:retina
RGD
PMID:23255365
RGD:13463486
NCBI chr 1:79,358,781...79,370,882
Ensembl chr 1:79,358,786...79,370,915
G
Tomm70
translocase of outer mitochondrial membrane 70
IEP
protein:decreased expression:retina
RGD
PMID:23255365
RGD:13463486
NCBI chr11:43,378,719...43,417,166
Ensembl chr11:43,377,216...43,417,202
G
Tp53
tumor protein p53
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21078376 PMID:23792339 PMID:24828139
RGD:8662307
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
IEP
protein:increased expression:prostate gland
RGD
PMID:20041964
RGD:11568648
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tpi1
triosephosphate isomerase 1
IEP
protein:decreased expression:retina
RGD
PMID:17465459
RGD:5147874
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Trex2
three prime repair exonuclease 2
IEP
RGD
PMID:20973890
RGD:5490977
NCBI chr X:151,151,862...151,153,470
Ensembl chr X:151,151,864...151,153,479
G
Trpc1
transient receptor potential cation channel, subfamily C, member 1
IEP
mRNA:decreased expression:kidney, liver
RGD
PMID:18184923
RGD:2301838
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
G
Tsc2
TSC complex subunit 2
IEP
protein:increased threonine phosphorylation:cortex of kidney
RGD
PMID:18599524
RGD:8657153
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
G
Twnk
twinkle mtDNA helicase
IEP ISO
mRNA,protein:decreased expression:retina,mitochondrion:
RGD
PMID:22743328 PMID:22229649
RGD:8694093 , RGD:8694187
NCBI chr 1:243,867,568...243,874,802
Ensembl chr 1:243,868,330...243,874,802
G
Txn1
thioredoxin 1
IEP
mRNA:altered expression:myocardium (rat)
RGD
PMID:20571744
RGD:5133714
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
IEP
mRNA:increased expression:glomerulus mRNA:altered expression:myocardium (rat)
RGD
PMID:15039483 PMID:20571744
RGD:2306161 , RGD:5133714
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnip
thioredoxin interacting protein
IEP
protein:increased expression:kidney
RGD
PMID:17675577
RGD:1642749
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
IEP
mRNA:altered expression:myocardium (rat)
RGD
PMID:20571744
RGD:5133714
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
IEP
mRNA:altered expression:myocardium (rat)
RGD
PMID:20571744
RGD:5133714
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:12171997
RGD:11352735
NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807
G
Uchl5
ubiquitin C-terminal hydrolase L5
IEP
RGD
PMID:23500140
RGD:9588239
NCBI chr13:55,520,722...55,556,503
Ensembl chr13:55,520,729...55,556,502
G
Uck2
uridine-cytidine kinase 2
IEP
protein:decreased activity:heart, skeletal muscle
RGD
PMID:221781
RGD:2317214
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
G
Ucp2
uncoupling protein 2
IEP ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14563825 PMID:16123366 PMID:19227473
RGD:2313501
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ucp3
uncoupling protein 3
susceptibility
IEP ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:10868941 PMID:12079841
RGD:2313524 , RGD:2313520
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
IEP
mRNA:increased expression:liver
RGD
PMID:20487213
RGD:11541075
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Umod
uromodulin
IEP
protein:increased expression:urine
RGD
PMID:10925066
RGD:2324705
NCBI chr 1:173,816,341...173,829,681
Ensembl chr 1:173,816,339...173,830,302
G
Umps
uridine monophosphate synthetase
IEP
protein:decreased activity:liver (rat) protein:decreased activity:mammary gland (rat)
RGD
PMID:3907307 PMID:1476792
RGD:5132278 , RGD:5132591
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Uprt
uracil phosphoribosyltransferase homolog
IEP
protein:decreased activity:mammary gland (rat)
RGD
PMID:1476792
RGD:5132591
NCBI chr X:69,516,573...69,546,811
Ensembl chr X:69,516,738...69,546,797
G
Uts2r
urotensin 2 receptor
IMP
RGD
PMID:16267137
RGD:2306839
NCBI chr10:106,438,092...106,439,252
Ensembl chr10:106,438,092...106,439,252
G
Vcam1
vascular cell adhesion molecule 1
IEP ISO
mRNA, protein:increased expression:kidney mRNA:increased expression:aorta
RGD
PMID:18983856 PMID:18093596
RGD:2312764 , RGD:2306988
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vdac1
voltage-dependent anion channel 1
IEP
protein:increased expression:kidney
RGD
PMID:19634143
RGD:10003054
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vegfa
vascular endothelial growth factor A
IEP ISO IDA
mRNA:decreased expression:heart CTD Direct Evidence: marker/mechanism mRNA:decreased expression:skeletal muscle
CTD RGD
PMID:22191573 PMID:16741021 PMID:19934008 PMID:16816123
RGD:2313724 , RGD:7421582 , RGD:2313725
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:16816123
RGD:2313725
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:21129425
RGD:5685622
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Vipr1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:21129425
RGD:5685622
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
G
Vldlr
very low density lipoprotein receptor
IEP
protein:decreased expression:heart, skeletal muscle
RGD
PMID:15878964
RGD:1625575
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vwf
von Willebrand factor
IEP
protein:increased expression:plasma
RGD
PMID:17546272
RGD:1625712
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wdr35
WD repeat domain 35
IEP
mRNA:increased expression:kidney (rat)
RGD
PMID:20224876
RGD:11553923
NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
G
Xdh
xanthine dehydrogenase
IEP
protein:increased expression:brain, heart, kidney
RGD
PMID:14532905
RGD:1304441
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18342293
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
G
Cbl
Cbl proto-oncogene
treatment
ISO
RGD
PMID:20890046
RGD:11038805
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Cbx7
chromobox 7
ISO
RGD
PMID:25434821
RGD:11352713
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
RGD
PMID:10090949
RGD:11251764
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Fgfr1
Fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:22781593
RGD:11352669
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:2117483
RGD:11051972
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Lat2
linker for activation of T cells family, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Nras
NRAS proto-oncogene, GTPase
induced
IAGP
DNA:transversion mutation, loss of heterozygosity:cds:
RGD
PMID:9142215
RGD:11535063
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Runx1
RUNX family transcription factor 1
treatment
ISO
RGD
PMID:19236814
RGD:11251683
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Abcb11
ATP binding cassette subfamily B member 11
IDA
RGD
PMID:15853769
RGD:1598580
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
IEP
RGD
PMID:8104413
RGD:5684351
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Adsl
adenylosuccinate lyase
IEP
protein:increased activity:liver (rat)
RGD
PMID:2937404
RGD:1598766
NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24012840 PMID:32961231
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agps
alkylglycerone phosphate synthase
IDA
RGD
PMID:7407223
RGD:1598794
NCBI chr 3:60,747,323...60,845,831
Ensembl chr 3:60,747,323...60,845,830
G
Alas2
5'-aminolevulinate synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
G
Apoa4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apoc2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Arid1a
AT-rich interaction domain 1A
disease_progression
ISO
RGD
PMID:26569409
RGD:11344640
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
G
Arrb2
arrestin, beta 2
IEP
mRNA, protein:increased expression:liver (rat)
RGD
PMID:21167192
RGD:5509890
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Atp7a
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp7b
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Bak1
BCL2-antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bbc3
Bcl-2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10426811 PMID:28100771 PMID:22414765
RGD:11353865
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Birc5
baculoviral IAP repeat-containing 5
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18246794
RGD:2293125
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
IEP
protein:increased activity:liver (rat)
RGD
PMID:13618893
RGD:5132586
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Car3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30603057
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccnb1
cyclin B1
IEP
mRNA:increased expression:liver
RGD
PMID:17342310
RGD:2315991
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28100771 PMID:17055752
RGD:2289139
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccndbp1
cyclin D1 binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16501603
NCBI chr 3:107,962,402...107,974,234
Ensembl chr 3:107,962,261...107,974,233
G
Ccng1
cyclin G1
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccng2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cd40lg
CD40 ligand
ISO
RGD
PMID:19035311
RGD:5491179
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd63
Cd63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:25319454
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP
protein:decreased expression:liver:
RGD
PMID:8640740
RGD:8662309
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
disease_progression
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
disease_progression
IEP
protein:decreased expression:liver (rat) protein:increased expression:liver (rat) mRNA:increased expression:liver (rat)
RGD
PMID:26606000 PMID:3965145 PMID:19533683
RGD:11354707 , RGD:152998958 , RGD:2315050
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cops5
COP9 signalosome subunit 5
IEP
protein:increased expression:liver (rat)
RGD
PMID:26606000
RGD:11354707
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cps1
carbamoyl-phosphate synthase 1
severity
IEP
mRNA:decreased expression:liver
RGD
PMID:3387993
RGD:2303406
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11280770 PMID:20118494 PMID:21147764
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA:increased expression:liver
RGD
PMID:22687991
RGD:7296954
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11376689 PMID:21147764
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18056438
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2f4
cytochrome P450, family 2, subfamily f, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
G
Dhodh
dihydroorotate dehydrogenase (quinone)
IEP
protein:increased activity:liver (rat)
RGD
PMID:6331524
RGD:5132618
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Dtymk
deoxythymidylate kinase
IEP
protein:increased activity:tumor (rat)
RGD
PMID:6244089
RGD:5133686
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Ephx1
epoxide hydrolase 1
IEP
RGD
PMID:7260898
RGD:11252158
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35044086
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
F12
coagulation factor XII
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Foxm1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15082532
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Gjb1
gap junction protein, beta 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18308698 PMID:1336494
RGD:7349398
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gjb2
gap junction protein, beta 2
IEP
RGD
PMID:1336494
RGD:7349398
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Glul
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:21147764
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Grp
gastrin releasing peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
G
Gstp1
glutathione S-transferase pi 1
IEP ISO
protein:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 PMID:12016164 PMID:3965145 More...
RGD:2317823 , RGD:152998958
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
H19
H19 imprinted maternally expressed transcript
IDA ISO
DNA:hypomethylation:promoter CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11420682 PMID:15352122
RGD:1342455
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Hat1
histone acetyltransferase 1
IEP
protein:increased expression:liver
RGD
PMID:17182829
RGD:2316578
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11896611
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Htr2c
5-hydroxytryptamine receptor 2C
IEP
protein:increased expression:brainstem, cerebral cortex
RGD
PMID:17258772
RGD:1624998
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Igf2
insulin-like growth factor 2
treatment
IEP
RGD
PMID:22425635
RGD:10402567
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igf2r
insulin-like growth factor 2 receptor
IAGP
RGD
PMID:15057872 PMID:9652747
RGD:2311623 , RGD:2311630
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il6
interleukin 6
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse)
CTD RGD
PMID:26297436 PMID:26569409
RGD:11344640
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Insr
insulin receptor
disease_progression
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat)
RGD
PMID:15520221
RGD:2306052
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kat6a
lysine acetyltransferase 6A
IEP
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
G
Kdr
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kras
KRAS proto-oncogene, GTPase
disease_progression
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:8603461 PMID:19533683
RGD:2315050
NCBI chr 4:178,185,418...178,218,484
G
Map2k1
mitogen activated protein kinase kinase 1
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver
RGD
PMID:15520221
RGD:2306052
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
G
Mir125a
microRNA 125a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
G
Mir145
microRNA 145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir151
microRNA 151
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:105,172,377...105,172,473
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
G
Mir181d
microRNA 181d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr19:23,983,706...23,983,788
Ensembl chr19:23,983,706...23,983,788
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
G
Mir186
microRNA 186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
G
Mir18a
microRNA 18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
G
Mir193a
microRNA 193a
ISO
miRNA:decreased expression:liver (mouse)
RGD
PMID:30165047
RGD:153323340
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir195
microRNA 195
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
G
Mir196b
microRNA 196b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:81,330,487...81,330,571
Ensembl chr 4:81,330,487...81,330,571
G
Mir200b
microRNA 200b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
G
Mir206
microRNA 206
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
G
Mir212
microRNA 212
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:60,023,403...60,023,513
Ensembl chr10:60,023,403...60,023,513
G
Mir221
microRNA 221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
G
Mir26a
microRNA 26a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 8:118,755,289...118,755,378
Ensembl chr 8:118,755,289...118,755,378
G
Mir26b
microRNA 26b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:75,976,596...75,976,680
Ensembl chr 9:75,976,596...75,976,680
G
Mir290
microRNA 290
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:65,964,648...65,964,728
Ensembl chr 1:65,964,648...65,964,728
G
Mir300
microRNA 300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:128,738,513...128,738,591
Ensembl chr 6:128,738,505...128,738,594
G
Mir301a
microRNA 301a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:71,925,336...71,925,435
Ensembl chr10:71,925,336...71,925,435
G
Mir30a
microRNA 30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
G
Mir30b
microRNA 30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:100,132,589...100,132,675
Ensembl chr 7:100,132,589...100,132,675
G
Mir30d
microRNA 30d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:100,136,391...100,136,472
Ensembl chr 7:100,136,391...100,136,472
G
Mir30e
microRNA 30e
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:134,352,232...134,352,323
Ensembl chr 5:134,352,232...134,352,323
G
Mir324
microRNA 324
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:54,734,678...54,734,766
G
Mir331
microRNA 331
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
G
Mir336
microRNA 336
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:34,185,579...34,185,674
Ensembl chr10:34,185,579...34,185,674
G
Mir339
microRNA 339
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr12:15,277,546...15,277,641
Ensembl chr12:15,277,546...15,277,641
G
Mir340-1
microRNA 340-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:34,393,568...34,393,665
Ensembl chr10:34,393,568...34,393,665
G
Mir347
microRNA mir-347
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
G
Mir349
microRNA 349
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:120,243,311...120,243,407
Ensembl chr 7:120,243,311...120,243,407
G
Mir34a
microRNA 34a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mir352
microRNA mir-352
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
G
Mir383
microRNA 383
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr16:54,040,340...54,040,413
Ensembl chr16:54,040,340...54,040,413
G
Mir409
microRNA 409
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
G
Mir429
microRNA 429
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:166,647,459...166,647,543
Ensembl chr 5:166,647,459...166,647,543
G
Mir598
microRNA 598
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr15:37,962,692...37,962,770
Ensembl chr15:37,962,692...37,962,771
G
Mir652
microRNA 652
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:106,343,293...106,343,373
Ensembl chr X:106,343,293...106,343,373
G
Mir671
microRNA 671
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:10,580,747...10,580,827
Ensembl chr 4:10,580,738...10,580,835
G
Mir708
microRNA 708
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:150,599,876...150,599,963
Ensembl chr 1:150,599,876...150,599,963
G
Mir760
microRNA 760
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:210,392,616...210,392,695
Ensembl chr 2:210,392,616...210,392,695
G
Mir92b
microRNA 92b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:174,633,890...174,633,972
Ensembl chr 2:174,633,890...174,633,972
G
Mir98
microRNA 98
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:20,981,235...20,981,342
Ensembl chr X:20,981,235...20,981,342
G
Mir99b
microRNA 99b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
G
Mirlet7b
microRNA let-7b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:116,804,186...116,804,270
G
Mirlet7d
microRNA let-7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr17:16,115,893...16,115,990
Ensembl chr17:16,115,893...16,115,990
G
Mirlet7i
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:58,642,485...58,642,569
Ensembl chr 7:58,642,480...58,642,571
G
Mmp2
matrix metallopeptidase 2
IEP ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression, increased activity:liver
CTD RGD
PMID:30603057 PMID:19528495 PMID:19539802
RGD:2325736 , RGD:2325734
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IEP
mRNA, protein:increased expression, increased activity:liver
RGD
PMID:19528495 PMID:19539802
RGD:2325736 , RGD:2325734
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpeg1
macrophage expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP ISO
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9079223 PMID:11280770 PMID:18560566 PMID:3335218
RGD:10059623
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nos2
nitric oxide synthase 2
IEP
protein:increased expression:liver
RGD
PMID:10383909
RGD:2325277
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
IEP
protein:increased expression:liver
RGD
PMID:18942116
RGD:2325310
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nqo1
NAD(P)H quinone dehydrogenase 1
IEP
mRNA, protein:increased expression:liver (rat)
RGD
PMID:27867096
RGD:13442478
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
susceptibility
ISO
RGD
PMID:17283114
RGD:14701032
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17172636 PMID:24769335 PMID:25656644
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nras
NRAS proto-oncogene, GTPase
ISO
human gene in mouse model
RGD
PMID:16286660
RGD:14975105
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Pemt
phosphatidylethanolamine N-methyltransferase
IEP
protein:decreased expression:liver
RGD
PMID:7929120
RGD:1642378
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
G
Plcl1
phospholipase C-like 1
disease_progression
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr 9:56,901,573...57,238,782
Ensembl chr 9:56,901,534...57,238,782
G
Pml
PML nuclear body scaffold
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20377131
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:761203
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:2562181
RGD:8693574
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Ptgr1
prostaglandin reductase 1
IEP
mRNA, protein:increased expression:liver
RGD
PMID:24853774
RGD:14401713
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Rad51
RAD51 recombinase
IEP
protein:decreased expression:liver
RGD
PMID:17219426
RGD:2292638
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17854601
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rida
reactive intermediate imine deaminase A homolog
IEP
protein:increased expression:liver (rat)
RGD
PMID:12939504
RGD:9685719
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
G
Rras2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rrm1
ribonucleotide reductase catalytic subunit M1
IEP
RGD
PMID:15224347
RGD:2316863
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rxra
retinoid X receptor alpha
IEP
mRNA, protein:decreased expression:liver
RGD
PMID:17786350
RGD:1643105
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Serpina1
serpin family A member 1
IEP
RGD
PMID:10569800
RGD:1626391
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Slc31a1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc7a5
solute carrier family 7 member 5
IEP
mRNA:increased expression:liver
RGD
PMID:17498859
RGD:151357003
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Snx27
sorting nexin 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr 2:182,135,904...182,218,906
Ensembl chr 2:182,135,905...182,218,906
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Sox4
SRY-box transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sqle
squalene epoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436 PMID:28100771
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tek
TEK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tgfa
transforming growth factor alpha
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9079223 PMID:16734725
RGD:2317490
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tk1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tnf
tumor necrosis factor
disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse) Morris hepatoma
CTD RGD
PMID:28100771 PMID:26569409 PMID:9063767
RGD:11344640 , RGD:14696818
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10626228 PMID:28100771
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15833021 PMID:17533171
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Vim
vimentin
IDA
RGD
PMID:19199359
RGD:6480440
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Xdh
xanthine dehydrogenase
IEP
protein:decreased expression:liver
RGD
PMID:3460692
RGD:13210515
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
RGD
PMID:19654309
RGD:2315553
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:14633655 PMID:19654309
RGD:2315553
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22767648
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
G
Adcy5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression treatment
ISO IEP
RGD
PMID:19447866 PMID:22246620
RGD:8694414 , RGD:8694468
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16322315
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agt
angiotensinogen
treatment
IDA
RGD
PMID:20837666
RGD:5129167
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8389152 PMID:18421211
RGD:2292665
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Agtr2
angiotensin II receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alcam
activated leukocyte cell adhesion molecule
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
IEP
mRNA:increased expression:mammary gland tumor (rat)
RGD
PMID:18959458
RGD:2313895
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Antxr1
ANTXR cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:22085271
RGD:9684855
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
G
Anxa1
annexin A1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Apaf1
apoptotic peptidase activating factor 1
IDA
RGD
PMID:14973070
RGD:2325748
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apoe
apolipoprotein E
ISO
RGD
PMID:22469977
RGD:7771597
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Ar
androgen receptor
IEP
RGD
PMID:12150826
RGD:6482679
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
ISO IEP
protein:increased expression:mammary gland mRNA:increased expression:mammary gland
RGD
PMID:10225449 PMID:18421211
RGD:2292663 , RGD:2292665
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arhgap5
Rho GTPase activating protein 5
disease_progression
IEP ISO
mRNA:increased expression:mammary gland
RGD
PMID:10939588 PMID:19703301
RGD:2316183 , RGD:126848766
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124350
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Bad
BCL2-associated agonist of cell death
treatment severity
IDA IEP
RGD
PMID:23404339 PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
ISO
RGD
PMID:19222350
RGD:2315700
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bard1
BRCA1 associated RING domain 1
ISO
RGD
PMID:18443292
RGD:2293149
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Basp1
brain abundant, membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Bax
BCL2 associated X, apoptosis regulator
treatment severity
IDA IEP
RGD
PMID:23404339 PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:23404339 PMID:22668016
RGD:10053670 , RGD:10054128
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bgn
biglycan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35234341
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
G
Brca1
BRCA1, DNA repair associated
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12203372 PMID:22767648 PMID:18443292 PMID:12203372 PMID:17505536
RGD:2293149 , RGD:1599502 , RGD:2293155
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Bst2
bone marrow stromal cell antigen 2
disease_progression
ISO
RGD
PMID:23806386 PMID:23806386
RGD:14398495 , RGD:14398495
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
disease_progression
IEP
protein:increased expression:mammary gland
RGD
PMID:6030068
RGD:2303540
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
G
Car9
carbonic anhydrase 9
IEP
RGD
PMID:17280655
RGD:2293194
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp1
caspase 1
treatment
ISO
RGD
PMID:10557324
RGD:2315886
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
treatment severity
IDA IEP
RGD
PMID:23404339 PMID:26699876 PMID:20732338
RGD:10053670 , RGD:13782283 , RGD:10053708
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
IDA ISO
RGD
PMID:23404339 PMID:26699876 PMID:23979166
RGD:10053670 , RGD:13782283 , RGD:13209143
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
severity
IEP
RGD
PMID:20732338
RGD:10053708
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment severity
IDA IEP ISO
RGD
PMID:17297389 PMID:26699876 PMID:20732338 PMID:20012353
RGD:2315933 , RGD:13782283 , RGD:10053708 , RGD:2315928
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
treatment onset
ISO
protein:decreased expression:mammary gland
RGD
PMID:9685399 PMID:15334058 PMID:15355971
RGD:2289100 , RGD:8661780 , RGD:2289106
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccna2
cyclin A2
ISO
protein:increased expression:mammary gland
RGD
PMID:10713672
RGD:2293347
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
ISO
RGD
PMID:11146550
RGD:2315939
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
ISO IEP
mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression:mammary gland
CTD RGD
PMID:12376462 PMID:14522882 PMID:16316942 PMID:17440082 PMID:12376462 PMID:16316942 PMID:12602925 PMID:12649181 More...
RGD:2296037 , RGD:2292404 , RGD:2306898 , RGD:2289337 , RGD:2289336
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
IEP ISO
mRNA, protein:increased expression:mammary gland
RGD
PMID:16311245 PMID:12853979
RGD:2316020 , RGD:2316015
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccne1
cyclin E1
IEP
protein:decreased expression:mammary gland
RGD
PMID:12649181 PMID:12602925
RGD:2289336 , RGD:2289337
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccnh
cyclin H
IEP ISO
mRNA:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12606953 PMID:12606953
RGD:9590264
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21621198
RGD:6893427
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:14597737 PMID:22637726
RGD:8551810 , RGD:8551813
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd274
CD274 molecule
treatment
IDA
RGD
PMID:29043842
RGD:40886270
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd40
CD40 molecule
ISO
RGD
PMID:21137078
RGD:8547744
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdc25a
cell division cycle 25A
ISO
RGD
PMID:17283130 PMID:17638870 PMID:16951165
RGD:2764000 , RGD:2754551 , RGD:2771824
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdc42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh13
cadherin 13
severity
ISO
RGD
PMID:18316604 PMID:18316604
RGD:2293540 , RGD:2293540
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
G
Cdk2
cyclin dependent kinase 2
ISO
RGD
PMID:16924466
RGD:2293558
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
susceptibility
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:14522882 PMID:25221644 PMID:14522882 PMID:16413469
RGD:2293581 , RGD:2293577
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkl2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,028,363...16,063,252
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
treatment
IEP IDA
protein:increased expression:mammary gland
RGD
PMID:15844214 PMID:22651929
RGD:2293626 , RGD:10045559
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
disease_progression
ISO IEP
RGD
PMID:18060046 PMID:20681787
RGD:2289674 , RGD:8552689
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
G
Clu
clusterin
disease_progression
ISO
RGD
PMID:23099883
RGD:8699504
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cnn3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
G
Col18a1
collagen type XVIII alpha 1 chain
severity
IDA
RGD
PMID:10766159
RGD:70690
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col5a1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Csf1
colony stimulating factor 1
ISO
RGD
PMID:15205327
RGD:2293710
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csn2
casein beta
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:9879772 PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr14:20,322,581...20,329,818
Ensembl chr14:20,322,581...20,329,817
G
Csn3
casein kappa
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr14:20,154,032...20,160,585
Ensembl chr14:20,154,032...20,160,587
G
Csnk2a1
casein kinase 2 alpha 1
IEP ISO
RGD
PMID:11827167 PMID:11827167
RGD:727632 , RGD:727632
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
G
Ctnnb1
catenin beta 1
ISO
DNA:missense mutations: :p.S33Y, p.S45F protein:increased expression:mammary gland
RGD
PMID:18060046 PMID:17510243
RGD:2289674 , RGD:2289816
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Dbi
diazepam binding inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21283680 PMID:29298894
RGD:151347446
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Des
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
G
Dio1
iodothyronine deiodinase 1
IDA
RGD
PMID:11765219
RGD:727335
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dnmt3b
DNA methyltransferase 3 beta
treatment
IEP
RGD
PMID:24447120
RGD:9588304
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:2523869 PMID:8603490 PMID:17203220
RGD:2289979
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif5a
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epo
erythropoietin
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
Erbb2
erb-b2 receptor tyrosine kinase 2
IDA ISO
Androgen-dependent CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8603490 PMID:25221644 PMID:1913683 PMID:12150826 PMID:17203220
RGD:2289920 , RGD:6482679 , RGD:2289979
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Esr1
estrogen receptor 1
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD RGD
PMID:15637090 PMID:18055862 PMID:11759285 PMID:15637090
RGD:2290019 , RGD:8553057 , RGD:8552983
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
treatment
IDA ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD RGD
PMID:15637090 PMID:24078029 PMID:15637090
RGD:7364911 , RGD:8552983
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F11r
F11 receptor
ISO
RGD
PMID:22120722
RGD:7488922
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:18094967
RGD:2290047
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbxo10
F-box protein 10
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:59,297,016...59,343,429
Ensembl chr 5:59,297,045...59,343,348
G
Fgf10
fibroblast growth factor 10
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgf7
fibroblast growth factor 7
ISO
RGD
PMID:9000125
RGD:2301094
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:9840935
RGD:2301098
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10498246
RGD:2302211
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Frmpd1
FERM and PDZ domain containing 1
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:59,443,076...59,545,125
Ensembl chr 5:59,443,076...59,545,080
G
Furin
furin (paired basic amino acid cleaving enzyme)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
G
G0s2
G0/G1switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gh1
growth hormone 1
treatment
IMP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12082019 PMID:15528971 PMID:17584969 PMID:17584969 PMID:6139974
RGD:2315650 , RGD:11352806
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:28810530
RGD:13792729
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
IEP
mRNA:decreased expression
RGD
PMID:8895730
RGD:1599869
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
H19
H19 imprinted maternally expressed transcript
IEP
RGD
PMID:15170812
RGD:1642758
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H3f3b
H3.3 histone B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:17280655
RGD:2293194
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16319139 PMID:23215791
RGD:10755708
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15538050
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
G
Hp
haptoglobin
treatment
IDA
RGD
PMID:23880232
RGD:11041861
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hras
HRas proto-oncogene, GTPase
IAGP ISO
DNA:mutation: :p.G12E (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8185828 PMID:11376698 PMID:19652463
RGD:2314834
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Id1
inhibitor of DNA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id3
inhibitor of DNA binding 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Id4
inhibitor of DNA binding 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276
RGD:8549490
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14999141
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18bp
interleukin 18 binding protein
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Ilk
integrin-linked kinase
ISO
late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands
RGD
PMID:11704830
RGD:2301733
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Insig1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Itgb3
integrin subunit beta 3
IEP
protein:increased expression:mammary gland:
RGD
PMID:22022542
RGD:8693386
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Kdr
kinase insert domain receptor
IDA ISO
inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ
RGD
PMID:15170218 PMID:19888452
RGD:2291936 , RGD:5684399
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IAGP
DNA:mutation (rat)
RGD
PMID:18445266
RGD:2302172
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
G
Krt7
keratin 7
IEP
RGD
PMID:8570173
RGD:2317439
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:132,873,532...132,898,975
Ensembl chr 7:132,873,540...132,882,325
G
Lep
leptin
treatment
IEP
RGD
PMID:22246620
RGD:8694468
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals7
galectin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
IMP
mRNA:splice variant (rat)
RGD
PMID:15044717
RGD:2302177
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lnpep
leucyl and cystinyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16619500 PMID:16619500
RGD:1582109
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lsr
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
G
Map2k3
mitogen activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map2k7
mitogen activated protein kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21317887
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mdh2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir155
microRNA 155
ISO
RGD
PMID:20354188 PMID:29643534
RGD:21079418 , RGD:21403681
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mmp1
matrix metallopeptidase 1
treatment
ISO
RGD
PMID:19622769
RGD:8549722
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
severity
ISO
RGD
PMID:18698413
RGD:2306081
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp15
matrix metallopeptidase 15
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15895410
RGD:2314949
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
G
Mmp2
matrix metallopeptidase 2
treatment
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28574600 PMID:19725228 PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
IMP
RGD
PMID:10428026
RGD:8662909
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
onset
ISO
RGD
PMID:9850086
RGD:9685350
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mmp9
matrix metallopeptidase 9
treatment
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21283680 PMID:19725228 PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpzl1
myelin protein zero-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:77,852,467...77,889,305
Ensembl chr13:77,852,467...77,896,616
G
Mrc2
mannose receptor, C type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mtor
mechanistic target of rapamycin kinase
IMP
RGD
PMID:22349822
RGD:10040957
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Muc1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:23015160
RGD:7349374
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncoa1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21080969
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22072621
RGD:10412719
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Notch4
notch receptor 4
ISO
RGD
PMID:15531924
RGD:2299154
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
G
Nudt1
nudix hydrolase 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:12036445
RGD:724605
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8647655 PMID:15089975
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Padi4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362
G
Pak4
p21 (RAC1) activated kinase 4
ISO
RGD
PMID:20697354
RGD:7775027
NCBI chr 1:83,849,904...83,889,188
Ensembl chr 1:83,849,904...83,859,413
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pcna
proliferating cell nuclear antigen
IEP
mRNA,protein:increased expression:mammary gland:
RGD
PMID:2567593
RGD:10448972
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcp4
Purkinje cell protein 4
IEP
mRNA,protein:increased expression:cytoplasm:
RGD
PMID:19480007
RGD:9850273
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
G
Pdgfa
platelet derived growth factor subunit A
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:16316942 PMID:12376462 PMID:16316942
RGD:2292404 , RGD:2306898
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
G
Pgam1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phb1
prohibitin 1
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:12376462
RGD:2292404
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
IEP
RGD
PMID:22064478
RGD:8693420
NCBI chr 8:19,189,408...19,200,785
Ensembl chr 8:19,189,373...19,200,785
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plau
plasminogen activator, urokinase
disease_progression
IMP
RGD
PMID:18052026
RGD:6484140
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plk2
polo-like kinase 2
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:12376462
RGD:2292404
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prlr
prolactin receptor
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Psma4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:55,340,386...55,347,890
G
Psme1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
G
Ptbp1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:9,842,574...9,852,332
Ensembl chr 7:9,842,574...9,852,397
G
Pten
phosphatase and tensin homolog
onset
ISO
RGD
PMID:18381417
RGD:2292496
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IMP
mRNA:increased expression:breast
RGD
PMID:21623034 PMID:18676768 PMID:18279516
RGD:5135030 , RGD:2300118 , RGD:2300130
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
disease_progression
ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:24809783 PMID:18056629 PMID:15930288
RGD:2292554 , RGD:2292560
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Ptprb
protein tyrosine phosphatase, receptor type, B
treatment
ISO
RGD
PMID:23899555
RGD:151660352
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:15,857,704...15,940,757
Ensembl chr 2:15,857,980...15,940,854
G
Rasgrf2
RAS protein-specific guanine nucleotide-releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:23,113,613...23,361,537
Ensembl chr 2:23,117,004...23,361,240
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbp1
retinol binding protein 1
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:12376462
RGD:2292404
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rbp4
retinol binding protein 4
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:decreased expression:peritoneal macrophage
RGD
PMID:16288051
RGD:2298764
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16260626
RGD:7777148
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rnpep
arginyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16619500 PMID:16619500
RGD:1582109
NCBI chr13:46,699,458...46,717,829
Ensembl chr13:46,699,463...46,717,998
G
Rpl3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:111,622,255...111,627,640
Ensembl chr 7:111,621,610...111,636,468
G
Rpl6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
G
Rps14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr18:54,227,854...54,232,638
Ensembl chr18:54,227,854...54,233,166
G
Runx1
RUNX family transcription factor 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:29435983
RGD:126779584
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Rxra
retinoid X receptor alpha
IMP
RGD
PMID:16344269
RGD:1643109
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
S100a6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scd
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Slc12a2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Slc25a10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Sncg
synuclein, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
G
Socs1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452 PMID:20354188
RGD:2298899 , RGD:21079418
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452
RGD:2298899
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23964924
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:84,558,159...84,580,616
Ensembl chr 1:84,558,166...84,580,616
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15318939
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Srsf2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:11325527
RGD:2291895
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
ISO IEP
mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16316942 PMID:17483332 PMID:16316942
RGD:2291914 , RGD:2306898
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
susceptibility
IEP ISO
protein:increased tyrosine phosphorylation:mammary gland mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism protein:altered localization:nucleus
CTD RGD
PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 PMID:20181624 PMID:12376462 PMID:16316942 PMID:15609129 PMID:12082622 More...
RGD:2291927 , RGD:151665819 , RGD:2292404 , RGD:2306898 , RGD:2291932 , RGD:2298539
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat6
signal transducer and activator of transcription 6
ISO
RGD
PMID:11086031
RGD:2298563
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stc2
stanniocalcin 2
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stmn1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Tdg
thymine-DNA glycosylase
ISO
mRNA:increased expression:mammary gland tumor (mouse)
RGD
PMID:9794235
RGD:2317355
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
G
Terc
telomerase RNA component
ISO
RNA:increased expression:mammary gland
RGD
PMID:9857231
RGD:2291975
NCBI chr 2:112,815,654...112,816,041
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
ISO
RGD
PMID:8466857
RGD:7394797
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Thbs1
thrombospondin 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:15459484
RGD:1626167
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thrsp
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19755514
RGD:7401185
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
ISO
RGD
PMID:17671220
RGD:2290495
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21252285
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
disease_progression
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24809783 PMID:17470299 PMID:18092324
RGD:2290577 , RGD:2290539
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpm3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Trps1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:81,916,668...82,142,733
Ensembl chr 7:81,921,601...82,141,905
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tubb2b
tubulin, beta 2B class IIb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Txnip
thioredoxin interacting protein
severity
IEP
mRNA:decreased expression:mammary gland
RGD
PMID:15170812
RGD:1642758
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Tyms
thymidylate synthetase
IMP
RGD
PMID:9635926
RGD:2315839
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ube2i
ubiquitin-conjugating enzyme E2I
ISO
MCF-7 human breast cancer cell tumors grown in nude mice CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16316942 PMID:15735760
RGD:2301345
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vamp8
vesicle-associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:104,442,383...104,452,884
Ensembl chr 4:104,442,393...104,452,897
G
Vdr
vitamin D receptor
ISO
RGD
PMID:15333467
RGD:8158073
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Wnt1
Wnt family member 1
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
G
Wnt2
Wnt family member 2
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:46,328,408...46,374,673
Ensembl chr 4:46,333,998...46,374,402
G
Wnt3
Wnt family member 3
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423
RGD:2298848
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Wnt3a
Wnt family member 3A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423 PMID:8065359
RGD:2298848 , RGD:2298863
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
G
Wnt5b
Wnt family member 5B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:152,609,566...152,733,790
Ensembl chr 4:152,609,569...152,733,407
G
Wnt6
Wnt family member 6
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523
G
Wnt7a
Wnt family member 7A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
G
Wnt7b
Wnt family member 7B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12766084
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Xrcc3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
G
Acss1
acyl-CoA synthetase short-chain family member 1
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Antxr1
ANTXR cell adhesion molecule 1
treatment
ISO
RGD
PMID:19622764 PMID:19609240
RGD:9684925 , RGD:9684939
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997 PMID:29438700
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Calr
calreticulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16388313
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Ccl20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:14500387
RGD:7483600
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
treatment
ISO
RGD
PMID:24041689
RGD:7411680
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Egr1
early growth response 1
ISO
mRNA, protein:increased expression:salivary gland (mouse)
RGD
PMID:19517020
RGD:5131885
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Esr2
estrogen receptor 2
severity
ISO
RGD
PMID:20354658
RGD:8694122
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Hgf
hepatocyte growth factor
ISO
RGD
PMID:9823327
RGD:8548620
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16417267
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
RGD
PMID:19276165
RGD:7495758
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:12230493 PMID:17411412
RGD:8655870 , RGD:8655901
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:8061895
RGD:7794735
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:1966551
RGD:7401226
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
ISO
RGD
PMID:11884028
RGD:8662950
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Kdm1a
lysine demethylase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
G
Kdm4c
lysine demethylase 4C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chr 5:88,100,710...88,306,821
Ensembl chr 5:88,100,733...88,306,818
G
Mc1r
melanocortin 1 receptor
ISO
RGD
PMID:20126537
RGD:5687319
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Pdcd1
programmed cell death 1
treatment
ISO
RGD
PMID:19208793
RGD:9589070
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Pxn
paxillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18492274
NCBI chr12:41,060,791...41,107,952
Ensembl chr12:41,060,791...41,107,931
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19903903
RGD:11038656
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Arl6ip5
ADP-ribosylation factor like GTPase 6 interacting protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29545876
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Axl
Axl receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26206560
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
Bcr
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chr20:13,469,325...13,596,942
Ensembl chr20:13,471,668...13,597,016
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Bsg
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21165561
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccr5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35072892
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27224422
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdk4
cyclin-dependent kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Ctcf
CCCTC-binding factor
ISO
human breast cancer cells in mouse model
RGD
PMID:21896759
RGD:151356745
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35066776
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ddr1
discoidin domain receptor tyrosine kinase 1
treatment
ISO
human cancer cells in mouse model
RGD
PMID:26719540
RGD:11520844
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22613180
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14612517
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Ergic3
ERGIC and golgi 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27588471
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
G
Esrra
estrogen related receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34524571
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
G
F2r
coagulation factor II (thrombin) receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374729
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
Grep1
glycine rich extracellular protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34652879
NCBI chr10:12,727,164...12,748,629
Ensembl chr10:12,727,166...12,741,819
G
Hdac6
histone deacetylase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34524571
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21273587
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3433577 PMID:11552296 PMID:26558449
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hrh2
histamine receptor H 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6224980
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2297754
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15711825
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37246217
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
G
Il12a
interleukin 12A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1949363 PMID:3495671 PMID:22306178
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Isg15
ISG15 ubiquitin-like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506701
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Itgav
integrin subunit alpha V
treatment
ISO
human cells in rat model
RGD
PMID:20841470
RGD:152998949
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Kif11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17974955
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243
NCBI chr 4:178,185,418...178,218,484
G
Ldha
lactate dehydrogenase A
IMP
RGD
PMID:11085542
RGD:1600281
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Lect2
leukocyte cell-derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
G
Mapk15
mitogen-activated protein kinase 15
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36425765
NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645
G
Mapk7
mitogen-activated protein kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28736328 PMID:31152816
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Mir300
microRNA 300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,738,513...128,738,591
Ensembl chr 6:128,738,505...128,738,594
G
Mir323
microRNA 323
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,725,539...128,725,624
Ensembl chr 6:128,725,539...128,725,624
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,538,903...128,538,999
Ensembl chr 6:128,538,902...128,538,998
G
Mir34b
microRNA 34b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22113133
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
G
Mir370
microRNA 370
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,572,257...128,572,335
Ensembl chr 6:128,572,257...128,572,335
G
Mir381
microRNA 381
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,740,976...128,741,036
G
Mir431
microRNA 431
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,544,210...128,544,323
Ensembl chr 6:128,544,210...128,544,323
G
Mir433
microRNA 433
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,545,119...128,545,211
Ensembl chr 6:128,545,112...128,545,217
G
Mir487b
microRNA 487b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,741,485...128,741,566
Ensembl chr 6:128,741,485...128,741,566
G
Mir497
microRNA 497
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35066776
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
G
Mir770
microRNA 770
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:128,515,843...128,515,918
Ensembl chr 6:128,515,835...128,515,928
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37246217
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9496914 PMID:21034357
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Pak1
p21 (RAC1) activated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35066776
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
G
Parg
poly (ADP-ribose) glycohydrolase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33044785
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
G
Pcna
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pip5k1a
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34755307
NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598
G
Polr1h
RNA polymerase I subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16609701
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
G
Pou5f1
POU class 5 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506701
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Prl
prolactin
treatment
IEP
RGD
PMID:26983879
RGD:152177690
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prnp
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21265952
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Puf60
poly-U binding splicing factor 60
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21435101
NCBI chr 7:107,782,799...107,793,759
Ensembl chr 7:107,782,770...107,794,531
G
Rasal2
RAS protein activator like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34826200
NCBI chr13:69,279,882...69,569,161
Ensembl chr13:69,258,622...69,569,940
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27137931
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rictor
RPTOR independent companion of MTOR, complex 2
disease_progression
ISO
RGD
PMID:24244675
RGD:152995458
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20164124
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21852811
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stim1
stromal interaction molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27863410
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1674182 PMID:3361654 PMID:12627504
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17767197 PMID:24345465
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tob1
transducer of ErbB-2.1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225 PMID:27137931
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25739959
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Trim47
tripartite motif-containing 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31981573
NCBI chr10:101,337,573...101,342,044
Ensembl chr10:101,337,573...101,342,044
G
Txn1
thioredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Uri1
URI1, prefoldin-like chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21397856
NCBI chr 1:90,646,392...90,704,811
Ensembl chr 1:90,646,393...90,709,026
G
Usp39
ubiquitin specific peptidase 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34822033
NCBI chr 4:104,373,948...104,406,359
Ensembl chr 4:104,373,955...104,406,359
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20376344 PMID:20932960 PMID:28574600
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:18486906
RGD:10450567
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Fgf21
fibroblast growth factor 21
treatment
ISO
RGD
PMID:19664632 PMID:19664632
RGD:10401870 , RGD:10401870
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
IDA
RGD
PMID:19195057
RGD:12791282
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Reg3b
regenerating family member 3 beta
IEP
protein:increased expression:pancreatic juice (rat)
RGD
PMID:7809015
RGD:9999210
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
G
Tbxa2r
thromboxane A2 receptor
treatment
IMP
RGD
PMID:11341608
RGD:11059600
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Agtr1a
angiotensin II receptor, type 1a
IMP
RGD
PMID:14982483
RGD:6903857
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Agtr2
angiotensin II receptor, type 2
IMP
RGD
PMID:14982483
RGD:6903857
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Aif1
allograft inflammatory factor 1
IEP
protein:decreased expression:brain (rat)
RGD
PMID:19070908
RGD:2313024
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:24939579
RGD:13782350
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:24939579
RGD:13782350
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:24939579
RGD:13782350
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccn2
cellular communication network factor 2
IEP
protein:increased expression:kidney (rat)
RGD
PMID:19080126
RGD:2314603
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Eng
endoglin
ISO IEP
kidney protein:decreased expression:lung (rat)
RGD
PMID:23022174 PMID:22151990
RGD:7248771 , RGD:7257525
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Fas
Fas cell surface death receptor
IEP
mRNA:increased expression:testis (rat)
RGD
PMID:9927315
RGD:8662886
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP ISO
protein:increased expression:white matter of spinal cord (rat) CTD Direct Evidence: therapeutic
CTD RGD
PMID:23065176 PMID:15161688
RGD:9068912
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IMP
RGD
PMID:22247972
RGD:10755582
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf2
insulin-like growth factor 2
IEP
mRNA:increased expression:brain
RGD
PMID:11213353
RGD:5509971
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Il10
interleukin 10
treatment
IDA IEP
protein:increased expression:plasma
RGD
PMID:23788042 PMID:23968122
RGD:7365012 , RGD:11049496
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Lcn2
lipocalin 2
IEP
mRNA,protein:increased expression:liver, heart, kidney,spleen, serum,
RGD
PMID:23331620
RGD:126790570
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mir122
microRNA 122
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32422326
NCBI chr18:58,758,703...58,758,787
G
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20726721
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Pcna
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21931560
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IEP
mRNA:altered expression:jejunum, duodenum, ileum (rat)
RGD
PMID:22227376
RGD:6767294
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IEP
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11121210 PMID:20726721
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Agps
alkylglycerone phosphate synthase
IDA
RGD
PMID:7407223
RGD:1598794
NCBI chr 3:60,747,323...60,845,831
Ensembl chr 3:60,747,323...60,845,830
G
Alb
albumin
ISO
mRNA,protein:decreased expression:liver,serum:
RGD
PMID:1900492
RGD:11035284
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9743294
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:2119881
RGD:10755752
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Kras
KRAS proto-oncogene, GTPase
IAGP
A to T transversion; Gln to His substitution
RGD
PMID:11295286
RGD:1598680
NCBI chr 4:178,185,418...178,218,484
G
Nras
NRAS proto-oncogene, GTPase
IAGP
DNA:transversion:exon p.Q61L (human)
RGD
PMID:11295286
RGD:1598680
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Slc6a14
solute carrier family 6 member 14
IEP
mRNA, protein:increased expression:brush border epithelial cell
RGD
PMID:17006743
RGD:1625275
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Agap2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
ISO
RGD
PMID:21925531
RGD:13838850
NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:23994218
RGD:11561923
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Ccl5
C-C motif chemokine ligand 5
IEP
protein:increased expression:hippocampus, vasculature (rat)
RGD
PMID:20940264
RGD:4889880
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr5
C-C motif chemokine receptor 5
treatment
IMP
RGD
PMID:20940264
RGD:4889880
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Dmd
dystrophin
IEP
RGD
PMID:9539217
RGD:12880363
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Gstp1
glutathione S-transferase pi 1
treatment
IEP
RGD
PMID:22038365
RGD:10401935
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Pdyn
prodynorphin
IEP
mRNA, protein:increased expression:frontal cortex, hippocamlpus, temporal cortex
RGD
PMID:10691294
RGD:401854253
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
IEP
protein:decreased expression:dentate gyrus, hippocampus CA1, cerebral cortex (rat)
RGD
PMID:23200899
RGD:10003135
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rgs10
regulator of G-protein signaling 10
IEP
RGD
PMID:12358788
RGD:13524540
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs4
regulator of G-protein signaling 4
IEP
RGD
PMID:12358788
RGD:13524540
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs7
regulator of G-protein signaling 7
IEP
RGD
PMID:12358788
RGD:13524540
NCBI chr13:86,979,269...87,408,834
Ensembl chr13:86,979,279...87,408,888
G
Rgs8
regulator of G-protein signaling 8
IEP
RGD
PMID:12358788
RGD:13524540
NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807
G
Sv2a
synaptic vesicle glycoprotein 2a
IMP
DNA:mutation:cds:p.L174Q(rat)
RGD
PMID:27265781
RGD:12792961
NCBI chr 2:183,741,489...183,757,290
Ensembl chr 2:183,741,547...183,756,927
G
Sv2am1Kyo
synaptic vesicle glycoprotein 2a; ENU induced mutant 1, Kyo,
IMP
RGD
PMID:27265781
RGD:12792961
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
IEP
protein:increased expression:hippocampus
RGD
PMID:15730530
RGD:2303356
NCBI chr17:33,977,908...33,982,478
Ensembl chr17:33,977,921...33,982,479
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:23589102
RGD:11561955
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bmp4
bone morphogenetic protein 4
ISO
RGD
PMID:19404941
RGD:9068434
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Col1a1
collagen type I alpha 1 chain
treatment
IEP
RGD
PMID:25128628
RGD:11041187
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Ddr2
discoidin domain receptor tyrosine kinase 2
treatment
IEP
RGD
PMID:25975052
RGD:150429975
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:22833219
RGD:10402072
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
RGD
PMID:23041435
RGD:10402106
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
treatment
IMP
RGD
PMID:16394269
RGD:10402538
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Lrpap1
LDL receptor related protein associated protein 1
IEP
mRNA:decreased expression:knee
RGD
PMID:24754147
RGD:10412054
NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:23589102
RGD:11561955
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Mapk3
mitogen activated protein kinase 3
IEP
RGD
PMID:29364174
RGD:13800565
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Ncam1
neural cell adhesion molecule 1
IEP
protein:decreased expression:skeletal joint
RGD
PMID:31742919
RGD:40924673
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Serpinf1
serpin family F member 1
severity
ISO
RGD
PMID:28122611
RGD:27226703
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Ulk1
unc-51 like autophagy activating kinase 1
treatment
IEP
RGD
PMID:23589102
RGD:11561955
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Dpyd
dihydropyrimidine dehydrogenase
treatment
IMP
RGD
PMID:8138551
RGD:11251753
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all